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Marek’s disease (MD) is an oncogenic disease affecting chickens and is es-
timated to cost the worldwide poultry industry $1-2 billion annually. The
causative agent of MD, Marek’s disease virus (MDV), provides a well-
documented example of virus virulence evolution occurring over a period of
sixty years. The reason behind this evolution is unknown, although certain
untested hypotheses have been suggested. These include vaccination (with in-
creasingly potent vaccines) and other aspects of industrialisation, such as the
decreased cohort duration of successive generations and an increased stocking
density of the broiler flocks.
In this thesis, four sections of work are undertaken. First, estimation of epi-
demiological parameters is tackled: virulence of MDV is quantified by look-
ing at host mortality and virus shedding rates in vaccinated and unvacci-
nated birds. This is achieved via maximum likelihood estimation and Bayesian
McMC techniques. Second, viral fitness is quantified by defining multiple
lifetime fitness functions using the parameters previously estimated to under-
stand the direction and force of virulence selection for different farm environ-
ments. Third, the impact of an outbreak of MDV on a broiler flock is examined
by simulating a whole flock of birds. This provides an epidemiological under-
standing of the virus at the flock level and can help elucidate methods for dis-
ease control and surveillance and can also give a fitness measure to understand
on-farm evolution of the virus. Fourth, a between-farm model is analysed to
evaluate which MDV strains are able to persist in a network structure of farms
and how this might be affected by biosecurity measures, different farm net-
works, farm size, bird lifespan and vaccination. This provides insights into
how quickly a different strain can invade a farm network and the plausibility
of it becoming endemic.
Parameter estimation results show that the time to death for an infected bird
decreases and its virus shedding rate increases with previous definitions of vir-
ulence in the literature. Model results suggest that the choice of fitness mea-
sure alters the conclusions reached. Increasing the amount of demographic
structure introduced into the fitness measure shows that neither vaccine in-
troduction nor decreasing a bird’s lifespan changes the ability of more vir-
ulent virus strains to outcompete less virulent strains. In any environment,
more virulent strains are always selected for. Epidemiological results suggest
that vaccination allows a low prevalence of virus on a farm although there are
no deaths from the disease itself. Analogous results for between-farm spread
suggest that if on-farm cleaning efficiency is low enough, a high prevalence
of disease throughout a network of vaccinated flocks can exist but the farms
themselves show no signs of increased mortality from the disease.
The hypotheses for explaining the increase in virulence of MDV may not be
consistent with the results of this work. Despite previous arguments that vac-
cines are driving the evolution of virulence of MDV, this first quantitative work
on the subject demonstrates that this might not be the case. This work also for-
mulates new hypotheses to explain why MDV virulence has increased over the
past sixty years which will pave the way for ongoing research in the area of
virulence evolution in farm environments.
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This thesis is concerned with human influence on the lethality of pathogens,
and examines the extent to which observable increases in this deadliness can
be attributed to our actions. Pathogens cohabit an environment that includes
humans, livestock and wildlife. Humans have been responsible for numerous,
abrupt changes to this environment, such as the introduction of vaccines and
alterations to livestock farming practices. The survival of pathogens has re-
lied upon their ability to adapt to these changes. These adaptations can be
observed in phenotypic changes of the pathogen, for example the malignancy
of an infection.
I will study whether the changes in a farm system are able to govern the vir-
ulence of a pathogen which infects farm animals. The pathogen of interest
is Marek’s disease virus (MDV), a pathogen infecting poultry farms, which is
known to have been progressively increasing in virulence since World War II.
There are few examples of observed virulence evolution and the explana-
tions of why these changes have occurred are usually qualitative. Relying on
these descriptive reasons to explain systems often involving complicated host-
pathogen life-history interactions does not seem adequate. The evolutionary
dynamics of a system must be studied quantitatively if reliable predictions of
the direction and force of selection are to be made.
There is no shortage of mathematical analyses devoted to the theoretical exam-
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ination of virulence (Bull, 1994; Frank, 1996; Boots and Sasaki, 1999; Dieck-
mann, 2002) or the effect of vaccine treatment on its evolution (Gandon et al.,
2001, 2003). However, the flurry of activity in this field in recent years relies
on many assumptions, and indeed there is a growing body of literature con-
cerned with documenting just how sensitive the results are on the form these
assumptions take (Ganusov and Antia, 2003; Bowers et al., 2005). It is impor-
tant to take a step back to better understand how we should formulate our
models of disease transmission and exactly what we need to include about the
life history of the disease. Justification of model choice and parameter values
can only feasibly be done with good data. There is much scope for testing pre-
dictions generated by theory, and it is imperative that not only these models
use data but the models themselves are driven by data and the real phenomena
of disease processes.
One of these assumptions in the field of virulence evolution modelling is the
trade-off between virulence and transmission of a pathogen. In this introduc-
tion it will be demonstrated that there is scant evidence that this occurs. If
it does, the functional form is sometimes unclear. However, most mathemati-
cal analysis concerning virulence evolution will include this trade-off in some
form. Therefore before continuing to develop a model of a Marek’s disease
system, I develop an intuitive notion of virulence which is extended from the
experimentalists’ interpretation. This quantitative notion of virulence is then
used throughout the work to formulate measures of virulence in order to an-
swer the question, why did Marek’s disease virus evolve to be more virulent, and
did humans play a part?
In particular, the following questions are addressed:
• Can MDV strains be pathotyped according to their mortality effects?
• Can key MDV epidemiological parameters be estimated?
• What is the impact of vaccination on MDV and host mortality?
• How can fitness be defined for MDV?
• In what environment do more virulent MDV strains do better? Specifi-
cally, do vaccination, host lifespan or density of hosts affect the optimum
virulence of MDV?
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• What is the probability of an MDV outbreak on a farm and is it difficult
to implement biosecurity against MDV?
• Do MDV mutants persist and spread through a population of farms or
are they independently arising on multiple farms?
1.2 Introduction
1.2.1 Marek’s Disease
1.2.1.1 Prevalence and Economic Impact
Almost all of the industrialised countries have experienced MD losses in their
poultry industry and a crude estimate of the cost of Marek’s disease is said to
be in the range of $1-2 billion annually (Morrow and Fehler, 2004). The Food
and Agriculture Organisation (FAO) valued the 2002 worldwide poultry in-
dustry (consisting of about 45 billion broilers (birds bred for meat) and 57 mil-
lion tonnes of eggs) between $100-200 billion, giving the MD-associated dam-
age as 1% of the total value. Comprehensive reports of the situation worldwide
of MD are difficult to obtain for four reasons elucidated by Morrow and Fehler
(2004):
1. MD is not a notifiable disease.
2. Vaccination failure is accepted and small losses are viewed as normal.
3. Records of cases of MD are usually related to financial claims between
farms and hatcheries or vaccine manufacturers and are not made public.
4. Companies are not willing to reveal cases of MD as outbreaks in case of
bad publicity.
There is variation in prevalence between countries, with some suffering from
increased mortality in layers (e.g. France and Germany), while others have
problems with broilers (e.g. Italy) (Morrow and Fehler, 2004). There is also an
increased chance of losses in developing countries where lack of temperature-
controlled climates, improper vaccine storage and use of multi-age farm struc-
tures lead to a heightened risk of outbreaks (Morrow and Fehler, 2004).
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1.2.1.2 Control and Prevention
Control of Marek’s disease is predominantly via vaccination of chickens. In-
deed the MDV vaccine was the first vaccine to be developed against oncogenic
(tumour-inducing) viruses (Davison and Kaiser, 2004). The use of mass vacci-
nation strategies is common across both the developed and developing worlds,
although there is some degree of heterogeneity in the use and type of vaccine
between countries (Morrow and Fehler, 2004).
There have been four types of vaccines which have been developed for control
of MD: a HVT (Herpesvirus of turkeys) based formula, a bivalent HVT/GaHV-
3 (Gallid Herpesvirus Type 3) vaccine and two attenuated forms of MDV (the
first superceded quickly and no longer in use, the second known as CVI988 or
Rispens) (Bublot and Sharma, 2004). The three vaccines in current commercial
use are listed in increasing potency and thus increasing protection. HVT has
been used worldwide since the early 1970s, bivalent vaccines have been in
widespread use since the early 1980s and Rispens has been used outside the
US since the early 1970s, although US use only commenced at the start of the
1990s (Witter, 2001). Poultry companies have a vaccination policy for either
just layers or both broilers and layers (Morrow and Fehler, 2004). Broilers
are sometimes not vaccinated since they live for a much shorter time than the
layers and are therefore less likely to develop the disease over their lifespan.
Vaccinated hosts are still able to become infected with, and transmit, MDV.
These vaccines are therefore examples of ‘leaky vaccines’. In successful MDV
vaccination, hosts maintain the “latent” stage of infection, albeit with a re-
duced viral load, with a fully productive infection in their feather follicle ep-
ithelium (FFE), causing them to be infectious (Baigent and Davison, 2004).
Vaccination is thought to target viral replication in the cytolytic and transfor-
mative phase of infection and prevents lymphoma. It achieves this by stimulat-
ing innate, antibody and cell-mediated immunity (Davison and Kaiser, 2004).
There is a delay between vaccination and full efficacy, of between 5 and 8 days
(Okazaki and Burmester, 1971; Witter and Lee, 1984; Islam et al., 2007). In
commercial situations, it is difficult to completely reduce the risk of exposure
immediately after introduction to a layer or broiler farm. To combat this, vac-
cination in ovo is becoming commonplace in the US and is recognised as an
efficient way to reduce the chance of symptomatic MD (Witter, 2001). Vacci-
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nation does however deplete any protection given by maternal antibodies in
the vaccinated bird, although vaccine-derived antibodies will be passed down
to the offspring of vaccinated individuals.
1.2.1.3 Discovery and the Causative Agent
Marek’s disease (MD) was described a century ago by Hungarian veterinarian
Joszef Marek (Marek, 1907). It was first described as a fowl paralysis and was
not differentiated from Avian Lymphoid Leukosis until the causative agent was
found in around 1950 (Pastoret, 2004). It is now viewed as “. . . one of the most
potent oncogenic herpesvirus known” (Nair and Kung, 2004).
The causative virus, MDV, is a DNA virus and a member of the mardivirus
genus, which belongs to the subfamily Alphaherpesvirinae (other example
members are the human infections Herpes simplex virus 1 and 2). MDV was
originally described as a Gammaherpesvirus (Roizman, 1990) because its infec-
tion pathway is similar to that of other oncogenic members of the subfamily
(for example the Epstein-Barr Virus (EBV) or Kaposi’s sarcoma herpesvirus
(KSHV)) in that it maintains latency in lymphocytes, which may undergo sub-
sequent transformation (Nair and Kung, 2004). The original classification,
based on similarities between biological properties, was superceded by a more
complex system which also incorporates tissue tropism, genomic organisation
and protein comparison (Silva et al., 2001).
There are two other members of the mardivirus genus: Gallid Herpesvirus 3
(GaHV-3, also known as MDV-2) and Herpesvirus of Turkeys (HVT). These
three sole members, which all have at least one sequenced representative, are
often referred to as 𝑠𝑒𝑟𝑜𝑡𝑦𝑝𝑒𝑠, although the large variation in base compostition
and genome size suggests independent evolution and thus different species
(Osterrieder and Vautherot, 2004). However, the three viruses do share many
antigenic properties. MDV has been termed MDV-1 in the past, but in line
with observed current nomenclature (Osterrieder and Vautherot, 2004), MDV,
GaHV-3 and HVT shall be employed throughout this work. MDV is the only
member of the genus to be pathogenic in chickens.
The origin of MDV is unknown although both highly virulent MDV and non-
pathogenic serotypes have been found to occur in wild geese (Murata et al.,
2007).
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1.2.1.4 Natural History of Marek’s Disease
MDV is an airborne virus and infection occurs via inhalation (Osterrieder
et al., 2006). Other possible transmission routes have been postulated as fae-
cal/oral (Witter et al., 1968) although there has been little evidence of this
in any other experimental systems. Virus shedding occurs via infected FFE
(feather follicle epithelium) by dead stratified cells and moulted feathers (Car-
rozza et al., 1973). The resulting dust and dander can then remain in the
environment and act as a reservoir for chicken infection. Early studies on the
lifespan of the excreted virus have suggested that chickens inoculated with
200 day old infective dust can cause MD-associated lesions (Carrozza et al.,
1973). The long duration of infectivity of the virus has been attributed to the
highly cell-associated nature of the virus, with shedding occurring via kera-
tinized desquamated cells, which provide protection for the virion, although
rendering it less infectious (Baigent and Davison, 2004). Cell-free particles
shed offer a labile yet highly infectious source of transmission (Baigent and
Davison, 2004).
Chickens are the most affected of bird species, and receive the largest focus of
attention (see Sections 1.2.1.1 and 1.2.1.2). However quail can also be natu-
rally infected and there have been recent reports of outbreaks in turkey flocks
in France, Israel and Germany (Merck et al., 2005), although turkeys are nor-
mally naturally infected with HVT.
According to the ‘Cornell Model’, the infection pathway of MD, once it has
infected a chicken, is described by four stages (Biggs, 1997; Calnek and Witter,
1986; Baigent and Davison, 2004; Nair, 2005): cytolytic, latent, late cytolytic
and transformative. Once the virus has entered the lungs, it moves to the
lymphoid tissue of the spleen, thymus and bursa via macrophages. The virus
undergoes a cytolytic stage. Current literature estimates this occurs between 2-
7 days post infection (dpi) when B cells are infected and inflammation occurs.
This is followed by a so called “latent” infection of many tissues as the immune
response is triggered and T cell production is activated. This is thought to
occur between 6-7 dpi onwards. There is a resulting immunosuppression and
a period of viraemia as the T cells are attacked. This is followed by a secondary
cytolytic infection around 14-21 dpi, which affects the thymus, bursa, some
epithelial tissues (including FFE), kidney, adrenal gland and proventriculus





















































Figure 1.1: The rise in severity and variability of clinical signs after infection with
Marek’s disease virus. Diagram taken from Nair (2005) and redrawn.
CD4+ T cells, holding latent virus (although the source of these CD4+ T cells is
contested in different models (Baigent and Davison, 2004)), which eventually
results in malignant tumours. This final stage may occur weeks or months post
infection.
Both the “latent” and transformative stages are non-productive since no repli-
cation nor progeny release occur and gene expression is limited. Both cy-
tolytic phases are semi-productive since non-enveloped intranuclear particles
are produced. Fully productive infection occurs solely in the FFE, which has
been estimated to take place around 13 dpi once the virus has migrated dur-
ing latency via the peripheral blood lymphocytes Baigent and Davison (2004).
However more recent quantitative estimates have found significant quantities
of MDV in the feather tips at 7 dpi (Baigent et al., 2005).
Note that the “latent” stage in the infection pathway is defined via gene expres-
sion and immunological response. However, this differs from the epidemio-
gists’ definition of ‘latent period’, which is defined as the delay between infec-
tion and infectivity (Anderson and May, 1992; Murray, 2002; Britton, 2003).
Using this definition current estimates of the ‘latent period’ for MDV there-
fore stand around 6-7 days (Baigent et al., 2005). The latter definition will be
used throughout this thesis from Chapter 2 onwards when the epidemiology
of MDV will be focused on.
Clinical signs are varied and result in morbidity and mortality (Baigent et al.,
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2006). Onset of lymphoma-like signs have usually occur within a few weeks of
infection during the transformative stage of the infection and death in this case
can happen weeks or months after infection (Witter, 1997). However there are
a wide range of symptoms which cause death anywhere between a few days
and a month (Witter, 1997, 1999). Symptoms of MDV can include polyneuritis
(an enlargement of multiple peripheral nerves), visceral lymphoma (tumours
affecting organs such as the heart, liver, spleen etc.), acute transient paralysis
(synonomous with one leg held back, the other forward and ‘floppy-chick’ syn-
drome), immunosuppression, brain oedema and acute rash. There has been a
change in the types of clinical signs since the disease was first noted (Morrow
and Fehler, 2004) (see Figure 1.1), when chronic polyneuritis was the only sign.
Since then, the previous list has been gradually populated over the decades
(Osterrieder et al., 2006). Current common MD symptoms for many patho-
types are chronic transient paralysis (Witter, 1999) and lesions (inflammatory,
occurring in early pathogenesis in direct response to the cytolytic infection of
B cells; proliferative, occurring as lymphoma; and, degenerative occurring as
arterial atherosclerosis) (Nair and Kung, 2004).
The disease outcome is varied and is known to be affected by five factors
Baigent and Davison (2004):
1. Virus Serotype and Pathotype. All mardivirus serotypes are infectious
for, and productive in, chickens, although only MDV is pathogenic.
There are various levels of pathogenicity of MDV, which are discussed
in Section 1.2.2.2.
2. Host Genotype. The existence and severity of the disease depending
on the genotype of the host was investigated by Emara et al. (2000),
who noticed a significant correlation between host growth rate and the
development of MD paralysis in commercial birds. Genetic resistance
has been found to be both associated and non-associated with the major
histo-compatibility complex (MHC). However, all chickens are in some
way susceptible to MDV (Davison and Kaiser, 2004).
3. Maternal Antibodies. The effects of early challenge can be lessened by
inherited immunity (see also Eidson et al. (1972)).
14
4. Age of Infection. Development of a functional immune system reduces
the pathogenicity (see also Witter (1999))
5. Stress and Immunosuppression. Concurrent infections and transporta-
tion stress may impact on disease outcome. Indeed, Witter and Gimeno
(2006) suggests this may be a explanation for late outbreaks in flocks,
which have suffered some immunosuppression, allowing a delayed in-
crease in MD symptoms. Immunosuppression has been associated with
a reduction in the weight of the thymus and bursa of Fabricius, the num-
bers of circulating T lymphocytes and B lymphocytes, and titres of anti-
bodies specific to other viruses.
1.2.1.5 Genetics of MDV
MDV has a Herpesviridae genome structure, with the 180kb double stranded
DNA arranged into two unique regions (long, 𝑈𝐿 and short, 𝑈𝑆), which are
both flanked by inverted repeat regions 𝑇𝑅𝐿, 𝐼𝑅𝐿, 𝑇𝑅𝑆 and 𝐼𝑅𝑆 (Nair, 2005).
The replication of alphaherpesviruses is known to be efficient, leading to a low
nucleotide substitution rate of 3x10−8 per site per year (Sasaoka et al., 1994).
The latter is still an order of magnitude greater than the mammalian/avian
host species these viruses can infect (Shackelton and Holmes, 2004), leading to
the possibility that these viruses can evolve faster than their host species (Thiry
et al., 2005). Possible high levels of recombination within an alphaherpesvirus
genome is suggested as the major cause of variation on which selection can act
(Thiry et al., 2005).
The vast majority of the genes found in the mardivirus genus consist of open
reading frames (ORFs) that are homologous to other members of Alphaher-
pesvirinae (Osterrieder and Vautherot, 2004), but there are a number of MDV-
specific genes whose putative function has been associated with the transition
to latency and transformation, most notably Marek EcoRI-Q-encoded protein
(Meq) and the phosphorylated protein gene pp38. Meq is sometimes described
as the major oncogene (Nair and Kung, 2004) with validation from knockout
experiments performed by Anderson et al. (1998), which showed the Meq-
null mutant virus replicated well in vitro but was not oncogenic in vivo. How-
ever, there is still very little evidence of any correlation between genotype and
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Virulence Rank Year first observed Vaccine introduced
mild pre 1940
virulent 1950 HVT 1970
very virulent 1980 Bivalent 1985
very virulent+ 1990 Rispens 1995
Table 1.1: Emergence of more virulent strains of MDV and associated vaccine
introductions.
pathotype despite efforts to that effect (Osterrieder and Vautherot, 2004).
1.2.2 Marek’s Disease: the Evolution of Virulence
1.2.2.1 Trend of Increased Virulence
Marek’s disease provides an example of a trend of increased virulence in virus
strains (Witter, 1997) (for a detailed discussion of the definitions of this con-
cept, please refer to Section 1.2.2.2). This evolution has been documented
since the 1950s (Osterrieder et al., 2006) (see Table 1.1) and is of interest and
concern to the poultry industry, poultry experts and evolutionary biologists
alike. The evidence for this shift in virulence has been recognised due to in-
creased chicken losses and the ensuing need for better vaccines to quell this
rise (Nair, 2005). However, actual data from sampled strains and pathotyping
have proved a less than robust method of assessing the rise in virulence, due to
small sample sets from pre-1990s strains and continued bias in isolate samples
(Witter, 1997).
The most-cited theory to explain this trend has been the ‘vaccination hypoth-
esis’, whereby pathogen evolutionary pressures are directly dictated by the
presence of a vaccine in the environment. The sudden, pronounced rises in
poultry losses are synonomous with ‘vaccine breaks’, whereby one or more
parasite genotypes become resistant to the current vaccine and the greater fit-
ness of these genotypes allows subsequent invasion of an area (Witter, 2001).
However, the first vaccine was developed as a consequence of increased mor-
tality in the poultry industry, and so this first wave of evolution requires an
alternative explanation. The initial rise in observed virulence (empirically
judged by the case mortality due to the MD per farm or area) has since been
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attributed to the emerging industrialisation of commercial poultry holdings
(Nair, 2005), with the availability of comparatively huge farms being an ideal
environment for the invasion of more virulent strains of a virus.
Other hypotheses exist for the continued virulence evolution which include:
‘resistant chicken’ (better housing and nutrition have led to increased resis-
tance to MD, thereby producing a selective pressure for more virulent strains
which can thrive in a resistant host, although there is little evidence for direct
selection of MDV-resistant chickens), ‘homogeneous chicken’ (reduction in ge-
netic diversity has left the population more susceptible to disease), ‘broiler
lifespan’ (a halved lifespan of broilers from around 70 days fifty years ago has
allowed more virulent strains to proliferate since there is no incentive for a
virus to keep its host alive if the host’s lifespan is very short), ‘chicken density’
(larger farms have lead to greater virulence since there is less of a disadvan-
tage in killing a host if there are other hosts to infect). They are all consistent
with the established evolutionary biology theory, which is elaborated in Sec-
tion 1.2.3.1. This thesis will only be examining the hypotheses concerned with
broiler lifespan, host density and vaccination, due to the limited data available
on the host genotype over the past half century.
1.2.2.2 Definition of Virulence
Definitions of virulence are numerous and the precise view depends on the
perspective of the researcher. Microbiologists equate virulence with the no-
tions of both infectivity and severity of disease; whereas, evolutionary bi-
ologists add a third component, that being evolutionary fitness (either the
pathogen’s or the host’s) (Read, 1994). Zoologists tend to focus on host fitness
(e.g. Levin and Pimentel, 1981; Anderson and May, 1982) with most math-
ematical models describing this specifically as host mortality (e.g. Anderson
and May, 1992; Tompkins et al., 2002).
The effect of MD on chickens has been described above and an infecting MDV
strain determines incubation period (time from infection to clinical signs) (Os-
terrieder et al., 2006), time to death (Witter, 1999) and severity of clinical signs
(Witter, 1997) within a host.
There have been various attempts at defining MDV virulence and subsequent
pathotyping of strains (e.g Witter, 1997; Witter et al., 2005). It is normally
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measured by a strain’s propensity to induce lymphoproliferative lesions in vac-
cinated chickens (Witter et al., 2005). In the pathotyping study done by Witter
et al. (2005), Virulence Rank measured the average percentage of individuals
displaying gross lesions or dying over an eight week period in two groups of
chickens, one vaccinated with HVT, the other with Bivalent vaccine.
Currently there are four recognised groups of virulence, each containing part
of the ‘continuum of virulence’ (lying between Virulence Rank 0-100%) (Wit-
ter, 1997), known as: mild, m; virulent, v; very virulent, vv; very virulent plus,
vv+. The definition of virulence of MDV is in vaccinated hosts, which is in
contrast to evolutionary biologists’ accepted definition involving naı̈ve hosts.
With the former approach, vaccine-induced virulence evolution becomes self
defining and is more akin to the notion of drug resistance.
There have been studies to associate Virulence Rank with various host infec-
tion outcomes. There is a significant association between density of gross vis-
ceral lesions with different vaccines and Virulence Rank (Witter, 1999). The
time-to-lesion production is not significantly correlated with Virulence Rank
(Witter, 1999). There have been efforts to find other correlates with virulence
of MDV isolates, most notably with viral load. This has been achieved by cell
culture techniques (e.g. Calnek and Witter, 1986) and by quantitative PCR
methods (Bumstead et al., 1997; Burgess and Davison, 1999; Reddy et al.,
2000; Baigent et al., 2005; Yunis et al., 2004; Islam et al., 2006). However,
the relationship between virus load (or replication) and Virulence Rank has
not been convincingly tested (Witter et al., 2005).
1.2.3 Evolution of Virulence
1.2.3.1 Theory, Models and the ‘Trade-Off’ Hypothesis
The notion of virulence evolution has been established as an important fac-
tor in the understanding of infectious diseases. It was not, however, until the
end of the C20th when a paradigm shift exposed a new way with which bi-
ologists could understand the concept (Ewald and de Leo, 2002). Previous
appreciation of the idea of virulence centred around recognising the necessary
evolutionary end-point of a pathogen as ultimately benign. This was termed
the classical Panglossian view (Sigmund et al., 2002) and has now been su-
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perceded by a thesis allowing virulence to evolve to any point on a pathogen’s
virulence spectrum (Ebert, 1999).
Central to this current theory is both empirical (e.g. Ewald, 1983, 1991,
1994) and theoretical (e.g. Anderson and May, 1981, 1982; Frank, 1996) re-
sults. Mathematical models, often coupled with an epidemiological frame-
work (such as the SIR model), have been employed to describe the often com-
plicated behaviour afforded by particular host/pathogen systems (e.g Levin
and Pimentel, 1981). However Ganusov and Antia (2003) show that the pre-
cise details of the epidemiology of the pathogen, such as host pathogenesis and
mechanisms of transmission, have a crucial role to play in predicting the evo-
lutionary outcome of virulence of a particular pathogen. The authors conclude
that simple models are not robust in their assertions and more complicated
models incorporating the biology of host-pathogen interaction are required.
The current understanding of virulence evolution is based on theoretical
frameworks, often themselves not mutually exclusive. These have been re-
viewed by many authors (e.g. Bull, 1994; Read, 1994; Frank, 1996; Ebert, 1999;
Galvani, 2003) and include:
1. Maximisation of Parasite Fitness
a) Transmission is directly increased by a particular feature of virulence
(e.g. the induction of cold symptoms in the host by rhinoviruses causing
increased likelihood of transmission between contacts).
b) Virulence maximises transmission (the ‘Trade-Off Hypothesis’)
whereby virulence will always decrease parasite fitness in the long term
since it harms its host, but is necessary to increase transmission. The
result is a trade-off for optimum lifetime fitness. This is often seen
as a central axiom of virulence evolution and has been formulated by
mathematical models, probably due to both the relative ease of inclusion
computationally and explanation biologically. A pathogen’s transmis-
sion and virulence capabilities are commonly modelled by a trade-off
relationship (Day, 2002; Fenner et al., 1956; Frank, 1996; Gandon et al.,
2001; Ganusov and Antia, 2003). There have been an number of em-
pirical results suggesting that this functional form may be a reasonable
assumption (Anderson and May, 1982; Lipsitch, 1997; Mackinnon and
Read, 1999; de Roode et al., 2008) for such pathogen infections as Myx-
oma in rabbits (Dwyer et al., 1990), Malaria in mice (Mackinnon and
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Read, 1999), Malaria in chickens (Paul et al., 2004), Pasteuria ramosa in
Daphnia magna (Jensen et al., 2006), HIV in humans (Fraser et al., 2007)
and Ophryocystis elecktroscirrha in monarch butterflies (de Roode et al.,
2008) however there is also evidence that a trade-off may not exist for
other systems such as ranavirus infection in salamanders (Brunner and
Collins, 2009). This is a key assumption for evolutionary biology theory
but there is scant evidence for it in practice.
2. Maximisation of Host Fitness
Hosts’ response (or failure to respond) causes the observed virulence
(e.g. it may be better to tolerate a small worm burden, say in the
case of a nematode infection of a host within an endemic area, than to
expel it by costly physiological means suggested by Behnke et al. (1992)).
3. Coincidental Selection
Movement of parasites to a new host species or tissues produces a more
virulent response. Any virulence is therefore a dispersive phenomenon
and not adaptive. An example of this has been postulated by Levin
and Eden (1990), who suggest that E. coli genes that code for bacterial
organelles that bind to host cells are selected for in other regions of the
body (e.g. in the gastrointestinal tract, where they do not cause disease)
and selected against in some regions of the body (e.g. in the urinary
tract, where the inflammatory response causes excretion of the parasite)
(Read, 1994). Any virulence observed would therefore arise due to
relocation from the gastrointestinal to the urinary tract.
4. Short Term Selection
Local within-host growth allows persistence of mutants, even though
transmission is depleted partially or completely by the virulence. An
example of this may be infection of the central nervous system by a
parasite strain. While serving the pathogen well in the short term,
subsequent transmission may be compromised due to difficulty exiting
the host (HIV, polio and bacterial meningitis have been postulated as
examples of this phenomenon by Bull (1994) and Levin and Bull (1994)).
5. Coevolution
The continued evolution of both parties and the genetic diversity of
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the hosts both act as determinants of the virulence expressed by the
parasites and experienced by the hosts. The best example of this has
been the introduction of the myxoma virus into Australia, which is
discussed in Section 1.2.3.2.
In the context of Marek’s disease, all but the ‘homogeneous chicken’ hypoth-
esis are examples of the ‘Trade-Off Hypothesis’. The ‘homogeneous chicken’
hypothesis is an example of virulence change through a shift in the host geno-
type.
1.2.3.2 Documented Examples of Virulence Evolution
There are relatively few naturally occurring examples of empirical evidence of
virulence evolution to support the vast theoretical literature in any rigorous
way (Bull, 1994). Nevertheless there are a few important examples outlined
below:
Myxoma
The story of the introduction of the myxoma virus into Australia in the 1950s
to control the rabbit population, centres around the coevolution of the host
and pathogen population. Mortality in the rabbits reached 99.8% during the
early stages of the epidemic. Less virulent strains were then isolated in the
population, which might have been attributable to the scarcity of mosquitoes,
which act as vectors, during the winter months, whereby transmission rates
are increased if host mortality is reduced (Ewald and de Leo, 2002). Strains
have been isolated over the last 50 years and given a virulence rank (I-VI)
based on the clinical survival time (short to long respectively) of inoculated
rabbits. Grade III predominated after the initial reduction of mortality rates
to around 90% of infected rabbits (de Leo et al., 2002). Data have suggested
that selection for resistant hosts has occurred, which has been followed by
an increase in the virulence of the pathogen, leading to an observable stable
state (Fenner and Fantini, 1999). The continuous adaptation of a system like




Failure of vaccines protecting against IBD have been noted throughout indus-
trialised farming countries since the mid 1980s. These new strains can cause
up to 60% mortality in unvaccinated birds (Read and Mackinnon, 2008). In-
terestingly the more virulent strains in Europe differ from those across the
Atlantic, with the former harbouring more virulent ancestral forms of IBDV
compared with the US, where novel antigenic strains have emerged (van den
Berg, 2000). This is a case where evolution of increased virulence has emerged
via two independent causes. The resulting increased mortality is, however, the
same.
1.2.3.3 Vaccination and Evolutionary Pressure
There are various host-pathogen systems in which a vaccine program has
been put in place to reduce the effects of disease and a resulting increase
in virulence has been detected (Read and Mackinnon, 2008). These include
bacteria (Pertussis, Pneumococcal disease, Diphtheria); RNA viruses (avian
Influenza), and DNA viruses (Hepatitis B, Infectious Bursal disease, Marek’s
disease). The question of why we have not seen more vaccine escape mutants
has been addressed by Read and Mackinnon (2008) who suggest two pos-
sible reasons: (1) the cases where vaccines have been successful have been
predominantly acute childhood infections which might be easier to eradicate
than both the chronic diseases, such as sleeping sickness, HIV, malaria etc. or
the diseases where reinfection of hosts by a multitude of strains is common,
such as influenza, pneumococcal disease, malaria etc., (2) it might be too
soon in the evolutionary timescale to understand the true ramifications of
vaccination thus far, indeed it might take decades for a very rare mutant to
become established in a population.
1.2.3.4 Quantifying Virulence Evolution
The theoretical approach to analyse the evolution of virulence centres around
the concept of an Evolutionary Stable Strategy (ESS), first formalised by Smith
and Price (1973). This has been calculated via maximisation techniques (in
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particular 𝑅0 (the number of infected individuals arising from a single infected
individual in an otherwise fully susceptible population) maximisation, known
as the ‘Game Theoretic’ approach), Adaptive Dynamics and methods similar to
those used in quantitative genetics and population genetics theory. The most
useful technique will be governed by the evolutionary and epidemiological
properties of the system. By assessing a general epidemiological model, Dieck-
mann (2002) explain how the the Game Theoretic and Adaptive Dynamics ap-
proaches are equivalent whenever one of the following is true: epidemiogical
rates don’t depend on host density, the host population size either stays con-
stant or changes only due to infection.
In the theory, mathematical models have often focussed on the factors govern-
ing the evolution of virulence which may provide scope for contributions to
human and animal welfare (Bull, 1994). Ewald and de Leo (2002) discuss the
implications of mobility of the parasite and host as potential determinants of
virulence and Gandon et al. (2001, 2003) study the evolutionary implications
of imperfect vaccines (in the sense they do not provide a complete block for ini-
tial infection and/or subsequent transmission of the parasite) in the context of
an epidemiological framework. In both these latter papers, the authors equate
virulence with parasite-induced mortality rate and increased host exploita-
tion, which is also associated with increased transmission of the parasite (a re-
lationship which has been suggested by some empirical systems (e.g. Lipsitch,
1997; Mackinnon and Read, 1999)). The studies found that targeting vaccina-
tion on different parasite life-cycle stages led to qualitatively distinct evolu-
tionary consequences. Using 𝑅0 maximisation methods, vaccinations working
to decrease infection or transmission, in general, selected for less virulent par-
asites, whilst those decreasing within-host exploitation or levels of toxicity se-
lected for more virulent parasites. Epidemiological feedback enabled systems
to be bistable (one high, one low virulence state), with the evolutionary stable
outcome determined by initial conditions.
Another important aspect of modelling virulence is understanding different
definitions of virulence. Although virulence can correspond to any reduction
in fitness of the host, such as loss of fecundity or movement, it is usually associ-
ated with death rate of the host. Day (2002) highlights the difference between
four different definitions of virulence as host mortality:
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• Parasite-induced instantaneous mortality rate
The standard form of denoting virulence in mathematical models, e.g.
infected host death rate.
• Case mortality
The most popular non-mathematical notion of virulence, seen as the
likelihood of death given infection.
• Expected lifespan
Corresponding to the lifespan of an infected individual, given that it dies
from the disease.
• Lethal dose
Used as a measure in empirical studies and defines the size of the parasite
inoculum required to produce a specific % case mortality.
Using a simple deterministic SI model with both disease-mortality and par-
asite clearance (although the results are true for a model where there is no
recovery), the oft-tested result that virulence should evolve to be higher with
increasing background mortality rate, is shown to be dependent on the defi-
nition of virulence: it is true for an instantaneous mortality rate (since this is
the standard definition for theoretical models) but false for a case-mortality
definition (with a decrease in the virulence level). Day (2002) recognises the
fact that host death rate does not capture the full extent to which the parasite
induces host mortality, since a high case mortality might be achieved by a rel-
atively low host death rate in the case of a small clearance rate or background
mortality rate.
1.2.4 Modelling Infectious Diseases: Relevant Sources
Predominantly, the published mathematical models of infectious diseases in
chickens concern Highly Pathogenic Avian Influenza (HPAI). Currently these
divide between ‘on farm’ epidemiological analyses (e.g. the effect of vaccina-
tion strategies on H5N1 (Savill et al., 2006)) and ‘area wide’ network mod-
els (e.g. parameterised for the H7N7 2003 Dutch outbreak (Le Menach et al.,
2006)). These two models exemplify two approaches of models: ‘what if’ and
data-fitting respectively. Savill et al. (2006) use past studies to estimate the re-
quired parameters (and then conduct sensitivity analyses around these values)
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to predict the dynamics arising from different culling and vaccination strate-
gies. Le Menach et al. (2006) fit their model to actual epidemic data via max-
imum likelihood methods to achieve an accurate representation of the spread
during an epidemic.
There are also publications concerned with the estimation of 𝑅0 via statistical
methods for different pathotypes of AI (e.g. van der Goot et al., 2003a,b) and
host vaccination status (e.g. van der Goot et al., 2005).
Klinkenberg and Heesterbeek (2005) have produced a discrete time epidemic
model of within-host dynamics of Eimeria spp. in chickens.
Modelling of the combined evolution and epidemiology of a system has been
explored previously by Gandon et al. (2001, 2003) as described above, which
gives a parameterised framework for malaria transmission. Grenfell et al.
(2004) also couple epidemiological dynamics, immunodynamics and evolu-
tionary biology to build a framework for understanding RNA viruses of verte-
brates.
Current mathematical models for evolution and epidemiology usually employ
continuous dynamics (Tompkins et al., 2002; Swinton et al., 2002), while those
for livestock do not tend to impose a strong cohort structure for on-farm dy-
namics (modelling instead the spread through one farm over the course of one
cohort (Savill et al., 2006) or the spread through a network over time with
a continuous transmission kernel (Truscott et al., 2007)). However, Klinken-
berg and Heesterbeek (2007) extended their previous model (Klinkenberg and
Heesterbeek, 2005) to include a cohort structure within the model and allow-
ing multiple cohorts through time. The results explore the epidemiology of
coccidiosis with varying levels of hygiene between the cohorts. This seems
to be the only published example of an explicitly modelled multiple cohort
system.
1.3 Thesis Plan
The overarching theme of this work concerns understanding the factors which
influence pathogen virulence evolution; and how man-made changes have
influenced the scale and rate of this evolution. In particular, the work is
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concerned with combining the aspects of the epidemiology and ecology of a
pathogen, its host demography and its external environment with the theoret-
ical framework ubiquitous to virulence evolution literature. Specifically, the
work here focuses on explaining past trends of virus evolution towards greater
virulence, seen in the case of Marek’s disease virus, a pathogen naturally in-
fecting chickens.
Chapter 2 investigates the epidemiologically important parameters for de-
scribing Marek’s disease virus as it spreads throughout a population. The
parameters of interest are formally estimated via statistical methods from ex-
perimental data. From this analysis I propose a new definition of virulence
for Marek’s disease requiring only mortality effects in unvaccinated birds,
which suggests a possible trade-off between virulence and transmissibility of
the virus.
Chapter 3 examines the evolutionary fitness of strains within the specific de-
mography of a farm of broiler birds. Key measures used in evolutionary life-
history and epidemiological theory, which are used to imply selection direc-
tion, are calculated for this system. I will argue that the host population struc-
ture might render these traditional methods suboptimal at explaining the se-
lection encountered by the pathogen.
Chapter 4 explores the effect of MDV exposure on a broiler flock and assesses
the extent to which the quantity of virus existing after an outbreak can deter-
mine the selection force and direction on the virulence of virus strains.
Chapter 5 considers a group of interconnected farms to understand how
Marek’s disease virus can persist in a network of host farms. This work can
shed light on whether new occurrences of more virulent strains are very rare,
but spread quickly, or whether many new strains are constantly introduced
into the farm population.
Chapter 6 discusses the main conclusions of the previous four chapters, and
merges their evidence to determine the most plausible answers to the ques-
tions posed in this introduction. It contains an interpretation of where this
thesis sits in relation to other studies done and its potential for directing fu-
ture work on the topic.
Together these chapters will provide the first quantitative assessment of how
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this economically important worldwide disease has persisted and thrived in
the face of sustained and adaptive interventions. The work uses and extends
epidemiological and evolutionary frameworks to both explain the causes of
historical change in Marek’s disease virus virulence and to highlight potential
future problems. This approach, I hope, will light the way for future work,
both experimentally, theoretically and in the field, so we might test the pre-
dictions made herein and further understand the implications of our farming
system on its virus denizens.
1.3.1 Notation
In each chapter, where appropriate, the abbreviations, mathematical notation
and formulae are given in a glossary at the end of each Methods section. For






In this chapter, fundamental parameters relating to the epidemiology of MDV
are estimated using mathematical methods. These parameters will be used in
later chapters as the evolution and epidemiology of MDV is explored further.
However, many of these parameters have not been formally estimated, to the
best of my knowledge, and their values are important in their own right in
explaining the character of an important poultry disease.
Outbreaks of MDV are very damaging to the farming industry and effective
control methods are required to limit the impact of the disease. Successful
control strategies for MDV require an understanding of the epidemiology of
the disease, which this chapter explores.
There will be four groups of parameters to estimate; those concerned with
• dust production by a bird;
• viral shedding capabilities;
• mortality of infected individuals;
• transmission of the virus to susceptible individuals.




The aim of this analysis is to characterise the dust shedding profiles for layer
birds. The results will be used later in this chapter.
2.1.2 Viral Shedding
Viral shedding rate is defined in this chapter as the viral copy number (VCN)
per 𝑚𝑔 of dust shed by a single infected bird over the infectious period. This
section estimates the quantity of virus material shed by an infected bird and
also when this viral shedding begins (i.e. the latent period of the infection).
Both these parameters are estimated for birds infected with different strains of
MDV and vaccinated with different vaccines.
Estimation of viral production in the dust is important epidemiologically since
MDV transmits via the inhalation of infected dust and quantifying the virus
in the dust enables the estimation of the transmission potential.
2.1.3 Host Mortality
Trying to quantify the impact of a disease on a host is a difficult matter. The
concept of ‘virulence’ can evoke different meanings depending on your organ-
ism viewpoint (host or parasite). In this work it must be clear what virulence
means. Therefore a short discussion is presented in the context of host mortal-
ity in Box 2.1.
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Box 2.1: Virulence Definitions
Definitions of virulence are numerous and varied (Dieckmann, 2002).
Microbiologists equate virulence with the notions of both infectivity
and severity of disease, whereas evolutionary biologists focus on evolu-
tionary fitness (either the pathogen’s or the host’s) (Read, 1994). Zoolo-
gists tend to focus on host fitness (e.g. Levin and Pimentel, 1981) with
most mathematical models describing this specifically as host mortal-
ity (e.g. Anderson and May, 1982; Tompkins et al., 2002). There have
been various attempts at virulence definitions in the context of MDV
and pathotyping of strains (e.g Witter, 1997; Witter et al., 2005). It is
normally measured by a strain’s propensity to induce lymphoprolifer-
ative lesions in vaccinated chickens (Witter et al., 2005). In the patho-
typing study done by Witter et al. (2005), a higher Virulence Rank was
attributed to strains inducing a more severe clinical response (mea-
sured as the proportion of individuals displaying gross lesions in a
group of chickens) in a combination of HVT and Bivalent vaccinated
chickens. Currently there are four recognised MDV pathotypes, each
occupying part of the ‘continuum of virulence’ (Witter, 1997), known
as: mild, m; virulent, v; very virulent, vv; very virulent plus, vv+.
Thus, the definitions of virulence associated with MDV have mostly
been measured in vaccinated hosts. I am unaware of any attempt to di-
rectly test for an association between Virulence Rank and host mortal-
ity rate in unvaccinated chickens. The data collected by Witter (1997)
and Witter et al. (2005) only report the total clinical signs and death
within a given period, making it difficult to assess the disease-induced
mortality by itself.
From an evolutionary standpoint, usually the most important aspect of vir-
ulence is its effect on host mortality. There are of course examples where
this is not true (for example, there is pathogenicity by non-lethal morbidity
in the case of the common cold; sterlising effects, both physical in the case of
Chlamydia and through changes in host behaviour, such as certain HPV infec-
tions). Yet for the industrial chicken system, where dead chickens are removed
from the population at regular intervals and movement of broiler chickens is
restricted, focusing on a measure of mortality as a measure of virulence seems
sensible, especially since dead chickens do not continue to transmit the virus.
Therefore, the parameter estimation work is based on a definition of virulence
of MDV in terms of host mortality alone.
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2.1.4 Transmission
In most MDV-related experimental work, transmission usually occurs via in-
sufflation (Baaten et al., 2004) or subcutaneous injection (Sharma, 1984). How-
ever, the natural route for infection is by inhalation of virus-contaminated dust
(Carrozza et al., 1973). To understand the consequences of viral shedding in
a flock, it is vital to understand the role of natural transmission and suscep-
tibility to infection. The aim is to quantify the daily transmission rates to
susceptible birds, who are either unvaccinated or HVT-vaccinated. Vaccinated
hosts are still able to become infected with MDV. However, an assumption in
the literature is that vaccination protects against clinical signs of the disease,
not infection (Nair, 2005), but this is largely an untested assumption and the




In an experiment conducted and described by Renz (2008), groups of layer
chickens were raised from an age of one day in isolators (a raised glass box
housing a group of birds, which allows air flow to be regulated via an exhaust
and air filter). All the dust from each isolator and its exhaust was retrieved
every 24 or 48 hours. With knowledge of the number of chickens per isolator
each day and the total dust, the total mass of dust shed per day per bird was
found for weeks 1-8, giving a total of 8 data points per isolator with confidence
intervals, from repeated sampling.
2.2.2 Virus Shedding and Host Mortality
The analysis looks at a single experiment conducted by Renz (2008) with two
response variables measured. Groups of maternal antibody positive Rhode
Island Red layer chickens were inoculated at one day old with one of three
vaccine treatments: sham (saline solution), HVT (first generation industry vac-
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cine) or Bivalent (second generation industry vaccine). At 5 days post vaccina-
tion (dpv), they were challenged (via injection) with one of three MDV strains:
04CRE, MPF57 and 02LAR. The experiment was therefore a 3x3 factorial de-
sign study, with vaccine type fully cross-factored against virus strain (i.e. for
each vaccine strain used there was a different virus isolate). There were either
26 or 27 birds in each group treated with the same virus-vaccine combination
and each group was housed in a separate isolator. The air in each isolator was
changed 8-20 times per hour. The whole experiment was replicated once to
give a total of 484 birds.
Due to regulatory requirements, birds who were thought to be nearing death
were removed from the isolator. The experiment lasted 56 days post infection
(dpi) and many of the birds were recorded as dying on the last day. Therefore
for the purposes of this analysis, the data were censored after day 55. All
birds were given a large dose of MDV isolate (500 pfu) via injection and it was
therefore assumed that all the birds were infected and would shed the virus.
The two variables recorded were the time to death of a bird (measured in days)
and the density of virus within each isolator every week (measured in VCN per
𝑚𝑔 of dust in the environment). The virus titres in the dust were determined
via PCR of dust in the isolator air filters.
The independently sampled isolates were Australian in origin and had been
pathotyped at Virulence Ranks of 16.5, 36 and 46 respectively (Walkden-
Brown et al., 2008) as shown in Table 2.1 according to the scheme developed
by Witter (1997) and Witter et al. (2005). In the last chapter, the metric ‘Vir-
ulence Rank’ for a strain of MDV was defined and discussed. To recapitulate,
Virulence Rank was defined by Witter (1997) to be the average percentage of
birds who either died or developed gross clinical signs during a time period
of 56 days. The average was taken with respect to two groups of birds - one
vaccinated with HVT, the other with the Bivalent vaccine. In the terminology
used by Witter, this leads to classifying 04CRE and MPF57 as v and 02LAR as
vv.
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Vaccine Treatment Virulence Rank
Sham HVT Bivalent (mean HVT/Bivalent)
04CRE 59 20 13 16.5
MPF57 69 43 29 36
02LAR 84 61 31 46
Table 2.1: Pathotyping of Australian Isolates: The percentage of infected birds who
either died or showed gross clinical signs within 56 days of inoculation with one of
the strain-vaccine combinations. The number of birds in each of the nine groups was
between 22 and 27. The mean value of the % clinical signs and death of the two
vaccinated groups was used to find the Virulence Rank, as defined by Witter (1997).
2.2.3 Transmission
The data on infection of susceptible birds were collected by Islam et al. (2008).
There were 10 identical floor pens with woodshavings, housing 60-72 infected
chicks in each. In each pen, at 21 dpi, 40 day old sentinel chicks (20 HVT-
vaccinated, 20 unvaccinated) were placed in a netted corner of the pen. 21 dpi
corresponds to 0 days post exposure (dpe). 5 unvaccinated and 5 vaccinated
sentinel chicks were removed at 5, 10, 15 and 20 dpe unless otherwise stated.
Their spleens were assayed for detection of MDV via PCR techniques. The dust
content of each of the pens was measured at regular intervals and calculated
in 𝑚𝑔/𝑚3) along with a quantification of MDV via quantitative PCR (qPCR),
so that the VCN per 𝑚3 was calculated for each pen at regular intervals.
2.3 Methods
For all the groups of data given in Section 2.2, parameters were estimated
which provided:
• daily dust shedding for layer birds;
• latent period (the time until an infected bird becomes infectious);
• viral shedding rate (VCN/𝑚𝑔 dust);
• host lifespan for an MDV infected host (without any other mortality);
• daily probability of transmission to a susceptible individual.
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All statistical tests were completed in R-2.6.2 (R Development Core Team,
2005) unless otherwise stated and all graphs were plotted in Matlab® (2007)
2.3.1 Dust Shedding
A cubic spline method is used, fitting three splines (one to the central estimate,
one to both the lower and upper confidence estimates). Matlab® (2007) was
used for this computation.
2.3.2 Viral Shedding
Latent period and rate of viral shedding cannot be estimated directly from
the data since the response variable (measured weekly in VCN per 𝑚𝑔 dust)
could vary with the number of birds housed together, which varies as birds die.
Therefore a discrete time dynamic model capturing this variability was used to
estimate the two infectiousness parameters. These parameters were estimated
for different virus strains infecting birds vaccinated with one of three vaccine
treatments.
To model the viral shedding of MDV from a dataset, there are several assump-
tions:
1. After MDV infection, there is a delay before virus is first shed (Baigent
and Davison, 2004). This latent period is assumed to be constant across
all the birds in a single isolator, but could vary between isolators.
2. Once shedding has begun, the rate of shedding (measured in VCN per
𝑚𝑔 of dust) is constant over the duration of the experiment and is the
same for all birds within an isolator, but could vary between isolators.
Not much is known about the viral shedding rates of infected birds, but
this is the most parsimonious model to start with and there is evidence
from the data that the density of MDV in the dust plateaus (indeed if this
is true, the true asymptote should be the constant rate of viral shedding).
3. The density of virus (VCN per 𝑚𝑔 dust) is calculated at the end of each
day and any removal of birds is assumed to occur at the start of the day.
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There are therefore two parameters estimated per isolator: latent period (in
days) (i.e. the time elasped before viral shedding occurs after infection) and
rate of shedding (VCN/𝑚𝑔 dust). A discrete time dynamic model was set up
accounting for the removal of birds at the start of days given in the mortality
data.
The latent period is denoted by 𝑇𝑠. Birds will then shed virus from 𝑇𝑠+1 at a
constant rate, 𝑎 (VCN per mg dust), for the remaining time of the experiment.
The density of MDV in the dynamic model can be compared to the amount of
virus recorded in the data (sampled every 7 days). Modelling all experiments,
both 𝑎(𝑣, 𝑗) and 𝑇𝑠(𝑣, 𝑗) were estimated for each Virulence Rank 𝑣 ∈ {16.5,36,46}
and each vaccine status 𝑗 ∈{sham, hvt, bivalent}.
In order to fit the model to the available data, a metric must be defined for
disparity between the model and data. MDV density in dust was only sampled
once at each time point for each isolator. This means that there is no direct way
of calculating the measurement error in a sample of dust since the replicate
isolators are themselves subject to different bird deaths at varying times in
the sampling period. The difference in MDV density between these replicates
at each time point can therefore not be taken as samples from the true error
distribution. Another method is sought.
Assuming that a final MDV density has been reached at some time before the
end of the sampling period, the sample points after that are assumed to be
replicates. Thus, assuming measurements errors are normally distributed, an
approximate estimate of error variance can be found. Let 𝑌1 and 𝑌2 be inde-
pendent measurements such that 𝑌1,𝑌2 ∼𝑁 (𝜇,𝜎2) then 𝑌1 −𝑌2 ∼𝑁 (0,2𝜎2).
To find the time point after which the data is assumed to have plateaued, sets
of consecutive points were examined: weeks 7-8, 6-8 and 5-8 (Table 2.2). The
first sample (Weeks 7-8) provides the highest probability that the Anderson-
Darling statistic is obtained from a distribution drawn from a normal distri-
bution (𝑝=0.79) given that the underlying distribution has a true mean of zero
(𝑝=0.40). The resulting estimated standard deviation is 0.33. The distribution
is displayed in Figure 2.1. The Anderson-Darling algorithm is used to test for
normality for all cases due to the small sample sizes.
This analysis gives an error distribution of the random variable, 𝑋, a random
sample of MDV density (VCN/𝑚𝑔 dust). Now, let log𝑋 = 𝑌 , then log𝑋 ∼
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k Weeks (comparison) Sample Size Norm. Test p value t test 95% CI
1 7-8 (7) 18 0.79 (-0.096, 0.23)
2 6-8 (6) 34 0.44 (-0.22, -0.034)
3 6-8 (7) 35 0.95 (0.013, 0.21)
4 6-8 (8) 35 0.36 (-0.098, 0.12)
5 5-8 (5) 53 0.69 (-0.19, -0.044)
6 5-8 (6) 51 0.90 (-0.14, -0.0019)
7 5-8 (7) 53 0.97 (0.064, 0.21)
8 5-8 (8) 53 0.50 (-0.042, 0.14)
Table 2.2: Anderson-Darling normality test results (with the null hypothesis
𝑌𝑘 ∼𝑁 (?̂?𝑘 ,𝜎𝑘)) and t test results (with the null hypothesis 𝑌𝑘 ∼𝑁 (0,𝜎𝑘) where 𝜎𝑘 is
estimated). The comparison week in brackets denotes the value to which the other
weeks (in the range) were compared.
.














Figure 2.1: Viral Shedding: Differences between virus density (logVCN per 𝑚𝑔
dust) data points within each isolator between weeks 7 and 8.
N(𝜇,𝜎2), where 𝜇 is the underlying mean given time and environment and
𝜎2=0.332/2.
Thus a distance function for mapping the data set, 𝑌 , to the model set, Θ,
is defined as the probability of the logged data point being sampled from a
normal distribution with mean defined as the logged model value at 𝑡 and
constant variance, 𝜎2 as defined above. Multiplying over all 𝑡, such that |𝑌 |=𝑛,
the likelihood is calculated. More formally:
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This can be calculated for combinations of the two parameters to create a dis-
cretised likelihood profile, which is maximised to find the maximum like-
lihood. Equivalently, the negative log-likelihood is found, which is usually
quicker and easier to calculate. For the normal distribution:








Moreover, since this is an order isomorphism of the likelihood, it is minimised
to find the maximum likelihood, by finding the maximum likelihood estimates
of 𝑎 and 𝑇𝑠 for each experiment. This is done by calculating a likelihood surface
for a complete parameter state subspace (to a certain specified level of accu-
racy, in this case 3 significant figures) since the parameters can be bounded
easily by observing the data.
Once the maximum likelihood estimates for each parameter have been found
the full realisation of the model can be plotted against the data. Credible in-
tervals are calculated by means of Markov chain Monte Carlo (McMC) real-
isations. For this, the McMC algorithm samples values from the respective
updated posterior distributions of the 2 parameters. After a burn in period,
these parameters can either be accepted or rejected according to the algorithm
rules. If accepted they enter the set of possible (repeated) values for the es-
timated parameters (Carlin and Lewis, 2008). The model output for each of
these sets of parameter values is calculated. At every time point for which we
have data, a 95% credible interval is found for the distribution of this output.
The prior distribution of each parameter was assumed to be uninformative and
were thus taken as uniform, to ensure equivalence to maximum likelihood
estimation. The burn in period was set to 20,000 iterations. Details on the
method with diagnostics and posterior distributions are given in Appendix
38
A.1.
The code for this analysis was written from scratch in 𝐶++ and compiled using
DevC++ (Busbee, 2009) .
2.3.3 Host Mortality
A survival analysis was undertaken for the mortality data because multiple
covariates need to be included to find the host lifespan. These covariates are
vaccine treatment and virus Virulence Rank.
The biology of Marek’s disease suggests that the probability of death by MDV
infection changes through time, since the virus enters a “latent” phase after
infection (note that this is not the same as the latent period of the infection,
but denotes a specific time in the infection pathway of the virus described
in Chapter 1). The lytic and transformation stages that follow are pathologi-
cally distinct and may lead to a different mortality rate. Therefore, a Weibull
distribution was chosen as a candidate distribution for modelling survivor-
ship curves, which is often used for time to death data since it is flexible and
can mimic other distributions but only has two parameters in its non-location
form. We therefore assume that time to death can be modelled as a random
variable, 𝑇 , such that 𝑇 ∼𝑊 (𝑟,𝜆) where 𝑟,𝜆 > 0 are the shape and scale param-












if 𝑡 ≥ 0
0 else
A Weibull model was fitted to all the data in the study. In the case when
𝑟=1, the distribution collapses to an exponential distribution. When 𝑟 > 1
or 𝑟 < 1 there is an increasing or decreasing chance of death respectively (see
Figure 2.2). Coefficients, 𝛽, are such that 𝜆 = exp(𝛽.x), where 𝛽 = [𝛽0,𝛽1,𝛽2,𝛽3]
are the covariate coefficients and x = [1,𝑥1,𝑥2,𝑥3]𝑇 are the covariates. In this
analysis, there are three covariates (one continuous: the arcsine square-root
transformation of the Virulence Rank of an isolate (𝑥1) and two binary: the
presence or absence of HVT (𝑥2) and Bivalent (𝑥3) vaccine). Therefore there
are 9 combinations on the set of possible covariates, thus 𝜆𝑗 = 𝛽.𝑥𝑗 where
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Figure 2.2: Host Mortality: Effect of changing the shape parameter, 𝑟, on the
Weibull survival function.
𝑗 ∈ [1,9]. The likelihood function can therefore be written
















where 𝛿𝑖 is zero when the 𝑖th observation is censored and unity elsewhere.
This function was maximised via the Newton-Raphson algorithm such that
ℒ(?̂?𝑗 , 𝑟) = maxℒ(𝜆𝑗 , 𝑟) where 𝜆𝑗 = exp(?̂?.x𝑗) and 𝑟𝑗 = 𝑟. Note that the Viru-
lence Rank, 𝑣, of an isolate is a percentage measure and to be used as an
explanatory variable in a regression analysis, it should be transformed such
that 𝑣𝑇 = arcsin
√
0.01𝑣. The regression fits the maximum likelihood estimates
for 𝛽, however further Bayesian analysis is required to estimate the associated
credible intervals when the covariate covariance matrix does not approximate
the identity matrix.
To test whether vaccine status is a possible covariate in the survival analysis,
the shape parameter, 𝑟, is fitted to the Sham vaccinated data with the covari-
ate being transformed Virulence Rank only. This is denoted as 𝑟0. Next, two
models are fitted to both the HVT and Bivalent vaccinated data: the restricted
model where 𝑟 is set to be 𝑟0 and secondly, an unrestricted model where r is
chosen to as the Maximum Likelihood Estimate (MLE), denoted by 𝑟1. The
log-likelihoods for each of these two models are denoted by 𝐿𝐿0 and 𝐿𝐿1 re-
spectively. Twice the likelihood difference follows a 𝜒2 distribution, which can
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be the basis for a statistical test where the null hypothesis states that the shape
parameter is the same for both models.
In the HVT case, 𝑟1 = 3.0864 (𝐻0: 𝑟0=𝑟1), so 𝑋2 = 2(𝐿𝐿1-𝐿𝐿0) = 2(-69.1+70) =
1.8 < 𝜒2(1)0.05 (p=0.1797). Therefore the null hypothesis is accepted. In the Bi-
valent case, the restricted model 𝑟1 = 6.4516. 𝑋2 = 2(𝐿𝐿1-𝐿𝐿0) = 2(-59.2+59.7)
= 1.0 < 𝜒2(1)0.05 (p=0.3173). Therefore the null hypothesis is accepted.
A likelihood test on the possible covariates suggests that the vaccine treatment
of a bird can be considered as a covariate and all the vaccine treated birds
(Sham, HVT and Bivalent) can be modelled together. The three vaccine groups
of data will therefore be analysed together with only one hazard function.
The prior distribution of each parameter was assumed to be uninformative and
were thus taken as uniform, to ensure equivalence to maximum likelihood
estimation. The burn in period was set to 22,000 iterations. Details on the
method with diagnostics and posterior distributions are given in Appendix
A.2.
R-2.4.2 (R Development Core Team, 2005) was used initially to find the max-
imum likelihood estimate and to fit the model using the function survreg
within the package Survival. WinBUGS 14 (Lunn et al., 2000) was used for the
McMC analysis.
2.3.4 Transmission
Daily transmission probabilities for unvaccinated and HVT vaccinated birds
were calculated independently and directly from the data via a statistical
model. Each pen was analysed separately for unvaccinated and HVT vacci-
nated birds and a maximum likelihood approach was used.
Let 𝑋 be defined as the random variable, the number of sampled individuals
who are infected. At each sample time, 𝑖 = 1,2,3,4 (corresponding to 5, 10,
15, 20 dpe respectively) birds are sampled without replacement. Therefore the
number of sampled infected individuals follows a hypergeometric distribution
(Kalbfleisch, 1985).
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𝑀𝑖 total number of infecteds in the population at time 𝑖 before sampling
𝑁𝑖 total population at time 𝑖 before sampling
𝑛𝑖 sample size at time 𝑖
Now the likelihood can be defined such that
ℒ(𝑘1, 𝑘2, 𝑘3, 𝑘4|𝑀1,𝑀2,𝑀3,𝑀4) =
4∏︁
𝑖=1
𝑃 (𝑋 = 𝑘𝑖 |𝑀𝑖)
where 𝑘𝑖 is the observed number of infected individuals in each sample at time





𝑃 (𝑋 = 𝑘𝑖 |𝑀𝑖)
Since 𝑘𝑖 , 𝑛𝑖 and 𝑁𝑖 are known, 𝑀𝑖 = ?̂?𝑖 can be calculated directly for the max-
imum likelihood estimate. There will therefore be a set of ?̂?𝑖 for each pen,
for each vaccination group. The newly infected individuals between each time
point, 𝑚𝑖 = ?̂?𝑖 can be calculated trivially, giving us the total number of infected
individuals in each group in each pen between each sample time.
Assuming the number of newly infected individuals between each time point,
𝐿𝑖 , follows a binomial distribution, with E(𝐿𝑖) = 𝑚𝑖 , 𝐿𝑖 ∼ Bin(𝑁𝑖 −
∑︀
𝑗<𝑖𝑚𝑗 +∑︀
𝑗<𝑖 𝑘𝑗 ,𝑞𝑖). The first parameter is the effective population size available to be
infected at timestep 𝑖, which is the number of unsampled individuals at time
𝑖 before sampling (𝑁 (𝑖)), minus the number of infected individuals who have




𝑗<𝑖 𝑘𝑗). The second parameter is the proba-
bility of infection between sample time 𝑖 − 1 and 𝑖. The maximum likelihood










Since 𝑞𝑖 is the probability of infection over 5 days and assuming there is an
equal chance of infection on any of the 5 days between sampling and the daily
infection per bird is 𝑝𝑖 ,
𝑞𝑖 = 1− (1− ?̂?𝑖)5
⇒ ?̂?𝑖 = 1− (1− 𝑞𝑖)1/5
The likelihood surfaces were characterised and solved in Matlab® (2007).
2.4 Results
2.4.1 Dust Shedding
An additional datapoint of 𝑑(0) = 0 is used to interpolate before the first value
to fit the cubic spline. The results are shown in Figure 2.3.






















Figure 2.3: Dust Shedding: The amount of dust shed over time by a layer chicken
(green, red and black circles are the mean, lower confidence interval and higher
confidence interval). Lines in blue are the cubic spline fits.
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2.4.2 Viral Shedding
The dynamic model output records the density of virus (measured in log VCN/
𝑚𝑔 dust). The dynamic model is fitted to the data from each isolator indepen-
dently and the model fits can be compared directly in Figures 2.4-2.6.




























(a) 𝑣 = 16.5, Replicate 1




























(b) 𝑣 = 16.5, Replicate 2




























(c) 𝑣 = 36, Replicate 1




























(d) 𝑣 = 36, Replicate 2




























(e) 𝑣 = 46, Replicate 1




























(f) 𝑣 = 46, Replicate 2
Figure 2.4: Viral Shedding: Sham vaccinated experiments. Graphs include the data
(black), the maximum likelihood realisation (red) and the 95% credible interval
(green)
For each isolator, the maximum likelihood estimate for the two parameters in
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(a) 𝑣 = 16.5, Replicate 1




























(b) 𝑣 = 16.5, Replicate 2




























(c) 𝑣 = 36, Replicate 1




























(d) 𝑣 = 36, Replicate 2




























(e) 𝑣 = 46, Replicate 1




























(f) 𝑣 = 46, Replicate 2
Figure 2.5: Viral Shedding: HVT vaccinated experiments. Graphs include the data
(black), the maximum likelihood realisation (red) and the 95% credible interval
(green).
the model (latent period and rate of viral shedding) are given in Tables 2.3-
2.4, where the dust shed function is the cubic spline fit to the means given in
Section 2.4.1. The credible intervals in all cases are calculated by the Bayesian
method as described in the Methods section. The diagnostics and posterior
distributions for the Markov chains are shown in Appendix A.1.
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(a) 𝑣 = 16.5, Replicate 1




























(b) 𝑣 = 16.5, Replicate 2




























(c) 𝑣 = 36, Replicate 1




























(d) 𝑣 = 36, Replicate 2




























(e) 𝑣 = 46, Replicate 1




























(f) 𝑣 = 46, Replicate 2
Figure 2.6: Viral Shedding: bivalent vaccinated experiments. Graphs include the
data (black), the maximum likelihood realisation (red) and the 95% credible interval
(green).
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Replicate 1 Replicate 2
𝑣 = 16.5 6.94 (6.79,7.08) 7.14 (6.99,7.29)
𝑣 = 36 7.64 (7.40,7.79) 7.85 (7.70,8.01)
𝑣 = 46 7.95 (7.80,8.11) 7.81 (7.64,7.98)
(a) log Shedding Rate, Sham
Replicate 1 Replicate 2
𝑣 = 16.5 6.71 (6.56,6.87) 6.51 (6.35,6.73)
𝑣 = 36 7.51 (7.36,7.67) 7.53 (7.37,7.69)
𝑣 = 46 7.74 (7.58,7.89) 7.40 (7.25,7.54)
(b) log Shedding Rate, HVT
Replicate 1 Replicate 2
𝑣 = 16.5 6.18 (5.93,6.32) 5.26 (5.09,5.41)
𝑣 = 36 6.91 (6.77,7.07) 7.25 (7.07,7.39)
𝑣 = 46 7.25 (7.09,7.40) 7.39 (7.25,7.65)
(c) log Shedding Rate, Bivalent
Table 2.3: Viral Shedding: maximum likelihood estimations of the logged viral
shedding rate (logVCN/𝑚𝑔 dust) for both replicates of the factorial study using mean
value of dust profile function. The 95% credible interval is calculated via McMC,
with the full posterior distributions given in Appendix A.1.
Replicate 1 Replicate 2
𝑣 = 16.5 4 (4,4) 5 (5,5)
𝑣 = 36 5 (5,5) 5 (5,5)
𝑣 = 46 5 (5,5) 5 (5,5)
(a) Latent Period, Sham
Replicate 1 Replicate 2
𝑣 = 16.5 5 (5,5) 5 (5,6)
𝑣 = 36 5 (5,5) 5 (5,5)
𝑣 = 46 5 (5,5) 4 (4,4)
(b) Latent Period, HVT
Replicate 1 Replicate 2
𝑣 = 16.5 5 (4,5) 4 (4,4)
𝑣 = 36 4 (4,4) 5 (5,5)
𝑣 = 46 5 (5,5) 4 (4,5)
(c) Latent Period, Bivalent
Table 2.4: Viral Shedding: maximum likelihood estimations of the latent period
(days) for both replicates of the factorial study using mean value of dust profile
function. The 95% credible interval is calculated via McMC, with the full posterior
distributions given in Appendix A.1.
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Using the mean dust profile fit (shown in Figure 2.3), the estimates of the two
parameters for all the experiments are shown in Table 2.3 (viral shedding rate)
and Table 2.4 (latent period). The credible intervals were calculated via McMC
and the diagnostics and posterior distributions are shown in Appendix A.1.
The variation between replicates and between treatments is very low for the
estimated latent period parameter. A linear model was fitted to try to account
for this variation, with the latent period as the response variable (Table 2.5).
None of the results are significant, showing that the latent period does not
differ among virus strains and nor is it altered by vaccination.
Df Sum Sq Mean Sq F value 𝑃 (>F)
Treatment 1 3.3e-1 1.7e-1 4.9e-1 6.3e-1
Transformed Virulence Rank 2 3.2e-1 9.3e-1 3.2e-1 3.5e-1
Interaction 2 1.2 6.2e-1 1.8 2.1e-1
Residuals 12 4.1 3.4e-1
Table 2.5: Viral Shedding: linear regression and resulting Anova model output with
interactions for latent period and effect of Virulence Rank and vaccine treatment.
Adjusted 𝑅2=0.039, 𝑝=0.39.
An association is wanted between the Virulence Rank pathotype and the es-
timated viral shedding rate. As a first approach, a linear regression was ap-
plied between the arcsine square-root transformed Virulence Rank and the
estimated rate of viral shedding. Results for this regression are in Tables 2.6a-
2.6c with the graph displayed in Figure 2.7. All the regression lines (testing
the fit between viral shedding rate as a function of Virulence Rank) for the
three vaccine treatments are significantly different from zero (𝑝=0.0068, 0.025,
0.0093 respectively).
The regression lines themselves can now be tested to find whether they are
indeed significantly different from each other. Results are displayed in Table
2.7 and show that the only gradients significantly different to each other are
Sham and Bivalent (𝑝=0.0066).
In summary, increasing the Virulence Rank of the MDV isolate increases
the viral shedding rate of the infected bird (measured in VCN per 𝑚𝑔 dust)
whereas vaccination of the bird with Bivalent vaccine reduces the viral
shedding. The latent period for all infected birds is 4-6 days.
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Estimate Std. Error 𝑡 value 𝑃 (> |𝑡|)
Intercept -7.3e+7 2.4e+7 -3.0 3.9e-2
Transformed Virulence Rank 2.0e+8 3.9e+7 5.1 6.8e-3
(a) Unvaccinated (adjusted 𝑅2=0.84)
Estimate Std. Error 𝑡 value 𝑃 (> |𝑡|)
Intercept -4.2e+7 2.0e+7 -2.1 1.0e-1
Transformed Virulence Rank 1.1e+8 3.2e+7 3.5 2.5e-2
(b) HVT (adjusted 𝑅2=0.69)
Estimate Std. Error 𝑡 value 𝑃 (> |𝑡|)
Intercept -2.5e+7 8.0e+6 -3.1 3.5e-2
Transformed Virulence Rank 6.1e+7 1.3e+7 4.7 9.3e-3
(c) Bivalent (adjusted 𝑅2=0.81)
Table 2.6: Viral Shedding: Statistics corresponding to a linear regression between
the arcsine square-root transformed Virulence Rank of an isolate and the fitted
shedding rate, 𝑎(𝑣, 𝑗), for each replicate. The three graphs correspond to the three
vaccine treatments labelled.
Estimate Std. Error t value 𝑃 (> |𝑡|)
Intercept -7.3e+7 1.9e+7 -3.9 2.1e-03
Transformed Virulence Rank 2.0e+8 3.0e+7 6.7 2.4e-05
HVT 3.1e+7 2.0e+7 1.2 2.7e-1
Bivalent 4.8e+7 2.6e+7 1.8 9.6e-2
TVR:HVT -8.9e+7 4.3e+7 -2.1 6.1e-2
TVR:Bivalent -1.4e+8 4.3e+7 -3.3 6.6e-3
(a) Comparison with Sham regression line
Estimate Std. Error t value 𝑃 (> |𝑡|)
Intercept -4.2e+7 1.5e+7 -2.8 2.5e-2
Transformed Virulence Rank 1.1e+8 2.5e+7 4.6 1.8e-3
Bivalent 1.7e+7 2.2e+7 8.0e-1 4.0e-1
TVR:Bivalent -5.2e+7 3.5e+7 -1.5 1.7e-1
(b) Comparison with HVT regression line
Table 2.7: Viral Shedding: Comparison of regression lines associating the arcsine
square-root transformed Virulence Rank of the strain to its shedding rate, 𝑎(𝑣, 𝑗).
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Figure 2.7: Viral Shedding: Linear regression analysis of the arcsine square-root
transformed Virulence Rank and the fitted shedding rate for all experiments. The
95% confidence intervals for the mean response are given by the dotted lines. All
three regression lines give significant associations (see Table 2.6). The blue, red and
green lines in (d) corresponds to unvaccinated birds, HVT vaccinated birds and
Bivalent vaccinated birds respectively.
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2.4.3 Host Mortality
A multiplicative covariate Weibull regression model was fitted to the bird sur-
vival data, but since the interaction terms were not significant, a more par-
simonious additive model was then fitted. The model estimates are given in
Table 2.8. The 𝑝 value for this Weibull model (with fixed shape parameter, 𝑟)
is 2.8e-09 with three degrees of freedom. The resulting graphs showing the
data and Weibull model fit are displayed in Figure 2.8. The model shows that
host lifespan decreases with Virulence Rank and increases with vaccination
(Figure 2.9 and Table 2.8), although there is no significant difference between
the effect of either vaccine on lifespan (Table 2.8). The effects of vaccine and
Virulence Rank on expected lifespan are seen in Figure 2.9.
Symbol Coefficient Value (95% CI) 𝑧 𝑝
𝑟 Shape Parameter 4.1 (3.3, 5.1) -12 4.2e-31
𝛽0 Intercept 4.5 (4.2, 5.0) 26 7.0e-150
𝛽1 Transformed Vir. Rank -0.53 (-1.1, -0.061) -2.0 4.1e-02
𝛽2 HVT vaccine 0.36 (0.21, 0.55) 4.0 7.8e-05
𝛽3 Bivalent vaccine 0.44 (0.27, 7.0) 4.3 1.8e-05
Table 2.8: Mortality: Regression statistics between mortality and arcsine
square-root transformed Virulence Rank as a continuous covariate and vaccine
treatment as a categorical covariate with no interactions. The credible intervals were
calculated via McMC.
For each maximum likelihood estimate of a parameter, there is an associated
standard error on that estimate. A confidence interval of the full distribution
can be drawn directly from this estimate only if the covariance of each pair-
wise set of parameters is equal to zero. Since this is not the case, the joint
distributions of the parameters were calculated via McMC. The diagnostics
and posterior distributions are given in Appendix A.2.
In summary, the lifespan of infected birds was modelled with a Weibull
distribution. The conclusion is twofold: that a bird infected with an isolate
of higher Virulence Rank has a shorter lifespan whereas vaccination of that
bird increases its lifespan significantly.
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(a) Sham, 𝑣 = 16.5

















(b) Sham, 𝑣 = 36

















(c) Sham, 𝑣 = 46

















(d) HVT, 𝑣 = 16.5

















(e) HVT, 𝑣 = 36



















(f) HVT, 𝑣 = 46

















(g) Bivalent, 𝑣 = 16.5

















(h) Bivalent, 𝑣 = 36

















(i) Bivalent, 𝑣 = 46
Figure 2.8: Host Mortality: Three different treatments with three different
Virulence Ranks as stated. Graphs show data (black), maximum likelihood estimate
of Weibull distribution (red) and 95% credible interval (green). Arcsine square-root
ransformed Virulence Rank (continuous) and vaccine treatment (categorical) are the
(additive) covariates.
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Figure 2.9: Host Mortality: Maximum likelihood estimates of 𝜆 and 𝑟 give the mean
of the lifespan as 𝜆Γ (1 + 1𝑟 ), where Γ (𝑧) =
∫︀∞
0 𝑡
𝑧−1𝑒−𝑡 d𝑡. The dashed lines represent
extrapolation outside Virulence Ranks given in the data.
mean sd MC error Lo 95% CI median Hi 95% CI
r 4.159 0.46 0.062 3.34 4.1 5.1
𝛽0 4.5 0.18 0.0095 4.2 4.5 5.0
𝛽1 -0.53 0.26 0.014 -1.1 -0.51 -0.061
𝛽2 0.36 0.088 0.0061 0.21 0.36 0.55
𝛽3 0.45 0.11 0.0077 0.27 0.45 0.70
Table 2.9: Host Mortality: Results from an additive regression using McMC
between the two covariates (arcsine square-root transformed Virulence Rank as a
continuous covariate and vaccine treatment as a categorical covariate) and the
lifespan of an infected individual. McMC diagnostics and posterior distributions are
given in Appendix A.2.
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Pen Number
1 2 3 4 5 6 7 8 9 10
𝑘1 0 0 0 1 1 0 0 0 1 1
𝑘2 3 3 2 3 2 2 1 3 3 5
𝑘3 4 5 4 5 4 5 5 5 4 5
𝑘4 5 5 5 5 5 5 5 5 5 5
𝑚1 0 0 0 4 4 0 0 0 4 4
𝑚2 9 9 6 6 3 6 3 9 6 12
𝑚3 2 4 4 4 4 6 8 4 2 0
𝑚4 1 0 1 0 1 0 0 0 1 0
𝑀1 0 0 0 4 4 0 0 0 4 4
𝑀2 9 9 6 9 6 6 3 9 9 15
𝑀3 8 10 8 10 8 10 10 10 8 10
𝑀4 5 5 5 5 5 5 5 5 5 5
𝑞1 0 0 0 0.2 0.2 0 0 0 0.2 0.2
𝑞2 0.6 0.6 0.4 0.5 0.25 0.4 0.2 0.6 0.5 1
𝑞3 0.5 1 0.67 1 0.67 1 1 1 0.5 -
𝑞4 1 - 1 - 1 - - - 1 -
𝑝1 0 0 0 0.044 0.044 0 0 0 0.044 0.044
𝑝2 0.17 0.17 0.10 0.13 0.056 0.10 0.044 0.17 0.13 1
𝑝3 0.13 1 0.20 1 0.20 1 1 1 0.13 -
𝑝4 1 - 1 - 1 - - 1 - -
Table 2.10: Transmission: Maximum likelihood estimates for quantities from the
hypergeometric distribution. For timestep 𝑖: 𝑘𝑖 is the observed number of infected
individuals; 𝑚𝑖 is the number of newly infected individuals; 𝑀𝑖 is the cumulative
number of infected individuals; 𝑞𝑖 is the probability per timestep of infection per
bird, and 𝑝𝑖 is the daily probability of infection per bird. The sampling was
conducted in an unvaccinated population of birds where the number of newly
infected individuals within a timestep is assumed to be binomially distributed.
2.4.4 Transmission
The maximum likelihood estimates for the number of newly infected individ-
uals, ?̂?𝑖 , and the daily probabilities of becoming infected, ?̂?𝑖 , can be calculated
for each replicate (pen) and are given in Table 2.10 and Table 2.11 for unvac-
cinated and HVT vaccinated birds respectively.
The amount of virus in each pen is known at certain days, and linear interpo-
lation estimates the average amount of virus (measured in VCN/𝑚3) between
days 0-5, 5-10, 10-15 and 15-20. The average amount of virus in each pen and
the probability of infection within that period is shown in Figures 2.10a and
2.10b. The associated probabilities per day are shown in Figure 2.11.
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Pen Number
1 2 3 4 5 6 7 8 9 10
𝑘1 1 0 0 0 0 0 0 2 0 0
𝑘2 1 2 0 0 0 0 0 0 1 0
𝑘3 0 1 0 1 2 0 2 0 1 0
𝑘4 0 1 0 2 1 0 1 0 1 1
𝑚1 2 0 0 0 0 0 0 2 0 0
𝑚2 0 4 0 0 0 0 0 0 3 0
𝑚3 0 0 0 2 3 0 3 0 0 0
𝑚4 0 0 0 1 0 0 0 0 0 1
𝑀1 2 0 0 0 0 0 0 2 0 0
𝑀2 1 4 0 0 0 0 0 0 3 0
𝑀3 0 2 0 2 3 0 3 0 2 0
𝑀4 0 1 0 2 1 0 1 0 1 1
𝑞1 0.1 0 0 0 0 0 0 0.1 0 0
𝑞2 0 0.29 0 0 0 0 0 0 0.2 0
𝑞3 0 0 0 0.2 0.3 0 0.3 0 0 0
𝑞4 0 0 0 0.25 0 0 0 0 0 0.2
𝑝1 0.021 0 0 0 0 0 0 0.021 0 0
𝑝2 0 0.065 0 0 0 0 0 0 0.044 0
𝑝3 0 0 0 0.044 0.069 0 0.069 0 0 0
𝑝4 0 0 0 0.056 0 0 0 0 0 0.044
Table 2.11: Transmission: Maximum likelihood estimates for quantities from the
hypergeometric distribution. For timestep 𝑖: 𝑘𝑖 is the observed number of infected
individuals; 𝑚𝑖 is the number of newly infected individuals; 𝑀𝑖 is the cumulative
number of infected individuals; 𝑞𝑖 is the probability per timestep of infection per
bird, and 𝑝𝑖 is the daily probability of infection per bird. The sampling was
conducted in a HVT vaccinated population of birds where the number of newly
infected individuals within a timestep is assumed to be binomially distributed.
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Figure 2.10: Transmission: 5 day probabilities for infection for different
atmospheric virus concentrations (measured in VCN per 𝑚3). Error bars are twice the
standard error of the estimate.






























Figure 2.11: Tranmission: Daily probability of infection per bird with different
vaccination treatments. The circles are the maximum likelihood point estimates for 𝑝




This chapter uses a mathematical approach to estimate key epidemiological
parameters for MDV. All the parameters were estimated from experimental
data using a range of statistical and mathematical techniques. Daily dust
shedding rates were estimated for layer birds; viral shedding rates and
latency times were found for a range of virus strains under different host
vaccination conditions; times to death for infected hosts were calculated for
different infecting strains and vaccination host status; and daily transmission
probabilities to fully susceptible and vaccinated individuals were estimated.
Data for the daily amount of dust shed in 𝑚𝑔 per layer bird were used to fit a
cubic spline to estimate the daily rate of dust shedding per bird.
Data from a single experiment were modelled to estimate the latent period and
viral shedding rate of birds. The birds were infected with one of three MDV
strains and inoculated with one of three treatments: sham (saline), HVT (first
generation vaccine) or Bivalent (second generation vaccine). I developed a dy-
namic model to simulate the shedding of virus by a group of birds and used
maximum likelihood techniques to estimate the two key parameters: latent
period and viral shedding rate. The credible intervals for these two parame-
ters were calculated via Bayesian techniques. The dynamic model was fitted to
the virus shedding profiles assuming a fixed delay to viral shedding and rate
of viral shedding for each group of chickens sharing an isolator (and infected
with the same vaccine strain and MDV isolate). The delay from infection to
viral shedding (latent period) does not change significantly with vaccine nor
infecting isolate (Table 2.5). An increase in Virulence Rank (again, as defined
by Witter (1997) and Witter et al. (2005)) correlates significantly with an in-
crease in viral shedding (Figure 2.7).
A sensitivity analysis varied the amount of dust shed by each bird based on
the spline fitting done in Section 2.4.1. In the main analysis, the mean dust
shed by each bird was used. The parameters were re-estimated using the low
and high confidence interval values of dust but this does not affect the results
in any significant way.
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Overall, the model tends to overestimate the density of MDV in dust in week
two. This may be because the viral shedding rate increases as infection pro-
gresses, contrary to our assumption that the shedding rate is constant. Fitting
a model with a further two parameters characterised by a delay to a higher
viral shedding rate would improve the fit of the model. However, this would
drastically increase the complexity of the problem, with a more intractable
likelihood surface and more difficult interpretation of the fitted parameter set.
Given the low sensitivity of the results to the amount of dust produced by each
bird, the simpler model would seem the best for understanding the biological
interpretation the effect of Virulence Rank and vaccination on the shedding of
virus strains.
Vaccination is thought to reduce the MDV load in an infected host (Baigent
and Davison, 2004), which is backed up by other empirical studies (e.g. Islam
et al., 2007, 2008) and the results presented here do not contradict this. My
estimate of the latent period is much shorter than earlier estimates of around
13 dpi (Baigent and Davison, 2004) but only slightly shorter than more recent
estimates based on new PCR techniques which have detected significant quan-
tities of virus in feather tips on 7 dpi (Baigent et al., 2005) (viral shedding is
estimated in this work to begin between 5 and 7 dpi (the day after the latent
period ends)).
There have been efforts to find other correlates with virulence of MDV
isolates, most notably with viral load (the density of virus within bird tissue).
This has been achieved by cell culture techniques (e.g. Calnek and Witter,
1986) and intra-cellular detection during the first 10 days of infection (Yunis
et al., 2004). However, the relationship between viral load (or replication)
and Virulence Rank had not been convincingly tested (Witter et al., 2005).
Current PCR methods enable viral loads in shed dust to be directly measured
(Baigent et al., 2005; Bumstead et al., 1997; Burgess and Davison, 1999; Islam
et al., 2006; Reddy et al., 2000; Yunis et al., 2004) and this enabled a more
quantitative analysis as used in this chapter.
Data from the same experiment (as discussed previously in the context of viral
shedding) was modelled to estimate the host lifespan. The birds were infected
with one of three MDV strains and inoculated with one of three treatments:
sham (saline), HVT (first generation vaccine) or Bivalent (second generation
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vaccine). Survival analysis, with a Weibull mortality function as a statisti-
cal model, was used to describe the lifespan of birds infected with MDV. The
relative impact of Virulence Rank and vaccine covariates were compared by
calculating credible intervals again using Bayesian methods.
Applying these statistical methods to the data for three strains, it was found
that increasing Virulence Rank of a virus strain decreases the lifespan of the
host (Figure 2.9). Vaccinating the host with either the first or second genera-
tion vaccine increases its lifespan, but neither one to any significantly greater
degree (Table 2.8). For example, a Virulence Rank of 20 produced a host lifes-
pan of 67 days for unvaccinated birds compared with 96 and 104 days for HVT
and Bivalent vaccinated birds respectively.
The value of 𝑟 = 4.09, for the shape parameter implies there is an increasing
death rate with age.
Analysis of transmission experiments allowed a formal estimation of daily
transmission rate of MDV from infectious individuals to susceptible, unvac-
cinated or HVT vaccinated birds. Maximum likelihood methods were used
to estimate the number of newly infected individuals within each time frame,
and binomial theory allowed conversion of these estimates to daily probability
values. The daily probability of transmission had large variability, especially
for small quantities of dust in the unvaccinated case and a precise model fit
was not analysed here. It will be revisited in the context of later chapters.
However, it was clear that vaccination can protect a bird from initial infection.
This result is not recognised in the literature on Marek’s disease, which
usually focuses on a vaccine’s ability to prevent clinical signs or death in
an infected individual (Baigent and Davison, 2004). However, the way the
vaccine protects against a disease dictates the direction and force of selection
applied on the pathogen, as demonstrated by Gandon et al. (2001). Providing
no protection from initial infection but serving only to reduce the clinical
signs of a disease (albeit with the ongoing transmission to other individuals
reduced), can drive virulence to higher levels very rapidly. On the other
hand, vaccines which provide protection from initial infection from disease
can drive virulence to lower levels. This result perhaps suggests that there
may be other factors at play and that vaccination may not be single-handedly
governing the drive to more virulent viruses, since initial infection by MDV is
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reduced by vaccination.
The results described here are qualitatively in line with current thinking on
MDV pathogenesis, but the new methods presented allow a formal quanti-
tative comparison of strains in an epidemiological meaningful way. It is an-
ticipated that this analysis will allow a more quantitative understanding of
the aetiology of MDV and the mechanisms governing a functional rise in the
virulence of a strain. With this analysis is it hoped that a more epidemiologi-
cally relevant characterisation of MDV strains will emerge which will eventu-
ally provide not only insight into the reasons for evolution to highly virulent
strains but also a metric to evaluate future risks and the efficacy of possible
control strategies.
The pathotyping of isolates pioneered by Witter (1997) and Witter et al. (2005)
is a useful tool for comparing the pathogenicity of strains with respect to oth-
ers in vaccinated birds. However several of the more recently isolated, highly
virulent strains have ranks above 80, in some cases 90. Should more virulent
strains emerge, it will be difficult to categorise them via this method, as the
scale is truncated at 100. The method of fitting a Weibull distribution pro-
posed in this chapter allows for a greater flexibility of pathotyping, in that an
isolate may be categorised according to its mean time to kill the host. The
subsequent effect of vaccination of the host on this metric can then be estab-
lished. Biologically, it may seem more logical to pathotype according to the
lifespan of an unvaccinated bird, but experimentally it may also be a solution
to the costly procedure of having two groups of birds, each vaccinated with
a different treatment. Even a simple ‘time to death’ metric can be estimated
using relatively few birds, as was the case for the myxoma virus in rabbits
in Australia. Myxoma strains were pathotyped effectively when the case fa-
tality rate proved experimentally intensive and ineffective in discriminating
between similarly virulent strains (Fenner and Fantini, 1999).
Furthermore, the approach adopted by Witter implies that the change in
pathotype is a form of ‘vaccine break’ where the resistant strains are less
pathological in vaccinated hosts than the wild-type (non vaccine-resistant)
strains. This is in contrast to evolutionary biologists’ accepted definition in-
volving naı̈ve hosts, such that a more virulent infecting strain causes more
morbidity or mortality in an unvaccinated host. To understand MDV viru-
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lence evolution it may be necessary to adopt an evolutionary approach to the
notion of MDV virulence.
Many of the evolutionary arguments for virulence evolution are based on the
trade-off hypothesis, which has been mentioned in Section 1.2.3.1 and will
be returned to in Chapter 3. Before a more confident assertion can be made,
it may be necessary to expand the analysis to include more strains of higher
Virulence Rank. Nonetheless, there are sufficient clues to suggest that MDV
may well show a trade-off between virulence and transmissibility and that an
optimum virulence could be selected for which maximises the potential for






There is evidence that Marek’s Disease Virus (MDV) has been evolving to
higher virulence over the past sixty years (Witter, 1997, 1998; Nair, 2005).
The aim of this chapter is to test hypotheses for the causes of virulence evo-
lution of MDV in broiler chickens. These hypotheses have been discussed by
authors including Morrow and Fehler (2004), Davison and Nair (2005), Nair
(2005) and Gimeno (2008) and include:
• introduction of vaccination;
• broiler lifespan reduction;
• increase in size of chicken flock population and stocking density of birds.
These hypotheses are examined in this chapter for their feasibility of driving
evolution of MDV virulence. The hypotheses above for the continued evolu-
tion of MDV virulence can all be explained within the context of the Trade-Off
Hypothesis (discussed in Section 1.2.3.1). The Trade-Off hypothesis states that
virulence (here defined as the ability for the pathogen to cause mortality in its
host) is positively associated with its ability to transmit infection to a new host.
This hypothesis has been shown to be consistent with only a few systems where
a functional form has been found (Mxyomatosis in European rabbits (Dwyer
et al., 1990), Plasmodium chabaudi in mice (Mackinnon and Read, 1999), Plas-
modium gallinaceum in chickens (Paul et al., 2004), Pasteuria ramosa in Daphnia
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magna (Jensen et al., 2006), HIV in humans (Fraser et al., 2007) and Ophryocys-
tis elektroscirrha in monarch butterflies (de Roode et al., 2008)). However, as
Chapter 2 showed, there is reasonable evidence that MDV does indeed exhibit
a virulence-transmission trade-off which might suggest that the hypotheses
for virulence evolution of MDV are consistent with the epidemiology and life
history of the virus.
It may be helpful to reiterate the arguments for why these changes to broiler
farming may have promoted higher virulence in MDV strains (as discussed in
Section 1.2.2.1), and this is done in Box 3.1.
Box 3.1: Arguments for MDV Virulence Selection
Using the assumption that there is a trade-off between transmission
and host death the possible reasons for MDV virulence evolution are
as follows:
Vaccination: This can select for increased virulence since infection
will still occur, but the fitness costs (i.e. host death) of the infection
will be greatly reduced. The parasite can then become more virulent
(and reap the increased transmission) without incurring such a great
disadvantage by killing its host.
Reduced Cohort Duration: A more virulent pathogen will have a
greater transmission rate for the lifespan of the host than a less
virulent pathogen will. However the more virulent pathogen does not
have a decreased fitness cost of host mortality since the host lifespan
will be shorter for both pathogens (assuming the host lifespan due
to both pathogens is greater than the length of the cohort). This
argument implies that virulence will be greater in shorter-lived hosts.
Increased Size of Cohort: If a host population is much larger and kept
in higher densities, this may give rise to evolution towards a higher
virulence, since there are more susceptible birds to infect in the pop-
ulation and there is less chance that a parasite could run out of hosts
and consequently be driven to extinction by being too deadly.
However, the evolutionary constraints and pressures on such a managed co-
hort system may be vastly different to a wild population, for which these ar-
guments are generally based. This analysis incorporates the life history of the
virus (examined in Chapter 2) with the demographic-specific parameters for a
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broiler system in order to directly test the ability of industry changes to have
driven virulence evolution over the past sixty years.
To examine drivers for evolution it is necessary to define functions to compare
the relative success of virus strains in a given environment. The success of
an individual genotype in its environment is known as its ‘fitness’ (Harvey,
1994). Defining the fitness of an individual organism can be a difficult task and
many authors use different and sometimes conflicting definitions (Dawkins,
1982; Henle, 1991). It is therefore imperative to be explicit about what one
means when the term ‘fitness’ is used and to explain why it is a good metric
for evolutionary study (Mylius and Diekmann, 1995; Dieckmann, 2002). This
chapter employs three different measures of fitness:
• The maximum amount of virus produced by a single infected bird over
its lifespan (which is analagous to LTS (Lifetime Transmission Success),
described in Jensen et al. (2006), which measures the transmission po-
tential of the parasite over the lifetime of its host);
• The basic reproductive number, 𝑅0, of the virus strain (the multiplicative
population growth rate in discrete population generations (Mylius and
Diekmann, 1995));
• The rate of infection of susceptible birds by one infected bird (which is
similar to the Malthusian parameter for exponential growth in continu-
ous time (Mylius and Diekmann, 1995)).
The first measure has been used by experimentalists as stated above. The last
two have been used to define fitness in previous studies in relation to parasite
fitness and are described in numerous studies (e.g. Roughgarden, 1979; Yodzis,
1989).
It is also worth pointing out that the fitness of an individual strain of MDV
refers solely to the fitness given the particular virulence of that strain (defined
in Chapter 2 as the mean time to cause the death of its host). The virulence
of a strain of MDV is assumed to be a heritable trait. Implicit in this assump-
tion is that viral phenotype has a one-to-one mapping with its viral genotype.
Therefore the ‘fitness of the virulence genes’ is interchangable with the ‘fitness
of the individual MDV strain’ in this chapter. Also the ‘virulence’ of a virus
strain is used interchangably with ‘Virulence Rank’ as defined in Box 2.1.
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Floor-reared broiler birds are raised from just after hatch to slaughter with
birds of the same age. Once the whole cohort are at a finishing weight (after
what is defined as the ‘cohort duration’) they are all removed, whereupon the
barn is cleaned pending a new cohort arrival. This artificially age-structured
population changes the quantitative fitness definitions from those used for
natural populations. The aim of the chapter is to identify fitness definitions
which have been used in other studies and, having adapted them for their
use for MDV, elucidate the reasons for MDV virulence evolution with these
measures.
3.2 Methods
All the notation for this chapter is found in Box 3.2 while the mathematical
equations and parameter values are in Box 3.3 at the end of the Methods sec-
tion.
3.2.1 Infectiousness Potential, W
The maximum amount of an MDV strain that can be shed by a single bird over
its lifetime is defined as its infectiousness potential, 𝑊 . During the cohort du-
ration, a bird can be removed from the population by natural mortality (any
cause of death other than MDV-related), by MDV-related death and by final
removal from the cohort (along with the other birds at the end of day number
𝑇𝑐). The lifespan and viral shedding of an individual depend on the infecting
virus strain virulence, 𝑣, and the vaccine status, 𝑗, of an individual (see Sec-
tions 2.4.2 and 2.4.3). A bird starts shedding virus after infection at time 𝑇𝑠 +1
(after the latent period) and does so until the end of the cohort duration at 𝑇𝑐,
unless it dies and is removed from the population. The amount of virus shed
on day 𝑡 by a single bird is defined as 𝑚(𝑡,𝑇𝑐,𝑣, 𝑗) and the probability that the
infected bird is alive at time 𝑡 is 𝐿(𝑡|𝑣, 𝑗), given the bird is infected with a strain
of virulence 𝑣 and has vaccination status 𝑗.
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Figure 3.1: The probability of survival until at least day 𝑡 for an individual infected
with a strain of virulence 𝑣. The solid and dotted lines correspond to daily
background mortality probabilities of 0.0001 and 0.001 respectively. The function is
a compound of Weibull (MDV-induced death) and Binomial (non-MDV-induced
death) survival curves. The Weibull distribution is given by
𝑓 (𝑡|𝑣, 𝑗) = (𝑟/𝜆)(𝑡/𝜆)𝑟−1𝑒−(𝑡/𝜆)𝑟 where both 𝑟 and 𝜆 have been fitted to the survivorship
curves analysed in Chapter 2.
3.2.1.1 Lifespan of an Individual
The probability that a bird survives until 𝑡 days in the cohort is the probability
of not dying from either MDV or background mortality until that time. The
daily background mortality probability per bird is denoted 𝜇. The probability
of a bird lifespan being 𝑡 days (with death due to MDV) is 𝑓 (𝑡|𝑣, 𝑗), given in-
fecting virus virulence, 𝑣 and vaccination status 𝑗. Therefore the probability
of dying from MDV on or before time 𝑡 is 𝑃 (𝑇 ≤ 𝑡) = 𝐹(𝑡|𝑣, 𝑗) =
∑︀𝑡
𝑇=1 𝑓 (𝑇 ,𝑣, 𝑗).
The probability of survival until 𝑡 days within the cohort is therefore
𝐿(𝑡|𝑣, 𝑗) = (1−𝜇)𝑡−1(1−𝐹(𝑡 − 1|𝑣, 𝑗))
A graph showing the dependency of 𝐿 on 𝑣 is shown in Figure 3.1.
3.2.1.2 Dust Shedding
The amount of dust shed daily by a broiler bird of age 𝑡 days in 𝑚𝑔 is calculated
in Appendix B, and is found to be
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𝑑(𝑡,𝑇𝑐) = 368exp(−𝑃 (𝑇𝑐)/𝑡1.64) + 10.8
where 𝑃 is a function of the duration of the cohort, 𝑇𝑐. A value for 𝑃 (45) is
found in the calculation (see Appendix B) since the slaughter time for the birds
in the experiment would usually be 45 days (S.W. Walkden-Brown, Personal
Communication, May 2008). If the cohort duration changes, the amounts of
dust shed by birds will also change, since the birds grow at a different rate to
reach the desired finishing weight at the end of a cohort duration. Therefore
when a different cohort duration is used, 𝑃 (𝑇𝑐) is reestimated. For example
𝑃 (45)=326 gives 𝑑(45,45)=206, so 𝑃 (70), for example, can be estimated by
solving 206 = 368exp(−𝑃 (70)/701.64) + 10.8. This then gives the new 𝑑(𝑡,𝑇𝑐)
which can be used for estimating the quantity of dust produced by a broiler on
day 𝑡 when in a cohort of duration 70 days. A graph depicting 𝑑(𝑡,𝑇𝑐) is dis-
played in Figure 3.2 for birds bred to live through different cohort durations.
3.2.1.3 Total Viral Shedding
Since the amount of virus is related to the mass of the dust shed, the virus shed
will also be a function of time. The virus shed (VCN) per 𝑚𝑔 of dust is given
by 𝑎(𝑣, 𝑗) and therefore the daily amount of virus (measured in VCN) is given
by
𝑚(𝑡,𝑇𝑐,𝑣, 𝑗) = 𝑑(𝑡,𝑇𝑐)𝑎(𝑣, 𝑗)
3.2.1.4 Formulating 𝑊
Combining the two results above, the expectation of the mean quantity of virus
produced in a bird’s lifetime (given infection at 𝑡 = 0, infecting strain virulence
𝑣 and vaccine status 𝑗) is therefore














































Figure 3.2: The amount of dust shed by a bird at different ages given that it resides
in a cohort of duration 𝑇𝑐. The black line corresponds to the initial fitted line for a
cohort duration of 45 days.
Since 𝑚(𝑡,𝑇𝑐,𝑣, 𝑗) is zero when the bird is not shedding virus in its latent period
(i.e. when 𝑡 ≤ 𝑇𝑠, where 𝑇𝑠 is the latent period), this leads to the following
equation:
𝑊 (𝑇𝑐,𝑣, 𝑗) = 𝑎(𝑣, 𝑗)
𝑇𝑐∑︁
𝑡=𝑇𝑠+1
(1−𝜇)𝑡−1(1−𝐹(𝑡 − 1|𝑣, 𝑗))𝑑(𝑡,𝑇𝑐)
3.2.2 Basic Reproductive Number, 𝑅0
The calculation of 𝑊 , the maximal expected amount of virus produced by a
single bird over the course of its life, did not take into account the transmission
potential of that virus, and hence the expected number of chickens infected by
this virus material. By using the transmission parameters gleaned from the
experimental data, the key epidemiological parameter 𝑅0 can be calculated
for each strain under a different set of environmental conditions. 𝑅0 is the
number of individuals that are directly infected by a single infected bird in
an otherwise susceptible population. Transmission of virus between birds is
indirect through the dust.
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3.2.2.1 Reduction in Transmissible Virus
In floor-reared broiler barns, there is thought to be an equilibrium of aerial
contaminants brought about by the continued production and removal of dust
and airborne material (Wathes, 1994). There is a growing realisation that
constant exposure to high levels of contaminants in the dust (such as ammo-
nia) harms not only the livestock, but also the workers on the establishments
(Wathes, 1998) and there have been implementations of Optional Exposure
Limits (OELs) in North America and Europe to reduce dust pollutants to a
reasonable level within broiler barns (Donham et al., 2000). Studies around
Northern Europe have revealed the density of inhalable dust in broiler build-
ings (sampled at around twenty eight days into the cohort duration) (Takai
et al., 1998). The mean inhalable dust ranged from 3.8-10.4𝑚𝑔/𝑚3. Therefore
in this model of a broiler farm, the density of dust is assumed to stay constant
once this limit has been reached. For the purposes of calculation, the new dust
(and virus) is assumed to be produced at the start of each day, is thoroughly
mixed with the old dust (and virus) and a proportion removed to regain the
equilibrium level of dust, before any new infection takes place that day.
If the limit for the density of dust in the barn is set to 𝐸 (𝑚𝑔/𝑚3), the fraction
of remaining dust at each time point 𝑡 is therefore
𝛾(𝑡,𝑇𝑐, 𝑠𝑑) = min
[︂ 𝐸𝑉 (𝑆0, 𝑠𝑑)
min[
∑︀𝑡−1
𝑠=1𝑆0𝑑(𝑠,𝑇𝑐),𝐸𝑉 (𝑆0, 𝑠𝑑)] + 𝑆0𝑑(𝑡,𝑇𝑐)
,1
]︂
where the volume, 𝑉 , of the barn can be calculated by the initial number of
birds, 𝑆0, and the stocking density, 𝑠𝑑 (𝑘𝑔/𝑚2) given the finishing weight, 𝑤
(𝑘𝑔), is fixed for all calculations. The equilibrium value of dust can vary be-
tween farm to farm, however in the study done by Takai et al. (1998) values
for Denmark, England, Germany and the Netherlands found averages of 3.8,
9.9, 4.5 and 10.4 𝑚𝑔/𝑚3, giving an mean value of 7.15𝑚𝑔/𝑚3. This value was
used for the concentration limit of dust in the atmosphere, 𝐸.
Therefore the effective amount of virus produced by a single bird,
𝑀𝑒(𝑡,𝑇𝑐,𝑣, 𝑗)(VCN) in the atmosphere at a given time 𝑡 when 𝑚(𝑡,𝑇𝑐,𝑣, 𝑗) virus
is released into the atmosphere by a single bird at time 𝑡 is therefore
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𝑀𝑒(𝑡,𝑇𝑐,𝑣, 𝑗) = 𝛾(𝑡,𝑇𝑐, 𝑠𝑑)[𝑀𝑒(𝑡 − 1,𝑇𝑐,𝑣, 𝑗) +𝑚(𝑡,𝑇𝑐,𝑣, 𝑗)].
3.2.2.2 Calculation of Basic Reproductive Number
Most calculations of 𝑅0 are derived from assumed infinite (and continuous)
populations occurring over continuous time and described using differential
equations. However this system requires an individual-based approach with
𝑅0 being calculated in a more heuristic way. Indeed Keeling and Grenfell
(2000) describe the differences in the formulation of 𝑅0 under these two differ-
ent systems and give a method for the calculation under the individual-based
setting. Keeling and Grenfell (2000) is therefore the motivation behind the
following formulation:










where 𝑝 is the daily probability of transmission to a single uninfected bird. As-
suming that the number of susceptibles stays approximately constant through-
out the cohort duration, 𝑆(𝑡) = 𝑆0 (i.e. that the number of infecteds remains
small compared to the cohort size)
𝑅0(𝑇𝑐,𝑣, 𝑗, 𝑠𝑑) = 𝑆0
𝑇𝑐∑︁
𝑡=𝑇𝑠+1
𝑝(𝑀𝑒(𝑡,𝑇𝑐,𝑣,𝑗))𝑉 (𝑆0,𝑠𝑑 ) , 𝑗)𝐿(𝑡|𝑣, 𝑗)
where 𝑅0 is the summation over all infectious days, of the probability that a
bird is alive on that day times the expected number of susceptibles that will
get infected (Keeling and Grenfell, 2000).
𝑅0 is dependent upon the vaccination status of a bird in the above formulation
and although vaccination is technically a control measure, this chapter sticks
to denoting the reproductive number, 𝑅0, under vaccination (compared with
𝑅𝑢 which is sometimes used (Porco et al., 2005)).
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3.2.3 Rate of Infection of Individuals
The number of infected individuals caused by a single bird at time 𝑡 follows
simply from the definition of 𝑅0 and may be written
𝑅(𝑡,𝑇𝑐,𝑣, 𝑗, 𝑠𝑑) = 𝑆0
𝑡∑︁
𝑠=𝑇𝑠+1
𝑝(𝑀𝑒(𝑠,𝑇𝑐,𝑣,𝑗))𝑉 (𝑆0,𝑠𝑑 ) , 𝑗)𝐿(𝑠|𝑣, 𝑗)
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Box 3.2: Glossary of Definitions
𝑎(𝑣, 𝑗) Amount of virus present (VCN per 𝑚𝑔 dust)
given strain virulence 𝑣 and vaccine status 𝑗
𝐸 Maximum Dust Concentration (𝑚𝑔/𝑚3)
𝑑(𝑡,𝑇𝑐) Dust shed by one bird on day 𝑡 in a 𝑇𝑐 day cohort
𝑓 (𝑡|𝑣, 𝑗) Lifespan (days) probability distribution due to MDV
infection given strain virulence 𝑣 and vaccine status 𝑗
𝐹(𝑡|𝑣, 𝑗) Lifespan (days) cumulative distribution due to MDV
infection given strain virulence 𝑣 and vaccine status 𝑗
𝐷𝑡𝑜𝑡𝑎𝑙 Total death % in cohort
ℎ Height of barn (𝑚)
𝑗 Vaccination status (Sham, HVT or Bivalent)
𝐿(𝑡|𝑣, 𝑗) Survival duration (days) cumulative distribution function
given strain virulence 𝑣 and vaccine status 𝑗
𝑚(𝑡,𝑇𝑐,𝑣, 𝑗) Virus produced by a bird infection on day 𝑡(VCN) given
strain virulence 𝑣 and vaccine status 𝑗
𝑀𝑒(𝑡,𝑇𝑐,𝑣, 𝑗) Cumulative virus produced by a bird remaining in the barn







Probability of transmission to a single individual on day 𝑡
𝑟 Shape parameter for Weibull distribution of host lifespan
𝑅0(𝑇𝑐,𝑣, 𝑗, 𝑠𝑑) Basic reproductive number
𝑠𝑑 Stocking density of birds (𝑘𝑔/𝑚
2)
𝑆0 Initial number of susceptible individuals in cohort
𝑆(𝑡) Number of susceptible individuals on day 𝑡
𝑇𝑐 Cohort duration (days)
𝑇𝑠 Latent period of virus (days)
𝑣 Virulence Rank of MDV strain
𝑣𝑇 Transformed Virulence Rank of MDV strain
𝑉 (𝑆0, 𝑠𝑑) Volume of the barn (𝑚
3)
𝑤 Final weight of broiler bird (𝑘𝑔)
𝑊 (𝑇𝑐,𝑣, 𝑗) Expected maximum virus production in one bird’s
lifetime (VCN) given strain virulence 𝑣 and vaccine status 𝑗
𝛼(𝑗) Gradient of linear regression in transmission rate estimation
𝛾(𝑡,𝑇𝑐, 𝑠𝑑) Fraction of dust remaining in barn after extraction on day 𝑡
𝜆(𝑣, 𝑗) Scale parameter for Weibull distribution of host lifespan
𝜇 Daily background mortality probability per bird
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Box 3.3: Glossary of Parameter Values
𝑎(𝑣,sham) = −7.27x107 + 2.01x108𝑣𝑇 (Chapter 2)
𝑎(𝑣,hvt) = −4.21x107 + 1.13x107𝑣𝑇 (Chapter 2)
𝑎(𝑣,biv) = −2.49x107 + 6.07x107𝑇 (Chapter 2)
𝐸 = 7.15𝑚𝑔/𝑚3 (Takai et al., 1998)
𝑑(𝑡,𝑇𝑐) = 368exp(−𝑃 (𝑇𝑐)/𝑡1.64) + 10.8 (Appendix B)
𝐷𝑡𝑜𝑡𝑎𝑙 = 3.6− 6.8% (Sheppard, 2004)
𝐹(𝑣, 𝑡, 𝑗) = 1− 𝑒𝑥𝑝(−(𝑡/𝜆(𝑣, 𝑗))𝑟)
ℎ = 2.5𝑚 (S.W. Walkden-Brown, pers. comm., 2008)
𝐿(𝑡|𝑣, 𝑗) = (1−𝜇)𝑡−1(1−𝐹(𝑣, 𝑡 − 1, 𝑗))















𝑟 = 4.09 (Chapter 2)
𝑠𝑑 = 5, 20, 35𝑘𝑔/𝑚
2 (N. Sparks, pers. comm., 2008)
𝑆0 = 500, 5,000, 30,000 Birds (N. Sparks, pers. comm., 2008)
𝑇𝑐 = 30, 50, 70, 90 days (Sheppard, 2004)




𝑉 (𝑆0, 𝑠𝑑) = 𝑆0𝑤ℎ/𝑠𝑑
𝛼(sham) = 8.97e-9 (probability of infection per bird per day
per VCN/𝑚3)
𝛼(hvt) = 1.47e-9 (probability of infection per bird per day
per VCN/𝑚3))
𝜆(𝑣,sham) = 4.541− 0.525𝑣𝑇 (Chapter 2)
𝜆(𝑣,hvt) = 4.541− 0.525𝑣𝑇 + 0.356 (Chapter 2)
𝜆(𝑣,biv) = 4.541− 0.525𝑣𝑇 + 0.442 (Chapter 2)





3.3.1 Infectiousness Potential, W
Figure 3.3 shows the Virulence Rank at which the maximum 𝑊 is reached, for
different values of 𝑇𝑐, 𝜇 and 𝑗. For unvaccinated populations, decreasing the
cohort duration, 𝑇𝑐, serves to increase the Virulence Rank at which there exists
a fitness peak. In HVT vaccinated populations, the same trend is apparent, al-
though only for longer cohort durations (since at shorter cohort durations, the
maximum Virulence Rank is reached). For Bivalent vaccinated populations,
there is no change in the location of the fitness peak, since the maximum Vir-
ulence Rank is selected for in all cases. Thus, introducing a first generation
vaccine and a second generation vaccine both serve to increase the Virulence
Rank at which there exists a fitness peak, unless the cohort duration is small
enough such that the maximum fitness has already been reached. The back-
ground mortality has little effect on the fittest Virulence Rank. The fittest
Virulence Rank is made ever so slightly higher in the presence of a greater
background mortality (when the maximum virulence has not been reached).
In summary, this fitness measure is defined as the total infectious material
produced over the course of the cohort duration by a single infected bird.
Optimising this fitness measure locates the fittest virulence. A reduction in
cohort duration and vaccination (or vaccination with a more recent vaccine)

























































































(c) Background Mortality, 𝜇 = 0.001
Figure 3.3: 𝑊 : Optimal virulence (the virulence at which 𝑊 is largest) for different
cohort durations (measured in days) with different vaccines and background
mortalities.
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Figure 3.4: 𝑊 : Impact of moving vaccine status from unvaccinated to HVT (blue
line) and from HVT to Bivalent (green line), measured in terms of the reduction in
cohort duration (days) to give the same virulence shift.
3.3.1.1 Relative Importance of Industry Changes
The optimal virulence in an environment is influenced by both cohort duration
and vaccine status of the hosts. To distinguish between these two effects, the
relative impact of vaccination can be viewed in terms of how much the cohort
duration would have to be decreased for the shift in optimal Virulence Rank
to be the same. A plot of the impact of vaccination relative to the alternative
reduction in cohort duration is given in Figure 3.4. The blue and green lines
correspond to the impact of moving from an unvaccinated population to an
HVT vaccinated population and from an HVT vaccinated population to a Bi-
valent one respectively. Since cohort durations have reduced from around 70
days to 40 days in the past sixty years (Morrow and Fehler, 2004; Sheppard,
2004), this would suggest that the effect of vaccine introduction and cohort
duration reduction are of the same order.
In summary, vaccine introduction and cohort duration reduction affect the
infectiousness potential 𝑊 by the same order of magnitude.
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3.3.2 Basic Reproductive Number, 𝑅0
If the equations used to calculate 𝑅0 are studied more closely, it is found that
𝑅0 itself is independent of the number of individuals within the cohort.

































𝛾(𝑡,𝑇𝑐, 𝑠𝑑)[𝑀𝑒(𝑡 − 1,𝑇𝑐,𝑣, 𝑗) +𝑚(𝑡,𝑇𝑐,𝑣, 𝑗)]𝐿(𝑡,𝑣, 𝑗)
Now since the reduction, 𝛾(𝑡,𝑇𝑐, 𝑠𝑑), can be further be broken down:





















it is clear that 𝑅0 is independent of 𝑆0, but not 𝑠𝑑 , the stocking density. Suppos-
ing the equilibrium value of dust has been reached, then since 𝛾 is a function
of 𝑠𝑑 , increasing the stocking density will reduce the fraction of dust remain-
ing. Mathematically, this is true since the numerator is reduced by increasing
78































Figure 3.5: Transmission for Small Virus Concentrations: the probability of
infection per day per bird as calculated in Chapter 2, with the average estimated
quantities of virus concentration in the atmosphere. The blue and red crosses are the
unvaccinated and HVT vaccinated birds respectively. The blue and red lines give the
least squares estimate of the line of best-fit to the unvaccinated and HVT vaccinated
birds respectively. The dotted lines give the 95% confidence intervals on the
regression line. Note that the dotted line at 𝑦 = 0 is the limit for the lower confidence
interval for both lines.
𝑠𝑑 more than the denominator in the above formulation. This makes intuitive
sense since the higher the stocking density, the more birds per unit volume and
the more dust per unit volume which implies that more dust must be taken out
if the equilibrium is to be maintained.
The transmission function, relating the concentration of virus in the atmo-
sphere (VCN/𝑚3), is calculated by using the results from Section 2.4.4. Since
the virus shed for one bird is much smaller than the quantities of virus exam-
ined in the experiment from Section 2.2, only the first datapoint (dpe 5) from
each replicate is used to fit a linear regression between virus concentration and
probability of infection per bird per day. Since the value of the intercept was
not significantly different to zero and it makes biological sense to fit the line
through the origin, the gradient was calculated as 𝛼(𝑠ℎ𝑎𝑚)=8.97e-09 (𝑝=0.07)
for the unvaccinated birds and 𝛼(ℎ𝑣𝑡)=1.47e-09 (𝑝=0.42) for the vaccinated
birds. This relationship is shown in Figure 3.5.
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Using 𝐸 = 7.15𝑚𝑔/𝑚3, and the lines of best-fit for the transmission probabil-
ities, results are displayed for unvaccinated (Figure 3.6) and HVT vaccinated
birds (Figure 3.7). In all cases, a more virulent strain always has a higher fit-
ness.














































































Figure 3.6: 𝑅0: Finding the value of 𝑅0, and hence the optimal virulence, for
different stocking densities, 𝑠𝑑 , and cohort durations, 𝑇𝑐. Background mortality
𝜇=0.0005, equilbrium 𝐸=7.15𝑚𝑔/𝑚3, unvaccinated population and population size,
𝑆0=40,000.
The time step of the summations in calculating 𝑅0 is set to one day, which ap-
proximates the continuous system well if there is an ever increasing amount of
dust. Since there is another continuous process occurring i.e. not just the pro-
duction of new dust, but also the removal of dust, this time step was changed.
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Figure 3.7: 𝑅0: Finding the value of 𝑅0, and hence the optimal virulence, for
different stocking densities, 𝑠𝑑 , and cohort durations, 𝑇𝑐. Background mortality
𝜇=0.0005, equilbrium 𝐸=7.15𝑚𝑔/𝑚3, HVT vaccinated population and population
size, 𝑆0=40,000.
However the results do not vary a huge amount and the results are qualita-
tively the same.
The transmission function chosen will change the results of 𝑅0 quantitatively.
However, varying both gradients within their respective confidence intervals
does not alter the qualitative results, such that more virulent strains will al-
ways have a greater fitness.
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In summary, using a realistic dust environment, the 𝑅0 of a strain increases
with strain virulence. This result shows that there is always a fitness advan-
tage for the more virulent strains, regardless of environmental pressures.
3.3.3 The Rate of Infection of Individuals
The rate at which susceptible individuals become infected is an alternative
measure of the fitness of a strain. Figure 3.8 shows this for four different
strains. In each case a greater Virulence Rank shows a larger number of in-
fected individuals at each time step. This implies that in all cases a more viru-
lent strain always has a higher fitness.







































(a) Sham vaccinated Population







































(b) HVT vaccinated Population
Figure 3.8: Rate of Infection of Individuals: The total infected individuals over time
where stocking density 𝑠𝑑=10𝑘𝑔/𝑚2, background mortality 𝜇=0.0005, equilbrium
𝐸=7.15𝑚𝑔/𝑚3 and cohort duration 𝑇𝑐=50 days and population size 𝑆0=40,000.
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3.4 Discussion
The work presented here proposes fitness functions for Marek’s disease virus
strains entering a cohort of broiler birds with one infected bird at the start
of the cohort duration and examines the evolutionary fitness for a spectrum
of strain virulences under different environmental conditions. Three fitness
functions were defined: the maximum expected amount of virus produced by
a single infected bird in a cohort, 𝑊 ; the basic reproductive ratio, 𝑅0; and, the
rate of increase in the number of infected individuals.
For 𝑊 , results suggest that decreasing the cohort duration drives virulence to
higher levels, until they could increase no more on the virulence scale. Once
a selected virulence was at the maximum on the scale, selection forces it to
remain there. This result is in accordance with evolutionary theory (Anderson
and May, 1982; Sasaki, 1991; Day, 2002).
Results also indicate that introducing the HVT vaccine (the first generation
vaccine) serves to drive virulence to higher levels and again with Bivalent vac-
cine (the second generation vaccine). Again this result is in line with evolu-
tionary theory which suggests that the introducing imperfect vaccination into
a population selects for higher virulence (Gandon et al., 2001, 2003).
Increasing the background mortality decreases the fitness of a viral strain, all
else being equal, however it only very slightly changes the fittest virulence, al-
most imperceptibly on the graphs. Increasing the mortality slightly increases
the Virulence Rank selected. This result is in line with the theory stating
that increasing background mortality selects for higher virulence (Kakehashi,
1992; Lenski, 1994; Ebert and Weisser, 1997).
The relative effects of vaccination and cohort duration were studied in Figure
3.4. Introducing a vaccine at longer cohort durations increases the selection
for more virulent strains. There is no effect on virulence if a vaccine was intro-
duced at very short cohort durations (under about 40 days if HVT was intro-
duced in an unvaccinated population and under about 60 days if Bivalent was
introduced in a HVT population). Since both cohort duration reduction and
vaccination select for higher virulence in most cases, for the instances where
vaccine introduction caused a change in virulence selection, the relative effect
of vaccine in terms of cohort reduction was determined. Vaccine introduction
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(from unvaccinated to HVT and HVT to Bivalent) had a similar effect as a re-
duction in the cohort duration of up to 10 and 27 days respectively depending
on the length of the cohort duration. Over the course of 30 years (1960-1990),
for example in the USA, 2 vaccines were introduced (HVT then Bivalent) and
cohort duration was reduced by about 30 days (75 days to about 45 days). This
suggests that the strength of selection by both vaccination and cohort duration
reduction are of the same magnitude.
The results from the optimisation of 𝑊 agree with evolutionary theory in that
reducing cohort duration, increasing background mortality and introducing
an imperfect vaccination all serve to select for higher virulence. If this was
the only information available, a reasonable conclusion would be that both
cohort duration reduction and vaccination are likely candidates for driving
the virulence of MDV higher. Since vaccination was initially brought in to
stem the first losses from more virulent strains emerging in the 1950/1960s,
the reduction of cohort duration from 75-80 days to 60 days is a reasonable
explanation for the first move from benignity to malignity.
When the role of transmission was included in the 𝑊 measure, a value for the
basic reproductive number, 𝑅0, could be calculated. However, since ventilation
is known to constantly remove dust to keep airborne dust contaminants to a
safe level, a more realistic broiler environment was modelled by introducing
a threshold above which the dust density did not increase. In this situation,
more virulent strains are always selected for regardless of other environmental
conditions, because the relative advantage of more virulent strains is increased
when there is reduced transmission (due to the constant removal of the virus).
If a realistic quantity of dust is kept in the environment, increasing the cohort
duration increases a strain’s fitness, as one would expect and vaccination al-
ways results in lower 𝑅0 for a strain, everything else being equal. This can be
explained by 𝑅0 explicitly including transmission, which is reduced for HVT
vaccinated birds. Since no data was available for transmission to Bivalent vac-
cinated individuals, 𝑅0 was not calculated.
𝑅0 does not depend on the initial number of susceptible individuals in a pop-
ulation. This is apparent, since the model setup changes the volume of the
barn based on parameters including the stocking density and number of indi-
viduals. If the number of individuals increases, then the volume of the barn
increases linearly, but the stocking density remains the same. Therefore for
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each area of the barn, there is the same density of birds.
It can also be seen that stocking density does change the value of 𝑅0, but not
greatly, especially towards higher stocking densities. The overall trend that
an increasing stocking density increases the 𝑅0 of a particular strain might be
expected. However the reason why this is is perhaps not so intuitive. There
are two opposing factors at play: firstly, with a higher stocking density, there
is a larger number of hosts per area, so the possible number of susceptibles to
infect increases, which increases 𝑅0; however secondly, as the stocking density
increases, the dust remaining fraction, 𝛾 , decreases since more dust is being
produced per volume. Therefore if 𝑅0 is seen as a function of 𝑠𝑑 , it is sublin-
early increasing, due to the linear increase for the first factor and the negative
weighting effect of 𝛾 , the second factor.
The conclusions for the causes of evolution are different if 𝑅0 or the rate of
infection of individuals is used for fitness. For the range of Virulence Ranks
considered, optimising either of these two fitness functions always results in
the maximum virulence chosen for any environment. Since the 𝑅0/Rate of in-
fection calculations are always maximised for more virulent strains, the trade-
off between virulence and transmission was not realised. The more virulent
strains were not reducing the host lifespan enough to be reducing their fitness
to levels lower than other less virulent strains. This is in contrast to Ander-
son and May (1982) suggesting that a medium virulence could exist if the
virulence-transmission trade-off exists. The conclusion from this analysis is
that the three hypotheses for the reasons for virulence evolution are not fac-
tors in promoting MDV virulence to higher levels. Indeed they are all impli-
cated in slowing the evolution by reducing the evolutionary pressure for more
virulent strains.
In this analysis data relating to maternal antibody positive birds were used,
however a discussion on the possible effects on virulence evolution within a
population of maternal antibody negative birds is in Appendix C. A changing
epidemiological background could not only have been associated with a move
from maternal antibody negative to positive birds but also with host genetics.
Genetic resistance to MDV (where chickens were less likely to harbour the in-
fection) or indeed tolerance of the virus (where MDV infection would occur
but without severe morbidity) could have played a role similar to that of the
introduction of maternal antibodies into the host population. However the se-
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lection for this would be in the breeder farms and since there is little evidence
for direct selection in response to MDV infection, it is unclear the extent to
which inadvertent selection of birds has occurred.
Since 𝑅0 takes into account more information about the environmental trans-
mission route of MDV infection, it is suggested that this may be the best fit-
ness measure studied in this chapter. An extension to this measure will be





In Chapter 3 the notion of ‘fitness’ was introduced to differentiate the environ-
ments in which more virulent strains did better than less virulent ones. This
chapter looks more closely at the epidemiology of Marek’s disease virus within
its natural setting of a flock of chickens in order to determine the epidemio-
logical dynamics of a strain of MDV. The aim of this approach is twofold: to
understand on-farm MDV dynamics to aid disease control in the future; and
to understand why MDV has become more virulent over the past half century.
This chapter studies the outcome in both the virus and chicken populations
when dust infected with a single strain of MDV enters a single barn of chick-
ens.
I know of only one published mathematical model looking explicitly at the
epidemiology of MDV; Gao et al. (2005) quantified the dynamics of infected
broiler birds within one cohort by a system of differential equations. The aim
was for the model to be used as a tool for farms to understand the effect of
different MDV strains under different management regimes. However, this
differs from the method presented here since the parameter values used in
this work are taken directly from novel parameter estimation work (described
in Chapter 2) and the model approach is a stochastic individual-based model,
to more easily incorporate the parameter estimates. Gao et al. (2005) did not
formally estimate the parameters used in their model (instead relying on con-
jectured values, based on data observation) and a complete exploration of the
model was not published.
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Dynamics within a cohort structure have not been well-studied, with many
more models concerned with the spread of disease in either well-mixed pop-
ulations (Anderson and May, 1992; Keeling and Rohani, 2008), or completely
spatially-explicit systems (Boots and Sasaki, 2000; Cook et al., 2007). However,
few have developed the theory for temporally-explicit dynamics for situations
such as these, where pathogens infect cohort-structured populations. The only
similar work I know of concerns Coccidiosis in broiler chickens (Klinkenberg
and Heesterbeek, 2007). Those authors model multiple cohorts by a series of
mean-field difference equations. They studied the free-living and within-host
stages of the parasite to describe optimal strategies for damage limitation for
flock infection.
This chapter simulates one cohort of broiler birds when exposed to MDV and
quantifies the behaviour of the virus strain and the effect on its hosts.
4.2 Methods
The model simulates a single cohort of susceptible broiler birds in a barn from
start to finishing time during a potential outbreak of MD initiated by MDV
infected dust entering the cohort barn at the same time as the birds.
Through the work in Chapter 2, the distributions of basic epidemiological pa-
rameters were found. These were estimates for different virus strains infecting
hosts of different vaccine status. The parameters estimated were the latent pe-
riod of MDV, the viral shedding rate, the time to death due to MDV infection
and the transmission rate. The uncertainty in the value of these parameters
included the variability between different groups of hosts in their response to
a MDV infection. Allowing these parameters to vary enables a broiler farm to
be modelled in a fully stochastic manner with every individual bird having a
different combination of ‘Infection Attributes’, given by sampling values from
the parameter distributions.
A full description of the stochastic model is laid out in this section, with all




The initial host population is a single cohort of 𝑆0 floor-reared broiler chickens.
The population is subject to no immigration, although there is a possibility of
host mortality, either non-MDV or MDV related. The removal of sick or dead
birds is done daily. Each bird sheds an amount of dust per day, 𝑑(𝑡,𝑇𝑐), which
is set at 326exp(−𝑃 (𝑇𝑐)/𝑡1.64) + 10.8 where 𝑃 is a function of the duration of
the cohort. This function is derived in Appendix B and explained in detail in
Section 3.2.1.2. At the end of each cohort duration, at the end of day 𝑇𝑐, the
remaining chicken population is removed for slaughter.
4.2.2 Cohort System
At the start of a cohort, the barn is seeded with an amount of infected dust,
𝐷0, (which is unknown, but varied) which determines the total amount of in-
fected virus, 𝑍0, measured in viral copy number (VCN). Since two values for
the concentration of virus per 𝑚𝑔 of dust were calculated in Section 2.4.2 for
each of the three virus isolates (04CRE, MPF57 and 02LAR, one value for each
replicate), an approximation for 𝑍0 is the virus concentration per 𝑚𝑔 of dust
as the average of the two values from each replicate, 𝑎(𝑣, 𝑗), multiplied by 𝐷0.
It is assumed the total amount of uninfected dust is set to zero.
If at any time the virus concentration in the air drops below a critical point, 𝑧𝑒
(VCN/𝑚3), the virus is assumed extinct as it becomes untransmissable. There
is no explicit virus decay rate in the model, since Jurajda and Klimes (1970)
showed that 44 day old virus had a similar infection potential as recently shed
virus and Carrozza et al. (1973) demonstrated that even infected dust 205 days
old was still able to infect birds to a high degree.
Floor-reared broiler barns can produce vast quantities of dust throughout the
lifespan of the cohort and ventilation mechanisms exist for the removal of dust
and its constituent air-borne contaminants, for the health of both the birds
and the farm workers (Wathes, 1998). Studies sampling the quantity of dust at
approximately twenty eight days at various farms over Northen Europe gave a
range of 2-10𝑚𝑔/𝑚3 in the barn atmosphere (Takai et al., 1998). It is therefore
assumed that the amount of dust never rises beyond a limit and a baseline for
this value is taken as the average of the samples, 7.15𝑚𝑔/𝑚3. The production
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of (and subsequent removal of any excess) dust is assumed to happen at the
start of each day and any infection of new birds occurs after.
4.2.3 Host Infection
Infection is known to be via inhalation of virus in the atmosphere, which is
shed by infectious birds (Calnek et al., 1970). Infection probability is there-
fore modelled as a scaled concentration of virus in the air (VCN/𝑚3). The
amount of virus in the air can be calculated since there is a density of virus in
the dust (VCN/𝑚𝑔), a known quantity of dust in the barn (𝑚𝑔) and a fixed barn
volume (𝑚3). The probability of infection depends only on the concentration
of airborne virus and the host’s vaccination status. The probability of infec-
tion was estimated as a function of virus concentration via linear regression
with no intercept (from the data and estimates in Section 2.4.4). The gradients
are defined as 4.93e-8 (s.e.=4.50e-9, 𝑃 < 0.005) and 8.26e-10 (s.e.=2.57e-10,
𝑃 < 0.005) per bird per VCN/𝑚3 for unvaccinated and HVT vaccinated birds
respectively. A graph of these functions is shown in Figure 4.1. The standard
errors on the estimates define a normal distribution of the possible gradients
which are used in the model (see Section 4.2.4).
4.2.4 Host Pathogenesis
Each bird has certain ‘Infection Attributes’ which have been estimated pre-
viously: latent period, viral shedding rate, Weibull parameters determining
time to death and gradient of infection rate determined by virus concentration.
Each bird has a value of each parameter which will determine its infection
course and whether it becomes infected. A value for each of these parameters
is sampled from the relevant distribution obtained in Sections 2.4.2, 2.4.3 and
4.2.3.
Once infection occurs there is a delay until the individual becomes infectious
(Baigent and Davison, 2004) as the virus infects the feather follicle epithe-
lium, the only source of a fully productive infection. This delay has been esti-
mated as between four and six days (Chapter 2). Once infectious, the bird has
a constant daily viral shedding rate, 𝑎(𝑣, 𝑗) (VCN/𝑚𝑔 dust) until it is removed
from the population. Once infected, each individual has an infection-specific
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Figure 4.1: Tranmission: Daily probability of infection per bird with different
vaccination treatments. The circles are the maximum likelihood point estimates for 𝑝
given for the different timesteps and pens (open for unvaccinated, filled for HVT
vaccinated). The upper and lower red lines are the lines of best-fit for unvaccinated
and HVT vaccinated hosts respectively and the green lines are the associated 95%
confidence intervals.
lifespan dependent on the virulence of the infecting virus and its own vac-
cination status. There are thus four states of the individual in the model -
Susceptible, Exposed, Infectious and Removed. Note that there is an underlying
mortality probability, 𝜇 (per bird per day), which is constant across chicken
states which acts to remove chickens from the population for reasons other
than MDV-related. The bird may then die as a result of MDV infection only
if it has not yet died of other causes or been slaughtered at the end of the co-
hort time. A schematic of the chicken states and environmental conditions is
shown in Figure 4.2.
4.2.5 Virus Strain
MDV is characterised by the Virulence Rank, which is the gold standard patho-
type as devised by Witter (1997) and Witter et al. (2005). It is the percentage
of cases of gross lesions produced by a strain when infecting HVT and Bivalent
vaccinated birds. The strain rank, 𝑣, of the virus determines the viral shedding
rate of an infected bird and its lifespan (if there are no other mortality causes).
The cumulative amount of virus strain in the atmosphere at time 𝑡 is defined
as 𝑍(𝑡) (VCN).
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Figure 4.2: Schematic of the state transitions of the host individuals in one cohort.
Susceptible (S), Infected-Uninfectious (E), Infected-Infectious (I), Removed-other
cause (R1), Removed-MDV related (R2) and production/loss of dust (D) and virus (Z).
4.2.6 Between Cohort Dynamics
At the end of each cohort all the birds are removed and a thorough cleaning of
the barn takes place (van de Giessen et al., 1996). The dust removed is there-
fore a fraction, 𝜖 (a contamination parameter), of the dust at the end of the
cohort. The model assumes the virus is well-mixed in the dust and therefore
the same fraction of virus will be left.
4.2.7 Model Outcome
The probability of an outbreak was calculated. Also found were the amounts
of virus at the end of the cohort duration and the number of infected individ-
uals and the total removed individuals throughout the cohort duration. An
increasing amount of infected dust was used to seed a single cohort. Realisa-
tions of the model were performed 100 times.
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Box 4.1: Glossary of Definitions (1 of 2)
Variables
(denoted at time 𝑡 for infecting strain virulence 𝑣 and host vaccine status 𝑗)
𝑆(𝑡,𝑣, 𝑗) Number of susceptible birds
𝐸(𝑡,𝑣, 𝑗) Number of exposed birds
𝐼(𝑡,𝑣, 𝑗) Number of infectious Birds
𝑅1(𝑡,𝑣, 𝑗) Number of dead (non-MDV-induced) birds
𝑅2(𝑡,𝑣, 𝑗) Number of dead (MDV-induced)
𝑍(𝑡,𝑣, 𝑗) Amount of virus within barn (viral copy number (VCN))
Fixed Parameters
𝑎(𝑣, 𝑗) Estimated viral shedding (VCN/𝑚𝑔 dust) for bird of vaccine
status 𝑗
infected with strain virulence 𝑣
𝑑(𝑡,𝑇𝑐) Dust shed per bird age 𝑡 per day in cohort duration of
𝑇𝑐 days (𝑚𝑔)
𝐷𝑡𝑜𝑡𝑎𝑙 Total background mortality (% in cohort)
𝑒 Age at introduction (days)
ℎ Height of barn (𝑚)
𝑇𝑚𝑎𝑡 Maturation time for Rhode Island Red birds (days)
𝑤 Final bird weight (𝑘𝑔)
Derived Parameters
𝐴 Area of barn floor (𝑚2)
𝑃 (𝑇𝑐) Shape parameter for the per bird dust function
𝑉 (𝑆0, 𝑠𝑑) Volume of barn
𝑍0 Initial amount of virus (VCN)
𝜇 Non-MDV mortality probability per bird per day
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Box 4.1: cont. Glossary of Definitions (2 of 2)
Sampled Parameters - estimates/distributions estimated in Chapter 2
𝑇𝑠 Latent period (days)
𝑎(𝑣, 𝑗) Virus present in dust (VCN/𝑚𝑔 dust) for bird of vaccine
status 𝑗 infected with strain virulence 𝑣
𝑟 Weibull shape parameter for host lifespan distribution
𝜆(𝑣, 𝑗) Weibull scale parameter for host lifespan distribution
𝑝( 𝑍(𝑡)𝑉 (𝑆0,𝑠𝑑 ) , 𝑗) Transmission probability per bird per day for bird of
vaccine status 𝑗 infected with strain virulence 𝑣
Farm Controlled Parameters
𝐸 Maximum dust quantity in barn (𝑚𝑔/𝑚3)
𝐷0 Initial dust (𝑚𝑔)
𝑗 Vaccine treatment (Sham or HVT)
𝑠𝑑 Stocking density (𝑘𝑔/𝑚2)
𝑆0 Initial number of birds
𝑇𝑐 Cohort duration (days)
𝜖 Dust reduction at end of cohort duration
Uncontrollable Parameters
𝑣 Virulence Rank of virus (%)
𝑣𝑇 Arcsine square-root trasnformed Virulence Rank
𝑧𝑒 Virus extinction parameter (VCN/𝑚3)
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Box 4.2: Glossary of Values
Fixed Parameters
𝑑(𝑡,𝑇𝑐) 368exp(−𝑃 (𝑇𝑐)/𝑡1.64) + 10.8 (Appendix B)
𝐷𝑡𝑜𝑡𝑎𝑙 3.6-6.8% (Sheppard, 2004)
𝑒 2 days (Sheppard, 2004)
ℎ 2.5 𝑚 (S.W Walkden-Brown, pers. comm. 2008)
𝑇𝑚𝑎𝑡 45 days (S.W. Walkden-Brown, pers. comm. 2008)
𝑤 2.5 𝑘𝑔 (S.W. Walkden-Brown, pers. comm. 2008)
Derived Parameters
𝐴 𝑆0𝑤/𝑠𝑑










𝐸 7.15 𝑚𝑔/𝑚3 (Takai et al., 1998)
𝐷0 0-560 𝑚𝑔 (unknown)
𝑗 Sham, HVT (Bublot and Sharma, 2004)
𝑠𝑑 5, 20, 35 𝑘𝑔/𝑚2 (N. Sparks, pers. comm 2008)
𝑆0 500, 5,000, 30,000 Birds (N. Sparks, pers. comm 2008)
𝑇𝑐 30, 60 days (Sheppard, 2004)
𝜖 0-1 (unknown)
Uncontrollable Parameters
𝑣 16.5, 36, 46% (Walkden-Brown et al., 2008)
𝑧𝑒 10−9,10−5 VCN/𝑚3 (unknown)
4.3 Results
4.3.1 The Probability of an Outbreak, 𝑃
An outbreak is defined such that there is at least one individual infected in the
cohort. The probability of an outbreak occurring is calculated as a function of
the initial inoculum of dust in a cohort. The results are shown in Figure 4.3.
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The coloured lines show the probability of an outbreak occurring for three
isolates of different virulences, while each plot displays results from different
environmental conditions.
A higher Virulence Rank increases the probability of an outbreak for a given
dust inoculum. Vaccination greatly decreases the probability of an outbreak.
Increasing the stocking density of individuals increases the probability of an
outbreak, whereas changing the population size has no effect. Increasing the
extinction parameter, 𝑧𝑒, increases the time available for the virus to seed an
outbreak in theory; however, the virus is removed relatively quickly and the
probability of infection at very low virus concentrations is very small, so vary-
ing 𝑧𝑒 between 10−9 and 10−5 does not change the probability of an outbreak.
The simulations can be checked against calculating the expected probability of
an outbreak. The definition that a viral inoculum will create an outbreak if and
only if it infects at least one individual is defined by the following equation:
𝑃 (no infection from inoculum) =
𝑇𝑐∏︁
𝑠=1




[1− 𝑝(𝑗,𝑍(𝑠,𝑣, 𝑗)/𝑉 (𝑆0, 𝑠𝑑))]𝑆(𝑠)
where 𝑝 is the probability of a single bird being infected on day 𝑡 given vac-
cination status, 𝑗 and atmospheric density of virus, 𝑍(𝑡,𝑣, 𝑗)/𝑉 (𝑆0, 𝑠𝑑). This
function is plotted is Figure 4.4, which shows that the expected probability of
an outbreak is the same as the complement of the probability that no birds are
infected with the initial inoculum.
4.3.2 The Outcome of an Outbreak
The following measures are not affected by the extinction parameter 𝑧𝑒.
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(a) 𝑠𝑑 = 5𝑘𝑔/𝑚2, 𝑆0=500,
Sham






























(b) 𝑠𝑑 = 20𝑘𝑔/𝑚2,
𝑆0=5,000,Sham






























(c) 𝑠𝑑 = 35𝑘𝑔/𝑚2,
𝑆0=30,000, Sham






























(d) 𝑠𝑑 = 5𝑘𝑔/𝑚2, 𝑆0=500,
HVT






























(e) 𝑠𝑑 = 20𝑘𝑔/𝑚2,
𝑆0=5,000, HVT






























(f) 𝑠𝑑 = 35𝑘𝑔/𝑚2,
𝑆0=30,000, HVT
Figure 4.3: Probability of Outbreak: The probability that there is at least one
individual infected during the cohort duration given a certain quantity of infected
dust inoculum, for given stocking densities (𝑠𝑑), number of individuals (𝑆0) and
vaccination status. The solid line corresponds to a cohort duration , 𝑇𝑐, of 30 days,
while the dotted line for one of 60 days. The probability is calculated as the
proportion of 100 cohort simulations where there has been at least one infected
individual. Note the scale on the x-axis changes for different vaccine treatments.
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Figure 4.4: Probability of Outbreak: The probability that there is at least one
individual infected during the cohort duration given a certain quantity of infected
dust inoculum. The probability is calculated as the proportion of 100 cohort
simulations where there has been at least one infected individual. The black line is
the expected probability that there is at least one infection from the initial inoculum
before the inoculum is removed from the barn. Stocking density, 𝑠𝑑=5𝑘𝑔/𝑚2,
background mortality, 𝜇=0.0005, number of individuals, 𝑆0=5000, sham vaccinated,
cohort duration, 𝑇𝑐=30 days.
4.3.2.1 Virus at the End of the Cohort Duration, 𝑍𝑐
The amount of virus in the atmosphere at the end of a cohort (given an out-
break occurs) is plotted against Virulence Rank for different environments in
Figure 4.5.
In the sham vaccinated case, increasing the Virulence Rank and population
size increases the quantity of virus left at the end of a cohort in all cases. How-
ever, decreasing the stocking density increases the total amount of virus left
since the volume of the barn is increased, leading to a greater amount of virus
in total (due to the upper limit of dust being enforced). There is little or no
effect of lengthening the cohort duration.
For the HVT vaccinated case, increasing the population size has no significant
effect on the amount of virus left. There is a rise in amount of virus due to both
increased Virulence Rank and decreased stocking density. A longer cohort
duration increases the quantity of virus at the end of the duration.
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(a) Sham Vaccinated, 𝑇𝑐=30 days


















































(b) Sham Vaccinated, 𝑇𝑐=60 days

















































(c) HVT Vaccinated, 𝑇𝑐=30 days
















































(d) HVT Vaccinated, 𝑇𝑐=60 days
Figure 4.5: Mean virus (VCN) at end of cohort duration given outbreak: Background
mortality, 𝜇=0.0005. The mean is calculated from all the 100 simulations of the
different inocula and 95% confidence intervals are given in all cases (although too
small to see in the unvaccinated cases). Note the different scales on y-axes.
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4.3.2.2 Number of Infected Cases
The percentage of infected and removed individuals at the end of the cohort is
plotted for various environments in Figure 4.6. This measure does not include
any birds dying of other reasons.
For unvaccinated birds with a short cohort duration, the two most virulent
strains cause the same amount of infection, the least virulent strain, slightly
less. The two most virulent strains infect all the cohort, the rest of the popula-
tion accounted for by being removed for some other non-MDV related reason.
For a longer cohort duration, all the birds are infected, with the rest being re-
moved for other reasons. The increase in the number infected or removed due
to Virulence Rank can be accounted for by the increased propensity for more
virulent strains to kill their host faster, which can only be seen when the co-
hort duration is long enough. The slight decrease in the numbers infected or
removed for the higher virulent strains when a longer cohort duration is used
can be explained by the death of infected individuals from other causes during
this time.
For vaccinated birds, there is a vastly reduced chance of infection or removal
due to MDV. The longer the cohort duration is, the more infection and removal
of birds there will be. The more virulent a strain is, the more infected and re-
moved birds will result in a cohort. If the size of the population increases, the
volume of the barn increases, so the initial inoculum is reduced in concentra-
tion and therefore the rate of infection is reduced. Similarly, if the stocking
density increases, there is more infection, since there is a higher concentration
of virus in the smaller volume.
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(a) Sham Vaccinated, 𝑇𝑐=30 days














































(b) Sham Vaccinated, 𝑇𝑐=60 days


















































(c) HVT Vaccinated, 𝑇𝑐=30 days














































(d) HVT Vaccinated, 𝑇𝑐=60 days
Figure 4.6: Mean % of infected individuals at the end of a cohort duration given
outbreak: Background mortality, 𝜇=0.0005. The mean is calculated from all the 100
simulations of the different inocula and 95% confidence intervals are given in all




The percentage of removed individuals is the farm’s yardstick for MDV preva-
lence and severity. The percentage of removed individuals who have died
through MDV-induced disease is shown in Figure 4.7 and results concur with
those found relating to the total infection and removed individuals. Namely,
increasing Virulence Rank and stocking density, in general, increases the re-
moved individuals, whereas introducing vaccination and increasing popula-
tion size reduces the number of removed individuals. Increasing cohort du-
ration in a vaccinated population will increase the total removed individuals,
which is not true in the unvaccinated population since the population is satu-
rated with infection in both cases.
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(a) Sham Vaccinated, 𝑇𝑐=30 days










































(b) Sham Vaccinated, 𝑇𝑐=60 days












































(c) HVT Vaccinated, 𝑇𝑐=30 days










































(d) HVT Vaccinated, 𝑇𝑐=60 days
Figure 4.7: Mean % of removed individuals due to MDV as percentage of initial
population size at the end of a cohort duration given an outbreak: Background
mortality, 𝜇=0.0005. The mean is calculated from all the 100 simulations of the
different inocula and 95% confidence intervals are given in all cases (although too
small to see in the unvaccinated cases). Note the different scales on y-axes.
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4.3.3 Impact of Contamination Parameter
Given that there has been an MDV outbreak on a farm, the virus in the barn
must be removed to a certain level to reduce the risk of an outbreak occurring
in the following cohort. The barn is assumed to be cleaned with an efficiency
of 1− 𝜖 before the next generation cohort of chickens is added to the barn.
The reduction needed to maintain a 𝛿 probability of an outbreak is plotted
in Figure 4.8 for sham vaccinated birds and in Figures 4.9 and 4.10 for HVT
vaccinated birds.
For Sham vaccinated environments, the reduction factor reduces with the viru-
lence of a strain, implying that if a farm is infected with a more virulent strain
of MDV, more cleaning is required to reduce the probability of a new outbreak
occurring to the same level. However in more populated and denser cohorts,
it becomes increasingly difficult to reduce the amount of virus to reduce the
chance of an outbreak in the next cohort to below 5%. Since the amount of
virus does not change with cohort duration, the effect of the contamination
parameter does not change with the cohort duration.
For HVT vaccinated it can require less cleaning to reduce the probability of
an outbreak to 5%. Since the length of the cohort increases the quantity of
virus left at the end of a cohort duration, increasing the cohort duration for a
vaccinated farm serves to increase the probability of an outbreak in the next
cohort (given the same level of contamination).
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Figure 4.8: Contamination Parameter: Sham vaccinated, background mortality,
𝜇=0.0005, cohort duration, 𝑇𝑐=30 days. The red circles give the fraction to reduce the
virus by at the end of the cohort to give a 𝛿=0.5 probability of an outbreak the next
cohort, the upper and lower blue circles give the reduction to obtain a 𝛿=0.05 to
𝛿=0.95 probability of an outbreak respectively.
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Figure 4.9: Contamination Parameter: HVT vaccinated, background mortality,
𝜇=0.0005, cohort duration, 𝑇𝑐=30 days. The red circles give the fraction to reduce the
virus by at the end of the cohort to give a 𝛿=0.5 probability of an outbreak the next
cohort, the upper and lower blue circles give the reduction to obtain a 𝛿=0.05 to
𝛿=0.95 probability of an outbreak respectively.
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Figure 4.10: Contamination Parameter: HVT vaccinated, background mortality,
𝜇=0.0005, cohort duration, 𝑇𝑐=60 days. The red circles give the fraction to reduce the
virus by at the end of the cohort to give a 𝛿=0.5 probability of an outbreak the next
cohort, the upper and lower blue circles give the reduction to obtain a 𝛿=0.05 to
𝛿=0.95 probability of an outbreak respectively.
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4.4 Discussion
A cohort of chickens exposed to MDV infected dust was simulated and the
probability of an outbreak, the total virus at the end of an outbreak, the total
number of infected individuals and the total removed individuals throughout
the cohort were tracked. The results obtained in this chapter provide a novel
way of assessing the impact of an MDV strain on a cohort of broiler chickens.
The probability of an outbreak given a certain quantity of infected dust was
dependent on the Virulence Rank of the strain, unsurprisingly because the
probability of infection depends only on the quantity of virus material and
the concentration of virus material in dust increases with Virulence Rank (de-
tailed in Section 2.4.2). The extinction of virus within a cohort occurs if only if
there is no infection by the viral inoculum, which is a tractable way of defining
whether an outbreak occurs or not given an initial inoculum.
The probability of an outbreak increases with the stocking density of indi-
viduals, since the number of opportunities to infect remains the same (since
the number of birds stays constant), but the probability of infection per op-
portunity increases since the virus concentration increases. Conversely, if the
number of individuals doubles, the chances for new infections doubles, how-
ever, the volume of the barn also doubles, which means the virus concentration
halves and thus the probability of an outbreak remains the same. Therefore an
increase in both the stocking density and the number of individuals to current
industrial conditions will have increased the chance of an outbreak if the farm
was exposed to any MDV.
Whatever the other cohort conditions are, if the flock is unvaccinated, most,
if not all, of the birds will become infected/removed, if they do not die of
other causes prematurely. For vaccinated cases the situation changes drasti-
cally. For longer cohort times (perhaps akin to a free range farm) with a small
flock size and low stocking densities (e.g. 500 birds at 5𝑘𝑔/𝑚2) a less virulent
strain gives only 1% infection/removed, compared with 54% for more virulent
strains. For shorter cohort durations in a more industrial farm (e.g. 30,000
birds at 35𝑘𝑔/𝑚2), for all Virulence Ranks studied here, there is less than 0.2%
infection/removal during the cohort lifetime. In the unvaccinated case, the
population is saturated by infection and therefore a bigger population will re-
sult in more infections.
108
The total number of birds removed due to MDV follows the same trend.
For shorter cohort durations in a more industrial farm (e.g. 30,000 birds at
35𝑘𝑔/𝑚2), for all Virulence Ranks studied here, a less virulent strain gives 2
birds removed due to MDV (0 for a vaccinated flock) compared with 1320 (0-
1 for a vaccinated flock) for more virulent strains. For longer cohort times
(perhaps akin to a free range farm) with a small flock size and low stocking
densities (e.g. 500 birds at 5𝑘𝑔/𝑚2) a less virulent strain gives about 165 birds
removed due to MDV (0-1 for a vaccinated flock), compared with 280 (27 for
a vaccinated flock) for more virulent strains.
For currently realistic environments (e.g. 30,000 birds at 35𝑘𝑔/𝑚2), where the
population is vaccinated, the cleaning efficiency would only have have to be
98% to remove enough virus to reduce the probability of an outbreak in the
next cohort to 5%. However if the population is unvaccinated, for there to be
a 5% chance of an outbreak in the next cohort the efficiency of cleaning needs
to be greater than 1− 10−9.
If an outbreak does occur the quantity of virus left at the end of the cohort
duration is a good measure of viral fitness since it is a fraction of this amount
which will enter the next generation through contamination. In both unvacci-
nated and vaccinated cases, the amount of virus left increases as the Virulence
Rank increases, implying that in all environments, selection always favours
more virulent strains. Using the amount of virus as a measure of fitness of a
virus strain, the results imply that any increase in virulence over the past sixty
years has been due to the continued shift of strains towards a higher virulence.
Regardless of the extent of industrialisation of the farming industry, more vir-
ulent strains are always selected for. In fact, increasing the stocking density
of the birds and introducing vaccination both serve to decrease the selection
pressure for more virulent strains.
There is very little information on MDV prevalence and severity around the
world, and even less data tracking MDV incidence within one farm. However,
Heier et al. (1999) present results from a longitudinal study with data collected
in Norway on flock-level cumulative incidence and mortality for Norwegian
and imported layer birds in caged housing. The mortality in this case refers
to the percentage of birds within the flock, when examined portmortem, had
evidence of MD. For layer flocks living together between the ages of 16 and 68
weeks, in groups of around 7,000, there was a range of 5-8.2% mortality. These
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birds in all the farms were vaccinated at hatch. It is difficult to compare these
data directly with the results shown in this chapter since the method of hous-
ing and chicken population are very different. However, for cohort durations
of 2 months, there is about a 1% total mortality when 5,000 vaccinated birds
are kept together. This is at least in the right order of magnitude (allowing for
the cohort duration) and the results do not falsify the validity of the results
presented here.
Since there is very little known about the prevalence of MDV on farms around
the world, this work sheds lights on the extent to which farms may be affected
by MDV. For real industrial broiler farms, where there are currently about
30,000 birds living together at a stocking density of 35𝑘𝑔/𝑚2 for around 30
days, usually there is no vaccination and, although the total mortality will rise
by only 0.7% (210 birds), there will be an MDV prevalence before slaughter of
88% for a relatively low virulence strain (04CRE). Therefore choosing shorter
cohort durations masks the huge infection rate on the farm. Suppose that the
same farm was infected with a more virulent strain (02LAR) and the owners
felt that the losses due to MDV were too high so they decided to vaccinate the
flock, the removed cases would drop to a negligible quantity. However, de-
spite there being no visible signs of Marek’s disease, it would still require a
98% reduction in the MDV persisting at the end of the cohort to reduce the
chance of MDV persisting the next generation to 5%. A combination of short
cohort durations and vaccination can therefore allow MDV to persist unde-
tected in farm environments. This would suggest to industry that the death
toll from a cohort may not be the best indicator for disease prevalence in the
flock. Furthermore, undetected virus within environments will not only allow
undetected spread from farm to farm, but will increase the risk of evolution of
more virulent strains as predicted by the model.
This is the first exposition of the effect of exposure to MDV on a flock of broiler
birds where all parameters have been formally fitted to data. This approach
enables understanding of the extent to which a flock of birds may be affected
by disease and how difficult it is for the farm to return to a disease-free state.
Quantification of the epidemiology of MDV can not only help to elucidate hy-
potheses for evolution and persistence of more virulent strains of the virus but
can provide evidence for implementing control methods to reduce the impact
of the virus and its evolution in the future.
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Farm Networks & MDV
5.1 Introduction
The last two chapters were concerned with the invasion and fitness of Marek’s
disease virus strains on a single farm in one cohort of birds. This approach is
extended to look at a network of poultry farms, using parameters estimated
from the past three chapters.
This work is the first attempt to track the persistence of MDV strains in a
network of farms. It will concern the extent to which cleaning, vaccination,
farm size, length of cohort duration, transmission network size and network
connectivity affect the persistence of the virus within that network.
There has been much modelling of pathogen spread through host networks
which have shown that there is much scope for complicated parameterisa-
tions of the demographic structure, disease transmission processes and biose-
curity measures. For example, Watts and Strogatz (1998) quantified the ef-
fect of ‘small-world networks’ on diverse modelling applications; May and
Lloyd (2001) assessed the impact on scale-free networks on qualitative dis-
ease dynamics; van Baalen (2002) introduced simple epidemiological models
on network structures and assess the implications for the evolution of viru-
lence; Read and Keeling (2003) studied the evolution of parasite traits within
different types of network; Keeling and Eames (2005) reviewed the implica-
tions of network structures on disease outcome and control; Woolhouse et al.
(2005) analysed specific cattle networks and assessed the impact the network
strucutre on the size of the basic reproductive number of an infection.
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However, choosing a good network model and estimating parameters comes at
the price of good data, which is unfortunately lacking for MDV. The reasons
behind this were noted in Chapter 1, but mainly hinge on the fact that MD
is not a notifiable disease. Thus, a clear picture of MDV prevalence within
farm networks is patchy at best, although there is evidence that in addition
to strains becoming more virulent, these strains have increased in prevalence
among farms (Witter, 2001). With this in mind, this chapter limits itself to
disease transmission on a simple network of farms, which can be easily pa-
rameterised with information gleaned from earlier studies. It is hoped that
this work may generate hypotheses concerning the prevalence of MDV strains
which can be tested in the field.
5.2 Methods
5.2.1 Network Epidemiological Model
A network of broiler farms is modelled such that each farm is in either one of
two states: ‘susceptible’ or ‘infected’. An infected farm is defined as having at
least one MDV infected bird during the life of the cohort. A susceptible farm
is one in which there is has never been an MDV infected bird during the life
of the cohort. For simplicity, I make a number of assumptions: that each farm
is assumed to have only one barn; that all farms have equal numbers of birds;
and, all other important parameters are the same.
An infected farm is assumed to have the potential to transmit to other farms
when the cohort of chickens reaches the end of its life in the barn. Therefore
transmission between farms is naturally modelled by using a discrete time
model, where each time step corresponds to the end of a cohort generation. At
the end of every cohort generation two processes are modelled in turn:
1. the removal of birds, by a catcher company, to slaughter. Infectious farms
infect the fomites (e.g. bird crates of the catcher company) and the virus
is transmitted to other farms in the network (note that the order in which
farms are visited is not considered), then;
2. the cleaning of farms before new cohorts arrive.
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The contamination of farms can occur via human movement, especially
catcher companies whose responsibility it is to remove a cohort of birds and
take them for slaughter. These catcher companies will service multiple broiler
farms (surveys suggest that each UK catcher company services between 1-200
farms (Dent et al., 2008)). The effective transmission network for a single
farm will be defined as either 1) all of the farms in the network (well-mixed
network) or 2) the closest four neighbours in a farm lattice model (von Neu-
mann neighbourhood). Any transmission between farms is within this effec-
tive transmission network.
At the end of a cohort generation before cleaning, a constant quantity of virus
is left in a barn at the end of a cohort, 𝑍𝑐 (Section 4.3.2.1), which is assumed
to be the same for all infected farms. Let the number of infected farms able
to transmit to farm 𝑗 at time 𝑛, be 𝐼 (𝑛)𝑗 . The total virus in all the farms able to
transmit to farm 𝑗 is therefore 𝑍𝑐𝐼
(𝑛)
𝑗 . The virus that contaminates farm 𝑗 is a
proportion, 𝜃, of this amount, 𝜃𝑍𝑐𝐼
(𝑛)
𝑗 , where 𝜃 is a contamination parameter.
All farms are then cleaned and a proportion, 𝜖, of this virus is left.
Therefore the amount of virus on a susceptible farm 𝑗 at the start of the next co-
hort is 𝜖𝜃𝑍𝑐𝐼
(𝑛)
𝑗 , where 1-𝜖 is the on-farm cleaning efficiency; and the amount
of virus on an infected farm at the start of the next cohort is 𝜖𝑍𝑐[1 + 𝜃𝐼
(𝑛)
𝑗 ]
because 𝑍𝑐 is left before cleaning from the previous cohort.
Therefore, the probability of a farm 𝑗 moving from a susceptible state to an









Whilst the probability of a farm 𝑗 moving from an infected state to a suscepti-
ble state at time 𝑛 is
𝑞
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where the probability of remaining in a susceptible or infected state is 1− 𝑝(𝑛)𝑗
or 1− 𝑞(𝑛)𝑗 respectively and 𝑃 is the probability of an outbreak given an initial






Figure 5.1: Transition diagram showing the possible transitions to and from each
state (Susceptible or Infected) at time 𝑛. The possible movements are associated with
probabilities.
The proportion of farms at time 𝑛 in an uninfected state is denoted by 𝑠𝑛 and
the proportion of infected farms by 𝑖𝑛. The total number of farms in the pop-
ulation, 𝑓 , is assumed to be constant and therefore 𝑠𝑛 + 𝑖𝑛 = 1 for any 𝑛 ∈ N.
For a given farm the probabilities can be represented in a transition diagram
depicted in Figure 5.1. This system is a Markov chain since the state of the sys-
tem at time 𝑛 only depends on the state of the system at 𝑛− 1 (Norris, 1997).
In the well-mixed transmission case, 𝑝(𝑛)𝑗 = 𝑝
(𝑛) and 𝑞(𝑛)𝑗 = 𝑞
(𝑛). At any time, 𝑛,
this system can be represented by the following equation,
⎛⎜⎜⎜⎜⎝ 𝑠𝑛𝑖𝑛
⎞⎟⎟⎟⎟⎠ = Q⎛⎜⎜⎜⎜⎝ 𝑠𝑛−1𝑖𝑛−1
⎞⎟⎟⎟⎟⎠ = ⎛⎜⎜⎜⎜⎝ 1− 𝑝(𝑛) 𝑞(𝑛)𝑝(𝑛) 1− 𝑞(𝑛)
⎞⎟⎟⎟⎟⎠⎛⎜⎜⎜⎜⎝ 𝑠𝑛−1𝑖𝑛−1
⎞⎟⎟⎟⎟⎠
Since the transition probabilities depend on the state of the chain at time
𝑛, the Markov chain is classified as time-inhomogeneous. Most theory for
Markov chain systems is concerned with time-homogeneous systems (e.g. Dur-
rett, 1999) and therefore this system is solved numerically.
5.2.2 Parameter Values
Two sizes of networks will be considered: small (𝑓 =20 farms) and large (𝑓 =200
farms). There are two scenarios: every farm is assumed to be equivalent to a
barn of either a small number of chickens (𝑆0=500 birds at a low stocking
density, 5𝑘𝑔/𝑚2) or a large number (𝑆0=30,000 birds at 35𝑘𝑔/𝑚2) where all
the farms in the network are all unvaccinated or HVT vaccinated. For every
114
farm in the network, the cohort duration will either have a short cohort du-
ration (𝑇𝑐 = 30 days) or a long cohort duration (𝑇𝑐 = 60 days). Contamination
parameters (𝜃, 𝜖) will be varied over the range 1x10−5 to 1.5x10−1.
The number of simulations for each parameter combination is set to 300, since
preliminary analysis showed an acceptable level of convergence on the mean
prevalence was reached with this number.
Note that the transmission parameters are not scaled with network size and
thus larger networks potentially have larger basic reproductive numbers.
5.2.3 Virus at the End of the Cohort Duration, 𝑍𝑐
The mean amount of virus left at the end of a cohort duration was calculated
in Chapter 4. Graphs of this are shown in Figure 5.2a (Unvaccinated birds)
and Figure 5.2b (HVT Vaccinated birds). In the unvaccinated case the farm
is saturated with infection and a larger barn, with more infected individu-
als, harbours more virus. In the vaccinated case the amount of virus does not
change with population size because the farm is not saturated with infection.
Although, when the individuals are more densely stocked, the volume of the
barn is reduced and therefore both the amounts of dust and virus in the atmo-
sphere are reduced too.
5.2.4 Probability of an Outbreak, 𝑃
The probability of an MDV outbreak was calculated in Chapter 4. A function
relating this probability, 𝑃 , to the virus inoculum, 𝑉0, was fitted to this ex-
pectation such that 𝑃 = 1 − exp(−𝑢𝑉0) where the constant, 𝑢, was estimated
via least-squares (Figure 5.3). For an unvaccinated population, 𝑢𝑢𝑛𝑣𝑎𝑐𝑐/𝑠𝑚𝑎𝑙𝑙 =
1.11x10−7, 𝑢𝑢𝑛𝑣𝑎𝑐𝑐/𝑙𝑎𝑟𝑔𝑒 = 3.51x10−7 for a small and large farm respectively. For
a HVT vaccinated population, 𝑢𝑣𝑎𝑐𝑐/𝑠𝑚𝑎𝑙𝑙 = 1.67x10−9, 𝑢𝑣𝑎𝑐𝑐/𝑙𝑎𝑟𝑔𝑒 = 5.46x10−9
for a small and large farm respectively. Curve fitting was carried out in Mat-
lab® (2007).
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Figure 5.2: Total Virus at Cohort Duration End: the estimates of virus left at the end
of a cohort duration from Chapter 4. This can vary with Cohort Duration, 𝑇𝑐,
measured in days, depending on whether the farm is small (𝑆0=500 birds at stocking
density of 5𝑘𝑔/𝑚2) or large (𝑆0=30,000 birds at stocking density 35𝑘𝑔/𝑚2). Note the
different y-axis scales.






















































Figure 5.3: Probability of Outbreak: An increasing probability of an outbreak on a
small farm (𝑆0=500 birds at 5𝑘𝑔/𝑚2) and large farm (𝑆0=30,000 birds at 35𝑘𝑔/𝑚2),
where the farm is either unvaccinated or HVT vaccinated. The grey lines correspond
to the expected value based on calculations discussed in Chapter 4, the red/green
lines are the best fit of 𝑃 = 1− exp(−𝑢𝑉0) to this expected value (𝑉0 is the virus
inoculum variable and 𝑢 is 𝑢𝑢𝑛𝑣𝑎𝑐𝑐/𝑠𝑚𝑎𝑙𝑙 , 𝑢𝑢𝑛𝑣𝑎𝑐𝑐/𝑙𝑎𝑟𝑔𝑒, 𝑢𝑣𝑎𝑐𝑐/𝑠𝑚𝑎𝑙𝑙 or 𝑢𝑣𝑎𝑐𝑐/𝑙𝑎𝑟𝑔𝑒 ). Note
the different x-axis scales.
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5.3 Results
For all the results presented here, the time-evolution of the Markov chain
showing the prevalence of the infected farms was run for 100 years. This cor-
responds to 1216 and 608 cohort generations of durations 30 days and 60 days
respectively.
The results show three qualitatively different types of Markov chain time-
evolutions: extinction (characterised by an immediate decline in the number
of infected farms), epidemic (characterised by an initial rise in the number of
infected farms, but an eventual decline to zero prevalence) and endemic (char-
acterised by an initial rise in the prevalence of infected farms such that the
prevalence rises to nearly, or equal to, 100%). Therefore there are two out-
comes to consider: 1) the maximum mean prevalence of a strain (i.e. the max-
imum prevalence an epidemic reaches, when the average of the simulations is
calculated) 2) the rate at which this maximum mean prevalence is reached (or
the rate at which an stable endemic prevalence is reached).
Figures 5.4-5.13 show the effect on outcomes 1) and 2) when parameters of
interest are changed which dictate the following variables: Virulence Rank,
contamination of farms, transmission network size, farm size, network size,
vaccination and cohort duration.
5.3.1 Effect of Virulence Rank, 𝑣
In all the figures presented in Section 5.3, the effects of different Virulence
Ranks on the prevalence of infected farms through time are shown. A strain
with a greater Virulence Rank has a greater maximum mean prevalence than
less virulent strains (clearly seen in Figures 5.4-5.13). A higher Virulence Rank
will also increase the rate at which that maximum prevalence is reached.
5.3.2 Effect of Contamination Parameters (𝜃,𝜑)
Increasing either parameter 𝜃 or 𝜖 increases the maximum mean prevalence
for all the strains and the rate at which that prevalence is reached, although
the effect of 𝜖 is much greater (compare Figure 5.4c to 5.5a and 5.5c, Figure
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5.4d to 5.5b and 5.5d) because 𝜃 does not affect the amount of virus remaining
on an infected farm after cleaning.
Therefore in all cases, increasing the contamination parameters 𝜃 and 𝜖 to-
gether increases the maximum prevalence for all the strains and increases the
rate at which the endemic prevalence is reached (seen in all figure columns
e.g. Figures 5.6a, 5.6c, 5.6d through to 5.13a, 5.13c, 5.13d).
5.3.3 Effect of Effective Transmission Network Size
Changing from a well-mixed network to nearest neighbour transmission slows
the rate at which that prevalence is reached (e.g. compare Figures 5.4 to 5.7 and
Figures 5.6 to 5.8).
5.3.4 Effect of Farm Size (𝑠𝑑,𝑆0)
For either unvaccinated or vaccinated networks, changing the farm structure
to a more industrial cohort size and density (from 500 birds at 5𝑘𝑔/𝑚2 to
30,000 birds at 35𝑘𝑔/𝑚2) increases the maximum mean prevalence of a strain
(compare Figure 5.4 to Figure 5.6 and Figure 5.9 to Figure 5.10).
5.3.5 Effect of Network Size
Increasing the number of farms in the transmission network decreases the
variability of the prevalence, giving a narrower confidence interval on the
mean prevalence for each strain over time (compare left hand columns of Fig-
ures 5.4-5.13 with right hand columns in the same figures). The consequence
of this stochasticity is that, in some cases, a small network of farms leads to a
extinction of the strain which is not the case for larger networks (e.g. compare
Figure 5.9a to 5.9b). This effect decreases when other parameters are such that
the probability of strain extinction is very low. However, when all strains in
each case can persist (with a combination of intermediate values for 𝜃 and 𝜖
and high virulences or simply large 𝜃 and 𝜖 values (e.g. compare Figure 5.8e to
5.8f), the size of the network only has a big positive effect on the rate at which
the maximum strain prevalence is reached. In nearest neighbour transmission,
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a larger network slows the rate of the spread, whereas when the transmission
is well-mixed, a larger network increases the rate at which the maximum mean
prevalance is reached as there are more contacts and the dynamics are acceler-
ated.
5.3.6 Effect of Vaccination (sham or HVT)
The prevalence of infected farms housing vaccinated birds was calculated
for well-mixed transmission (Figure 5.9 (small farms) and Figure 5.10 (large
farms)) and nearest neighbour transmission (Figures 5.11 (small farms)). Us-
ing a network of farms in which all the birds are vaccinated drastically de-
creases the maximum mean prevalence of all strains. Note the large increase
in the size of the contamination parameters 𝜃 and 𝜖 to achieve similar preva-
lences for some strains (e.g. compare Figure 5.4e to Figure 5.9e, Figure 5.6e to
Figure 5.10e and Figure 5.7e to Figure 5.11e).
5.3.7 Effect of Cohort Duration (𝑇𝑐)
There is no effect of changing the cohort duration for unvaccinated networks
on the maximum mean prevalence and the number of cohort generations is
takes to reach that maximum mean prevalence. Although using a cohort dura-
tion of 30 days instead of 60 days will half the time it takes to reach the maxi-
mum mean prevalence. For vaccinated networks, there is a substantial rise in
the maximum mean prevalence of a strain for longer cohort durations because
there is more virus is produced at the end of each cohort duration. Figures 5.9
and 5.10 show well-mixed transmission results for vaccinated populations for
𝑇𝑐=30 days which should be compared to Figures 5.12 and 5.13 showing the
same results for 𝑇𝑐=60 days.
5.3.8 Rate at Which The Maximum Prevalence Is Reached
The time taken to reach a maximum prevalence (in the case of an epidemic or
endemic situation) varies widely. In most cases only a couple of generations
are needed (e.g. Figure 5.10f), for others a number of years is required (e.g.
Figure 5.4e). In the case where an epidemic occurs and the strain subsequently
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Increasing Variable Rate to Maximum Maximum Mean
Prevalence Prevalence
Virulence Rank + +
Contamination, 𝜃 + +
Contamination, 𝜖 + +
Farm Size (𝑆0,𝑠𝑑) + +
Network Size, 𝑓 +/-* +
Transmission Network Size + +
Vaccination (introduction) na -
Cohort Duration, 𝑇𝑐 + +
Table 5.1: Effect of Increasing Variables on both the rate at which an epidemic
occurs or the rate at which an endemic prevalence is reached and the maximum mean
prevalence of the strain. *There is an increase in the rate to maximum prevalence for
well-mixed networks, but a decrease in the nearest neighbour transmission networks.
becomes extinct in the population, the rate of decline may be so slow that it
appears to be endemic (e.g. Figure 5.11e for a strain where 𝑣=50).
5.3.9 Summary
A table of the main results of this chapter are given in Table 5.1. Included are
the outcomes: rate to maximum prevalence and maximum mean prevalence.
The rate at which an epidemic occurs correlates with how severe it is (i.e. the
rate to the maximum prevalence changes positively with the maximum mean
prevalence). This can be seen by noting that if one outcome is changed by a
variable in one way, the other outcome changes in the same way.
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(a) 𝑓 = 20, 𝜃,𝜖=0.0001 (b) 𝑓 = 200, 𝜃,𝜖=0.0001
(c) 𝑓 = 20, 𝜃,𝜖=0.0003 (d) 𝑓 = 200, 𝜃,𝜖=0.0003
(e) 𝑓 = 20, 𝜃,𝜖=0.0005 (f) 𝑓 = 200, 𝜃,𝜖=0.0005
Figure 5.4: Convergence of Markov chain with Well-Mixed Transmission
(Unvaccinated Population): The trajectory of the proportion of infected farms, when
initially one farm is infected with a strain of virulence, 𝑣. The coloured regions show
the 95% confidence interval for their respectively mean values. In all cases, 𝑆0 = 500
and 𝑠𝑑 = 5𝑘𝑔/𝑚2 and 𝑇𝑐=30 days.
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(a) 𝑓 = 20, 𝜃=0.0003,𝜖=0.0005 (b) 𝑓 = 200,𝜃=0.0003,𝜖=0.0005
(c) 𝑓 = 20, 𝜃=0.0005,𝜖=0.0003 (d) 𝑓 = 200,𝜃=0.0005,𝜖=0.0003
Figure 5.5: Convergence of Markov chain with Well-Mixed Transmission
(Unvaccinated Population): The trajectory of the proportion of infected farms, when
initially one farm is infected with a strain of virulence, 𝑣. The coloured regions show
the 95% confidence interval for their respectively mean values. In all cases, 𝑆0 = 500
and 𝑠𝑑 = 5𝑘𝑔/𝑚2 and 𝑇𝑐=30 days.
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(a) 𝑓 = 20, 𝜃,𝜖=0.00001 (b) 𝑓 = 200, 𝜃,𝜖=0.00001
(c) 𝑓 = 20, 𝜃,𝜖=0.00005 (d) 𝑓 = 200, 𝜃,𝜖=0.00005
(e) 𝑓 = 20, 𝜃,𝜖=0.0001 (f) 𝑓 = 200, 𝜃,𝜖=0.0001
Figure 5.6: Convergence of Markov chain with Well-Mixed Transmission
(Unvaccinated Population): The trajectory of the proportion of infected farms, when
initially one farm is infected with a strain of virulence, 𝑣. The coloured regions show
the 95% confidence interval for their respectively mean values. In all cases,
𝑆0 = 30,000 and 𝑠𝑑 = 35𝑘𝑔/𝑚2 and 𝑇𝑐=30 days.
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(a) 𝑓 = 20, 𝜃,𝜖=0.0001 (b) 𝑓 = 200, 𝜃,𝜖=0.0001
(c) 𝑓 = 20, 𝜃,𝜖=0.0003 (d) 𝑓 = 200, 𝜃,𝜖=0.0003
(e) 𝑓 = 20, 𝜃,𝜖=0.0005 (f) 𝑓 = 200, 𝜃,𝜖=0.0005
Figure 5.7: Convergence of Markov chain with Nearest-Neighbour Transmission
(Unvaccinated Population): The trajectory of the proportion of infected farms, when
initially one farm is infected with a strain of virulence, 𝑣. The coloured regions show
the 95% confidence interval for their respectively mean values. In all cases, 𝑆0 = 500
and 𝑠𝑑 = 5𝑘𝑔/𝑚2 and 𝑇𝑐=30 days.
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(a) 𝑓 = 20, 𝜃,𝜖=0.00001 (b) 𝑓 = 200, 𝜃,𝜖=0.00001
(c) 𝑓 = 20, 𝜃,𝜖=0.00005 (d) 𝑓 = 200, 𝜃,𝜖=0.00005
(e) 𝑓 = 20, 𝜃,𝜖=0.0001 (f) 𝑓 = 200, 𝜃,𝜖=0.0001
Figure 5.8: Convergence of Markov chain with Nearest-Neighbour Transmission
(Unvaccinated Population): The trajectory of the proportion of infected farms, when
initially one farm is infected with a strain of virulence, 𝑣. The coloured regions show
the 95% confidence interval for their respectively mean values. In all cases,
𝑆0 = 30,00 and 𝑠𝑑 = 35𝑘𝑔/𝑚2 and 𝑇𝑐=30 days.
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(a) 𝑓 = 20, 𝜃,𝜖=0.05 (b) 𝑓 = 200, 𝜃,𝜖=0.05
(c) 𝑓 = 20, 𝜃,𝜖=0.1 (d) 𝑓 = 200, 𝜃,𝜖=0.1
(e) 𝑓 = 20, 𝜃,𝜖=0.15 (f) 𝑓 = 200, 𝜃,𝜖=0.15
Figure 5.9: Convergence of Markov chain with Well-Mixed Transmission (HVT
vaccinated Population): The trajectory of the proportion of infected farms, when
initially one farm is infected with a strain of virulence, 𝑣. The coloured regions show
the 95% confidence interval for their respectively mean values. In all cases, 𝑆0 = 500
and 𝑠𝑑 = 5𝑘𝑔/𝑚2 and 𝑇𝑐=30 days.
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(a) 𝑓 = 20, 𝜃,𝜖=0.01 (b) 𝑓 = 200, 𝜃,𝜖=0.01
(c) 𝑓 = 20, 𝜃,𝜖=0.05 (d) 𝑓 = 200, 𝜃,𝜖=0.05
(e) 𝑓 = 20, 𝜃,𝜖=0.1 (f) 𝑓 = 200, 𝜃,𝜖=0.1
Figure 5.10: Convergence of Markov chain with Well-Mixed Transmission (HVT
vaccinated Population): The trajectory of the proportion of infected farms, when
initially one farm is infected with a strain of virulence, 𝑣. The coloured regions show
the 95% confidence interval for their respectively mean values. In all cases,
𝑆0 = 30,000 and 𝑠𝑑 = 35𝑘𝑔/𝑚2 and 𝑇𝑐=30 days.
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5.4 Discussion
Three types of phenomena can be observed in these results: extinction, epi-
demic, or persistence at endemic prevalences near, or equal to, 100%. It is
anticipated that the limit distributions of the system are 𝑖𝑛 = 0 and 𝑖𝑛 = 1,
since the epidemic strains always include a zero prevalence in their confidence
intervals and the endemic strains never include a zero in theirs. The limit dis-
tribution would then depend on the initial values of the variables which have
been highlighted in Section 5.3.
The more virulent a strain is the better able it is to persist in a network of
farms, the better able it is to persist at a higher maximum mean prevalence
(in an epidemic situation) and the better able it is to reach that positive preva-
lence at a faster rate. This is expected because Virulence Rank is positively
correlated with a greater amount of virus per 𝑚𝑔 of dust.
Improved cleaning on a farm and reduced contamination between farms can
provide a better chance of the virus becoming extinct in the farm population,
or at least can reduce the mean maximum prevalence of the strains within the
network in the epidemic situation. This result is intuitively correct and should
be expected in this simple network model. The effect of on-farm cleaning has a
greater impact on reducing the maximum mean prevalence of a strain and its
rate of increase within the network than between-farm cleaning. This can be
expected due to the fact that virus extinction on one farm reduces the network
prevalence by both that one farm plus any reduction in transmission to other
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(a) 𝑓 = 20, 𝜃,𝜖=0.05 (b) 𝑓 = 200, 𝜃,𝜖=0.05
(c) 𝑓 = 20, 𝜃,𝜖=0.1 (d) 𝑓 = 200, 𝜃,𝜖=0.1
(e) 𝑓 = 20, 𝜃,𝜖=0.15 (f) 𝑓 = 200, 𝜃,𝜖=0.15
Figure 5.11: Convergence of Markov chain with Nearest-Neighbour Transmission
(HVT vaccinated Population): The trajectory of the proportion of infected farms,
when initially one farm is infected with a strain of virulence, 𝑣. The coloured regions
show the 95% confidence interval for their respectively mean values. In all cases,
𝑆0 = 500 and 𝑠𝑑 = 5𝑘𝑔/𝑚2 and 𝑇𝑐=30 days.
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(a) 𝑓 = 20, 𝜃,𝜖=0.01 (b) 𝑓 = 200, 𝜃,𝜖=0.01
(c) 𝑓 = 20, 𝜃,𝜖=0.05 (d) 𝑓 = 200, 𝜃,𝜖=0.05
(e) 𝑓 = 20, 𝜃,𝜖=0.1 (f) 𝑓 = 200, 𝜃,𝜖=0.1
Figure 5.12: Convergence of Markov chain with Well-Mixed Transmission (HVT
vaccinated Population): The trajectory of the proportion of infected farms, when
initially one farm is infected with a strain of virulence, 𝑣. The coloured regions show
the 95% confidence interval for their respectively mean values. In all cases, 𝑆0 = 500
and 𝑠𝑑 = 5𝑘𝑔/𝑚2 and 𝑇𝑐=60 days.
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(a) 𝑓 = 20, 𝜃,𝜖=0.01 (b) 𝑓 = 200, 𝜃,𝜖=0.01
(c) 𝑓 = 20, 𝜃,𝜖=0.05 (d) 𝑓 = 200, 𝜃,𝜖=0.05
(e) 𝑓 = 20, 𝜃,𝜖=0.1 (f) 𝑓 = 200, 𝜃,𝜖=0.1
Figure 5.13: Convergence of Markov chain with Well-Mixed Transmission (HVT
vaccinated Population): The trajectory of the proportion of infected farms, when
initially one farm is infected with a strain of virulence, 𝑣. The coloured regions show
the 95% confidence interval for their respectively mean values. In all cases,
𝑆0 = 30,000 and 𝑠𝑑 = 35𝑘𝑔/𝑚2 and 𝑇𝑐=60 days.
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farms. Reduction of contamination between-farms serves to limit the rate of
spread between farms, but does nothing to stop the reinfection of a farm in-
fected in its last cohort.
The bigger the farms are in a network, the greater the maximum mean preva-
lence at which a virus can persist in that network. Farm size positively affects
the total virus produced by a cohort for unvaccinated farms (Figure 5.2a), but
negatively affects it on vaccinated farms (Figure 5.2b). However, the proba-
bility that an inoculum creates an outbreak is always less on smaller farms.
The net result in both cases is that there is always a larger maximum mean
prevalence when the farm is large.
Small farm networks lead to more variability in the prevalence of a virus
strain, and hence the strains are more likely to go extinct in both well-mixed
and nearest-neighbour transmission models. Larger networks of farms reduce
this variability and so have higher persistence probabilities when there is a
chance of extinction for the smaller networks. The stochastic effects of small
networks are well-documented, and these results are in line with the theory
(Murray et al., 1986; Mollison, 1995; Shigesada and Kawasaki, 1997).
Nearest-neighbour transmission increases the probability of virus extinction
for small contamination probabilities. The increased chance of extinction can
be accounted for by the fact that, at the start of an outbreak, there are only
a few farms to which transmission can occur and stochastic effects can force
the initial outbreak to zero more easily due to the reduced transmission. This
limited transmission also slows the rate at which the strain mean maximum
prevalence is reached. This is because the spatially explicit nature of the net-
work allows an epidemic wave front to limit the size of the epidemic at each
generation.
Cohort duration only changes the rate at which the maximum mean prevalence
is reached when the network is comprised of unvaccinated farms (because the
duration of each generation changes). This is because the probability of an out-
break does not depend on the duration of a cohort, and the quantity of virus is
not affected by cohort duration in any significant way (Figure 5.2a). However,
for vaccinated networks, since a longer cohort duration is associated with a
large quantity of virus within a barn (Figure 5.2b), a longer cohort duration is
associated with an increased maximum mean prevalence for a virus strain in
the network.
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Vaccinated networks require a much greater level of contamination to allow
any of the strains to reach the same maximum mean prevalences. For any
of the more virulent strains to reach the same probabilities of persistence as
the unvaccinated network, both contamination parameters 𝜃 and 𝜖 have to
increase by over 2000 times (e.g. compare Figure 5.4c (unvaccinated) to Fig-
ure 5.4e (vaccinated)). If the contamination parameters are this high (i.e. for
strains to reach even low prevalences in vaccinated networks) in unvaccinated
networks, all strains examined here will become endemic in the network and
persist at 100% prevalence.
If a strain is able to persist in the farm network, and the network is well-
mixed, it can usually reach maximum prevalence in less than 30 generations.
Only in the cases where either transmission is by nearest neighbour or when
the contamination parameters are very small is the maximum mean prevalence
reached in over 10 years (indeed the extreme cases suggest that the strains can-
not reach their maximum prevalence even after 100 years (e.g. Figure 5.7a)).
Since there has been approximately one vaccine introductions every 10-15
years in response to the waves of more virulent strains, each strain would have
to spread significantly through the farm network in less than 10-15 years to
cause concern. It is possible that a more virulent strain, having entered a sys-
tem of farms, could spread quickly (if the transmission occurred frequently
between farms), and an introduction of a single virulent strain would be suf-
ficient to generate a country-size epidemic. In a well-mixed farm network, in-
creasing the number of farms will only increase the rate at which the maximum
mean prevalence is reached and therefore a more virulent strain could spread
through a network of broiler farms the size of the UK in less than 10 years.
However, in the more realistic case where transmission is more restricted (i.e.
there is either limited contact between the different farms in a country or the
contamination levels on farms is so low), an invading strain would not be able
to create an epidemic on the time scale that MDV has been evolving. In the
latter case for a country the size of the UK with 3000 broiler farms (Sheppard,
2004), it would require multiple introductions of more virulent strains to cre-
ate an country-wide epidemic of MDV over a time scale of decades.
Despite some strains eventually becoming extinct, the length of time they may
take to do this can be in the order of decades, if not longer. For example, Figure
5.11f shows a strain of virulence 70 reaching a mean prevalence of 30% before
slowly decreasing its prevalence in 95 years to 20%. This phenomenon of an
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epidemic appearing as an endemic has been postulated previously; Woolhouse
et al. (2001) looked at sheep scrapie in the UK and explained how its epidemic
behaviour could have been masked by the long generation time of the disease,
making it seem like an endemic problem.
This model only looks at the situation where there is one circulating strain
in the network. Past work in Chapter 4 has shown that the cohort structure
of broilers always favours more virulent strains, which suggests that if two
strains enter a cohort of birds, the more virulent strain will always outcompete
the less virulent strain. This study is therefore collapsing this competition and
assuming that the circulating strain is the most virulent at the time. Implicit
in this model is the assumption that the presence of a less virulent strain has
no effect on a more virulent strain. There is limited information about the out-
come of superinfection with two MDV strains. Most work is concerned with
the dynamics of a vaccinal (non-pathogenic) strain in response to a superin-
fecting MDV (pathogenic) strain (e.g. Islam et al., 2007) and there is no reason
to assume the same dynamics occur with two pathogenic strains. However,
this chapter assumes that superinfection with a more virulent strain can dis-
advantage a less virulent strain either by simply killing off its host quicker or
by both killing off its host quicker and suppressing its replication potential
(and therefore its shedding rate). If there is some competition between strains,
then the invasion of a more virulent strain would be slower.
In the case where short cohort durations are used instead of vaccination as a
control to curb the losses due to MDV, it is apparent that the disease is more
likely to be endemic than in the case where longer cohort times are used but
where broilers are vaccinated.
The prevalence in a farm network may not correlate with the prevalence of
disease-induced death on a farm. For example, when a vaccinated large farm
has an outbreak of MDV of Virulence Rank 46, there is little or no MDV seen
in terms of clinical signs (see Chapter 4 where a Virulence Rank of 46 causes
0.002% extra mortality), however the disease may persist at high prevalence if
the biosecurity both on- and between-farm is lax (see Figures 5.10c-f). Indeed
it may well be the case that a decreased perception of risk may lead to risky
behaviour with a farm’s disease-protection measures. A high prevalence of
virus circulating in the farm network could then be acting as a reservoir for
the emergence and proliferation of new more virulent strains.
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The results of the model are consistent with reports that smaller back-yard
poultry holdings suffer from MDV less than large commercial holdings (Nair
and Kung, 2004) and that more virulent strains exist at higher prevalences
than less virulent strains (Witter, 2001). The latter case also highlights the
problem that future, more virulent strains may be harder to eliminate from the
farm networks than those which have previously been (relatively) successfully
controlled.
To reduce the ability of MDV strains to persist in the network, a farm must
first and foremost:
• vaccinate their stock;
• reduce the dust contamination within the barn during the cohort dura-
tion.
Other effective control measures are then to:
• reduce the contamination between each cohort and have better hygiene
facilities for on-farm visitors/catchers;
• maintain shorter cohort durations if the flock is vaccinated;
• use smaller catcher companies and avoid contact with other farms.
This model highlights the situation in which there are strains circulating in
the farm networks but are not currently observable. This fact reinforces the
need for a clear understanding of the actual prevalence of MDV strains and to
investigate the spectrum of virulences currently infecting our poultry flocks.
This will provide us forewarning of the potential risk from new, more virulent,
strains, which cannot be so easily controlled by our current vaccines and which





This thesis is the first quantitative assessment of Marek’s disease virus (MDV)
to answer the question of why the virus has evolved to higher virulence over
the past sixty years. The work examines the effect of the virus on its chicken
host and the ability of the virus to persist in a host population. The work draws
on epidemiological and evolutionary theory to formalise and test hypotheses
related to the increase in MDV virulence.
MDV is an ongoing concern in the poultry industry and vaccines are routinely
used to control the disease; indeed new vaccines are brought into circulation
every decade or so to quell the tide of problems which emerge as the virus
strains increase in virulence and the previous vaccine efficacy wanes. How-
ever, since there has been no testing of the causes of this virulence evolution it
is hoped that this work will provide crucial first steps in both explaining the
problem caused by MDV virulence increases and shed light on the best course
of action to limit the damage caused by future evolution.
Little was known about many important parameters needed for an evolution-
ary analysis of MDV strains. Chapter 2 was concerned with formally estimat-
ing parameters for viral shedding, host mortality and the transmission process.
There was good evidence that viral shedding and host mortality positively cor-
relate with the notion of virulence defined by previous authors (see Witter
(1997) and Witter et al. (2005)). It was demonstrated that the probability of
infection increases with the virus density in the atmosphere. There was good
support for the hypothesis that the first and second generation vaccines reduce
host mortality due to MDV. It was shown that the first generation vaccine did
137
not effect the viral shedding rates, although it did significantly lower the prob-
ability of infection for a susceptible bird. The second generation vaccine did
lower the viral shedding rates of the birds significantly but was not examined
in the infection experiment. The work also supports the claim that there exists
a trade-off between virulence and transmission for MDV. Host mortality rate
in unvaccinated individuals is proposed as a better definition of virulence for
future pathotyping studies.
The fact that this work estimated the latent period of the virus as shorter than
previously published (4-6 days compared with 6-7 days (Baigent et al., 2005)),
may highlight the different methods and virus strains used to obtain the esti-
mates. Baigent et al. (2005) worked with a vaccine strain (CVI988), whereas
the estimates used in this work are based on pathogenic forms of MDV.
It is not certain that all virus produced is viable. However, the transmission
experiments measured the total viral copy number (VCN) in the atmosphere
and the estimated probability of infection could be correlated with this figure.
Therefore the issue of how one relates VCN to viable virus can be side-stepped.
However, the estimates of transmission probability in either low or high viral
concentrations showed a wide variation. Unfortunately, this may be due to the
limitations of the data, which have small samples sizes and from which only
indirect estimates of transmission probability are obtained.
Only three different strains of MDV are examined in this study and ex-
trapolation beyond the virulence ranges were undertaken in some cases for
explorative purposes. To improve the validity of the conclusions, more strains,
constituting a broader range of virulences could be used in further analyses.
Using current evolutionary biology methods, the fitness of MDV strains was
defined in Chapter 3. The fitness of a virus measures how well a strain per-
sists in a certain environment. By changing the environment in which the
strains reside, one may elucidate which environmental factors lead to the per-
sistence of more virulent strains. Three definitions of fitness were formalised
in this work. Without full inclusion of the transmission processes and spe-
cific demography of the host system different conclusions were reached. With-
out these inclusions, the model concluded that both reducing cohort duration
and introducing vaccination both select for more virulent strains. In the more
complex model, more virulent virus strains are always more able to persist
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compared to their less virulent counterparts whatever the environment. This
meant that changing neither the duration of time the birds live, nor the density
and size of the population in which the birds live, nor the vaccine status of the
birds alters the selection for more virulent strains of MDV. This was the first
study to test these hypotheses. It was concluded that under present conditions
(most notably when broiler chickens are vaccinated or have maternal antibod-
ies for MDV) changing farming conditions does not change the direction of
selection for more virulent strains, but can change the strength of selection. In
particular, vaccination dramatically reduces the strength of selection for more
virulent strains. These findings therefore imply that the rate of evolution of
more virulent strains and their subsequent persistence in farm networks might
be limited by virus genetics.
The role of host mortality and its association with virus shedding was found
to be extremely important in the conclusions. MDV would have experienced
maternal antibody negative hosts when it first emerged in chicken flocks at the
turn of the last century. Therefore the selection on MDV could have occurred
first in maternal antibody negative birds. Consequently, it is necessary to un-
derstand the precise role that maternal antibodies have on the life-history of
the virus before one can draw definite conclusions about the most plausible
route of MDV becoming more virulent.
The role of broilers are studied since all the hypotheses for virulence evolution
can be tested: vaccination introduction, cohort duration reduction and bird
density and population size increases. However, it is unclear at this current
time in which sector of the poultry industry the evolution of MDV is occurring
(i.e. broilers, layers or breeders).
In Chapter 4 a farm of broiler chickens was simulated to measure the effect
of a virus entering a cohort of hosts. The total amount of virus at the end
of each cohort was used as a fitness measure and the results concurred with
Chapter 3, such that host vaccination, cohort duration and host population
structure do not change the selection direction for more virulent strains, al-
though again vaccination in particular reduced the strength of this selection.
The epidemiological impact of an MDV outbreak in a chicken population was
examined by tracing the number of infected individuals and the number of
dead or removed individuals over the life of the cohort. Vaccination accounts
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for a drastic reduction in the perceived impact of MDV infection (such that
there are no removed or dead individuals in many cases) but a pool of virus
could still be maintained undetected on the farm.
It is clear from this work how introducing vaccination into a farm suffering
from substantial MDV losses can radically improve the situation. This result
is corroborated by the substantial use of vaccines within the field and their
success to alleviate MDV losses (Bublot and Sharma, 2004).
The important epidemiological variables, such as quantity of virus emerging
from a cohort and outbreak probability, found in Chapter 4, were used to cre-
ate a stochastic model of between-farm spread of MDV in Chapter 5. As ex-
pected, the probability of an epidemic of MDV in a network of farms increases
with the virulence of the strain causing an outbreak. For certain parameter
ranges vaccination and good hygiene methods are both highly effective in lim-
iting the probability of an endemic situation occurring.
This result is in line with anecdotal evidence that not only have strains
increased in virulence in the post-war period, they have also increased in
prevalence (Witter, 2001).
There is no evidence that vaccination of broilers or increases in farm size have
contributed to the selection for more virulent strains of MDV. With the cur-
rent situation, it is concluded from this work that MDV strains are in evolu-
tionary transition and the rise in virulence is the observation of a virus not
having reached its evolutionary stable strategy. It is not clear in which part
of the poultry sector the selection of more virulent strains emerged. However
the conclusions that vaccination, nor increases in farm size, have selected for
greater virulence should hold when the MDV hosts are not just restricted to
broilers, but include layers and breeders also. Broiler cohorts may only be the
source of the rise in virulence if the cohort duration of broiler birds, which
were maternal antibody negative (the case for rare non-endemic diseases), was
reduced. Decreasing cohort duration may have given rise to more virulent
strains if an absence of maternal antibodies can confer a strong selection for
less virulent strains (if maternal antibodies have a very large effect on the sur-
vival of a bird, but little effect on viral shedding). To test this result properly, a
quantitative assessment of the effect of maternal antibody negative birds must
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first be established. Alternatively, if the initial rise in virulence occurred in
other birds (layers or breeders), it is plausible that if maternal antibodies pro-
duce a great enough protection against disease mortality, the spreading of the
virus itself was enough to allow MDV evolution to more virulent strains. If the
maternal antibody hypothesis is incorrect, the alternative plausible hypothesis
is that the rise in virulence was inevitable and could occur in every poultry
farm. There are two competing hypotheses for the emergence, spread and per-
sistence of more virulent strains; the first is that is it caused by the emergence
of a single strain which can spread through the entire population of farms, the
second that it is caused by multiple lineages of strains, introduced at different
points in the population. This work shows that the rate of spread through a
network of poultry farms is largely determined by the transmission mecha-
nisms involved and without further information on between-farm transmis-
sion parameters neither hypothesis can be ruled out.
6.1 Future Work
Since relatively mild strains were used in this analysis it would be sensible to
look at the effect of some more virulent strains on a farm. It would then be
possible to calculate whether there was a point after which our current vac-
cines would not be sufficient to prevent larger losses from MDV. Furthermore,
it would then be possible to work out how efficacious a future vaccine would
have be to prevent huge losses in the face of much more virulent MDV strains.
It is difficult to estimate the prevalence of MDV within farm networks. If data
were available, the model in Chapter 5 could be formally fitted to prevalence
samples in the field. It still remains a open question as to how much virus
there is circulating in the farm networks. If the virus is not persisting in the
farm networks then there must be constant introduction from another source,
such as wild birds, which could also be acting as a means of spread. It would
therefore be sensible to test for MDV in wild birds (in the way that Murata
et al. (2007) have done) specifically around a variety of poultry houses. Müller
et al. (1999) attempt a similar analysis for the risk of Newcastle disease in
Europe due to the prevalence in migratory birds. This, together with under-
standing of the MDV within a network of farms, could provide better instruc-
tion for a more complex model of between-farm MDV spread to ascertain the
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most plausible contamination process. Furthermore, having a large sample of
recent and historic isolates would allow a formal phylogenetic tree to be con-
structed which can provide crucial facts about the introduction, persistence
and evolution of a population’s MDV strains and the host size in which they
have remained.
If strains are being sampled from the field to test for prevalence, the same
strains can also be used for pathotyping experiments. Not only is the preva-
lence of MDV unknown, but so is the current virulence of strains. It is not
clear for how long circulating strains can be controlled by current vaccines.
To understand the current situation is to understand whether more virulent






Two chains are used to diagnose convergence in the estimation of both the
latent period, 𝑇𝑠(𝑣, 𝑗), and the shedding rate of the virus, 𝑎(𝑣, 𝑗). These chains
are shown in Figures A.1 and A.2, with the Brooks-Gelman-Rubin statistic
for each parameter given in Figures A.3 and A.4. The Brooks-Gelman-Rubin
statistic is described in more detail in Box A.1. The final posterior distributions
are shown in Figures A.5 and A.6. The burn-in time was set to 20,000 and the
posterior distribution was calculated from every 10th accepted value from the
following 25,000 iterations. Raftery and Lewis (1992) suggest taking every 𝑘th
sample to ensure independence of consecutive samples, where 𝑘 ≥ 10. Results
correspond to credible intervals used in Section 2.4.2.
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(a) Sham, 𝑣 = 16.5























(b) Sham, 𝑣 = 36




















(c) Sham, 𝑣 = 46























(d) HVT, 𝑣 = 16.5




















(e) HVT, 𝑣 = 36























(f) HVT, 𝑣 = 46























(g) Bivalent,𝑣 = 16.5























(h) Bivalent,𝑣 = 36























(i) Bivalent,𝑣 = 46
Figure A.1: Viral Shedding: Two parallel Markov chains estimating the latent
period, 𝑇𝑠, for each combination of vaccine and Virulence Rank as stated (first
replicate).
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(a) Sham, 𝑣 = 16.5
























(b) Sham, 𝑣 = 36

























(c) Sham, 𝑣 = 46



























(d) HVT, 𝑣 = 16.5
























(e) HVT, 𝑣 = 36

























(f) HVT, 𝑣 = 46



























(g) Bivalent, 𝑣 = 16.5




























(h) Bivalent, 𝑣 = 36






















(i) Bivalent, 𝑣 = 46
Figure A.2: Viral Shedding: Two parallel Markov chains estimating the logged
shedding rate, log 𝑎(𝑣, 𝑗), for each combination of vaccine and Virulence Rank as
stated (first replicate).
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(a) Sham, 𝑣 = 16.5











(b) Sham, 𝑣 = 36











(c) Sham, 𝑣 = 46











(d) HVT, 𝑣 = 16.5











(e) HVT, 𝑣 = 36











(f) HVT, 𝑣 = 46











(g) Bivalent, 𝑣 = 16.5











(h) Bivalent, 𝑣 = 36











(i) Bivalent, 𝑣 = 46
Figure A.3: Viral Shedding: Brooks-Gelman-Rubin statistics for the latent period,
𝑇𝑠, for each combination of vaccine and Virulence Rank as stated (first replicate).
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(a) Sham, 𝑣 = 46













(b) Sham, 𝑣 = 16.5











(c) Sham, 𝑣 = 36













(d) HVT, 𝑣 = 46











(e) HVT, 𝑣 = 16.5













(f) HVT, 𝑣 = 36













(g) Bivalent, 𝑣 = 46













(h) Bivalent, 𝑣 = 16.5













(i) Bivalent, 𝑣 = 36
Figure A.4: Viral Shedding: Brooks-Gelman-Rubin statistics for the logged
shedding rate, log𝑎(𝑣, 𝑗), for each combination of vaccine and Virulence Rank as
stated (first replicate).
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(a) Sham, 𝑣 = 16.5














(b) Sham, 𝑣 = 36















(c) Sham, 𝑣 = 46















(d) HVT, 𝑣 = 16.5















(e) HVT, 𝑣 = 36














(f) HVT, 𝑣 = 46














(g) Bivalent, 𝑣 = 16.5














(h) Bivalent, 𝑣 = 36















(i) Bivalent, 𝑣 = 46
Figure A.5: Viral Shedding: Posterior distribution for the latent period, 𝑇𝑠, for each
combination of vaccine and Virulence Rank as stated (first replicate).
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(a) Sham, 𝑣 = 16.5












(b) Sham, 𝑣 = 36















(c) Sham, 𝑣 = 46















(d) HVT, 𝑣 = 16.5












(e) HVT, 𝑣 = 36












(f) HVT, 𝑣 = 46















(g) Bivalent, 𝑣 = 16.5












(h) Bivalent, 𝑣 = 36















(i) Bivalent, 𝑣 = 46
Figure A.6: Viral Shedding: Posterior distribution for the logged shedding rate,




It is often stated that it is difficult to prove whether a Markov chain
has converged, only that it has not (Carlin and Lewis, 2008). Brooks
and Gelman (1998) build on previous work done by Gelman and
Rubin (1992) and provide a method for testing the convergence of a
Markov chain without using the variance, thereby bypassing the need
for the assumption of normality. The statistic is 𝑅 and is defined thus:
𝐴 = width of central 80% interval of pooled runs
𝐵 = average width of the 80% intervals within individual runs
𝑅 = 𝐴/𝐵
𝑅→ 1 as more iterations are included in the calculation. In an analysis,
the chain is thought to have converged when 𝑅 ≈ 1. Initially 𝑅 should
be greater than 1 to ensure over-dispersal of the initial values (Carlin
and Lewis, 2008).
A.2 Host Mortality
The burn in for two Markov chains corresponding to the estimation of the
Weibull shape and scale parameters, 𝑟 and 𝜆 are shown in Figure A.7. Con-
vergence diagnostics were calculated by the Brooks-Gelman-Rubin statistic
(Brooks and Gelman, 1998) described in Box A.1. The convergence diagnos-
tics are shown in Figure A.8. After a burn in period of 22,000 iterations, the
chain was run for a total of 100,000 iterations, every 10th accepted figure was
recorded to calculate the posterior distributions of the five parameters, shown
in Figure A.9. Results correspond to credible intervals used in Section 2.4.3.
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Figure A.7: Host Mortality: Mixing of 2 independent chains for each estimated












































Figure A.8: Host Mortality: Brooks-Gelman-Rubin statistic for diagnosing chain
mixing for each estimated parameter. Mixing is considered to have occurred when
the statistic, 𝑅 equilibriates at 1.
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Figure A.9: Host Mortality: Posterior distributions of the five fitted parameters





Broilers and layer birds are known to have different growth patterns (Sewalem
et al., 2002), with broilers having a faster growth rate and also growing to a
larger size.
B.1 Data
In an experiment conducted and described by Islam et al. (2007), groups of
broiler chickens were raised from an age of one day in isolators. All the dust
from each isolator and its exhaust was retrieved every 24 or 48 hours. With
knowledge of the number of chickens per isolator each day and the total dust,
the total mass of dust shed per day per bird was found for weeks 1-8, giving a
total of 8 data points per isolator.
B.2 Methods
The aim is to fit a function of the form 𝑦 = 𝑑(𝑡) where 𝑦 is the mass of the dust
shed per day (𝑚𝑔) and 𝑡 is the age of the bird. Biologically, the dust produced
by a recently hatched bird will not be zero. Other assumptions are the dust
shed is a non decreasing function of age and that the bird will shed an amount
of dust which will tend to a fixed amount as the growing process ends. A
possible candidate model for 𝑑 is therefore:
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𝑑(𝑡) = 𝜂1exp(−𝜂2/𝑡𝜂3) + 𝜂4
where 𝜂𝑖 , ∀𝑖 ∈ [1,4] are parameters to be estimated. Since the aim is to iden-
tify a good fit of the model to the data, point estimates for the parameters
are sought. The least squares method is used, together with the Levenberg-
Marquardt algorithm to minimise the resulting sum function. Matlab® (2007)
was used for this analysis with the lsqcurvefit function.
Since we have multiple dust profile curves and need to estimate a dust shed-
ding function, it can be proved that in this case minimising the sum (over
all observations) of the distances from each data point to the model point is
equivalent to minimising the distance from the arithmetic mean of multiple
data points to the model point.
To show this, consider one time point at which the sum of the distance, 𝑔, from




















Similarly, minimising the distance from the mean of the data points, 𝑥𝑗 , to a





























Since it is true for one point, without loss of generality, it is true for fitting
multiple 𝑦𝑗 to each 𝑥𝑗 .
B.3 Results
A least squares fitting gives the quantitity of dust (in 𝑚𝑔 per day) as
𝑑(𝑡) = 368exp(−326/𝑡1.64) + 10.8
with the graph displayed in Figure B.1.




















Figure B.1: Dust Shedding: The amount of dust shed over time by a broiler chicken





All the data being used in the analysis in Chapter 3 are from experiments using
maternal antibody positive birds. However, in a situation where the disease is
not endemic, maternal antibody positive birds would not be widespread in
the population. There is evidence that maternal antibodies have an important
role to play in protecting unvaccinated birds against MDV-induced mortality
(Calnek, 1972; Eidson et al., 1972). Maternal antibody negative chickens show
increased mortality effects. Using maternal antibody negative birds, infection
with a very virulent strain (for example Virulence Rank 85) can kill a group
of birds within 9 days of infection, compared to 45 days for those infected
with a less virulent strain (Virulence Rank 20) (A.F. Read, Personal Commu-
nication, January 2008.). The following extension to the results will take this
phenomenon into account by looking at the fitness of strains (𝑅0) in a mater-
nal antibody negative environment, assuming there is no effect of maternal
antibodies on the transmissibility of the parasite.
The increase in MDV-induced mortality due to the absence of maternal anti-
bodies is simulated by reducing the expected lifespan of an infected bird if
it is maternal antibody negative. This can be naturally achieved by reducing
the regression parameter which is responsible for taking into account the ef-
fects of Virulence Rank on the survival of the infected bird, 𝛽1. By choosing
𝛽1=-2.0, the expected lifespan of an maternal antibody negative bird infected
with a strain of Virulence Rank 20 or Virulence Rank 85 is 32 and 7 days re-
spectively. This is the correct order of magnitude for the data provided (A.F.
Read, Personal Communication, January 2008). Figure C.1 shows the expected
lifespan of an infected individual with reduced 𝛽1. Figure C.2 shows 𝑅0 when
𝛽1 is reduced. Changing the regression parameter 𝛽1, to reflect a greater effect
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of a virus on the lifespan of an individual, reduces the 𝑅0 of a strain. Also,
𝑅0 is optimized at an intermediate virulence when 𝛽1 is reduced. In this case,
decreasing the cohort duration may serve to select for higher virulence.








































Figure C.1: Lifespan: Background mortality, 𝜇=0.0005, equilbrium, 𝐴=7.15𝑚𝑔/𝑚3,
unvaccinated population. Lifespan for maternal antibody positive bird (blue dash),
increased susceptibility to death due to MDV (red solid) and simulated maternal
antibody negative (green solid).
























Figure C.2: 𝑅0: Simulating maternal antibody negative birds where 𝛽1 = −2.0.
Background mortality 𝜇=0.0005, equilbrium 𝐴=7.15𝑚𝑔/𝑚3, unvaccinated
population, population size, 𝑆0=40,000.
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These findings suggest that if mortality effects were originally higher than they
are for current birds, the trade-off between virulence and transmission would
indeed lead to a medium virulence being selected. Since there is no evidence
that maternal antibodies would act in a way much different to vaccine-derived
antibodies, maternal antibody negative birds, although showing a higher mor-
tality rate, might also have a higher viral shedding rate (as the vaccinated birds
do, compared with the unvaccinated). However if maternal antibodies do not
have enough of an effect on viral shedding rate to negate the effects of the re-
duced lifespan, then the shift from the farming of maternal antibody negative
birds (when MDV was not endemic in the bird population) to the farming of
mainly maternal antibody positive birds (when MDV became endemic in the
bird population) may have been the reason for the initial rise in the virulence
of MDV.
There are numerous theories consistent with the results shown in this section,
beginning with the assumption that in an almost disease-free state, a cohort
of birds will not possess maternal antibodies for MDV, leading to selection for
less virulent strains. Then,
1. If the industry introduced shorter cohort durations for broilers this
might lead to selection for more virulent strains. The response would
be the introduction of the vaccines to stem the wave of these more viru-
lent isolates and selection would favour more and more virulent strains.
2. Again, if changes were made to reduce the cohort duration (which led
to more virulent strains) these more virulent strains may be able to sur-
vive at higher prevalences in the environment (since they have a higher
fitness in this environment) and lead to an endemic state in which ma-
ternal antibody birds would become the majority. In this situation, more
virulent strains would therefore always be selected for.
3. Less virulent strains may be able survive at higher prevalences in the en-
vironment (since they have a higher fitness in this environment) and lead
to an endemic state where the emergence of maternal antibody positive
birds would lead to a selection for more virulent strains whatever the
environment.
These three suggestions use different factors as their evolution drivers. They
in turn use 1) cohort duration reduction then vaccine introduction, 2) cohort
161
duration reduction and the emergence of an endemic disease state in the bird
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